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Abstract 
Increasing global temperatures and limited fossil resources make it increasingly urgent to find 
alternative ways of producing fuels and chemicals. Metabolic engineering offers a promising 
solution to this problem by using microbes as cell factories for manufacturing a diverse set of 
products from renewable resources. However, cell factory development requires extensive 
knowledge of microbial biology as well as expensive and time-consuming strain engineering. Non-
rational methods allow the strain development process to be accelerated by taking advantage of 
evolutionary processes. 
This thesis addresses the integration of adaptive laboratory evolution into cell factory development 
workflows through computational methods. By studying a large set of Escherichia coli strains 
evolved to tolerate 11 different chemicals of industrial relevance, it was shown that there is 
significant cross-tolerance between compounds of the same chemical class, and that pre-evolving 
strains to tolerate a product can improve production rates when the evolved strain is engineered 
with a production pathway. Metabolic profiling of the evolved strains using direct-injection mass 
spectrometry showed that strains evolved in the same conditions had converged to similar 
metabolic phenotypes, suggesting that metabolism is involved in chemical tolerance. It was shown 
that the effects of individual mutations could be predicted, both by directly comparing the 
metabolic profiles of evolved strains to previously measured metabolic profiles of knockout strains, 
as well as using deep neural networks to predict metabolite level changes directly from genetic 
perturbations. 
Adaptive laboratory evolution can be used to optimize growth rates under various growth 
conditions, but through clever strain engineering it is possible to couple production to growth, 
thereby allowing optimization of production rate. This thesis also presents an algorithm based on 
genome-scale metabolic modelling that can predict genetic modifications that enable growth-
coupling in combination with addition of specific supplements to the growth medium. The algorithm 
could predict known growth-coupled strain designs that are shown to work in vivo as well as novel 
promising strain designs, for production of itaconic acid, propionic acid and for product methylation.  
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Resumé 
På grund af stigende globale temperaturer og begrænsede fossile ressourcer er det kritisk at finde 
alternative måder at producere kemikalier og brændstoffer. Dette problem kan løses ved at 
konstruere mikrobielle cellefabrikker der kan producere en bred vifte af produkter fra vedvarende 
ressourcer. Anvendelse af cellefabrikker kræver dog en vidtrækkende viden om mikrobiel biologi 
såvel som dyr og tidskrævende udvikling af mikrobielle stammer. Gennem brug af non-rationelle 
metoder kan stammeudviklingsprocessen accelereres ved at udnytte evolutionære processer. 
Denne afhandling omhandler integrering af adaptiv laboratorieevolution i udvikling af cellefabrikker 
gennem beregningsmetoder. Ved at studere et stort antal Escherichia coli stammer der er 
evolutionært udviklet til at tolerere 11 forskellige industrielt relevante kemikalier, blev det vist at 
der er betydelig kryds-tolerans mellem stoffer der har kemiske ligheder. Derudover blev det vist at 
brugen af laboratorieevolution til at forbedre en stammes produkttolerans også kan øge stammens 
evne til at producere stoffet, når der er blevet indsat en produktionspathway. Metabolisk profilering 
af de evolutionært udviklede stammer ved hjælp af direct-injection massespektrometri viste at 
stammer udviklet under de samme betingelser havde konvergeret til lignende metaboliske profiler, 
hvilket tyder på at metabolisme er involveret i kemisk tolerans. Det blev yderligere vist at 
individuelle mutationers effekter kunne forudsiges både ved at sammenligne de målte metaboliske 
profiler med tidligere målte metaboliske profiler for knockout-stammer, samt ved at anvende dybe 
neurale netværk til at forudsige ændringer i metabolitniveauer direkte fra genetiske ændringer. 
Adaptiv laboratorieevolution kan bruges til at optimere vækstrate under forskellige betingelser, 
men gennem snedige stammedesigns er det muligt at koble produktion til vækst, hvorved 
produktionsraten kan optimeres. Denne afhandling præsenterer også en algoritme baseret på 
metaboliske modeller i genoskala, som kan forudsige genetiske ændringer der kan forårsage 
vækstkobling i kombination med at specifikke supplementer tilføjes til vækstmediet. Algoritmen 
kunne forudsige kendte vækstkoblede stammedesigns som tidligere er valideret in vivo, og kunne 
også forudsige nye lovende designs til produktion at itakonsyre, propionsyre samt til produkt-
methylering.  
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Thesis outline 
A major challenge of modern society is the need to find sustainable methods for upholding our 
current way of living. This necessitates the development of renewable alternatives to oil-derived 
fuels and chemicals. Using microbial cell factories to produce useful and valuable chemicals from 
sustainable resources is a promising solution to this problem. However, developing successful cell 
factories by employing metabolic engineering is a slow and difficult process that is impeded by our 
limited understanding of microbial metabolism. 
This thesis addresses the use of so-called non-rational engineering – specifically adaptive laboratory 
evolution (ALE) – which leverages evolutionary processes to quickly optimize cell factories without 
requiring comprehensive knowledge about the functioning of the cell. The thesis, which will focus 
on computational methods that can be used in combination with ALE, is divided into two parts: Part 
I (Chapters 1-3) focuses on methods that can help understand the evolved strains resulting from 
ALE, while Part II (Chapters 4-5) focuses on the use of mathematical models to design selection 
conditions that can be used to optimize production characteristics. 
Chapter 1 contains a manuscript for a research article describing study where Escherichia coli was 
evolved to tolerate high concentrations of various potential products. Through genome sequencing 
and growth characterization we found that overall chemical tolerance obtained in the different 
evolution conditions varied widely, and that only very few mutations were universally observed 
across strains from a given condition. Furthermore, we found that evolving strains to tolerate a 
compound can also have beneficial effects on the strains’ ability to produce the compound. This 
work was done in collaboration with other researchers at the Center for Biosustainability, and 
mainly the data analysis parts, i.e. analysis of genome sequences and growth profiles, were done as 
part of this thesis. 
Chapter 2 describes a follow-up study to Chapter 1, where all the evolved tolerant strains were 
subjected to metabolomics analysis in order to study how the evolution of tolerance affects 
metabolism. It was found that strains evolved under the same condition tend to be very similar 
metabolically, such that all the tested conditions had a specific characteristic metabolic phenotype. 
This suggests that strains evolved on the same condition reach the same phenotype despite 
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considerable differences in genotype. Furthermore, the metabolic profiles of the evolved strains 
were combined with previously published metabolomics data and used to predict how each 
observed mutation impacts the function of the gene(s) it affects. Finally, a time-series perturbation 
analysis was used to investigate how different toxic environments affect metabolism.  
Chapter 3 describes a machine learning method for predicting how genetic perturbations affect 
metabolite levels. The method is based on a deep neural network and the main novelty is using 
biological networks through which signals in the input data are propagated. The motivation for 
developing such a method was to take advantage of prior knowledge encoded in networks for 
various prediction tasks using graph-structured input and output data. While the obtained 
predictive performance limits the practical use of the method, it represents a proof-of-concept of 
the technical feasibility of propagating input signals through a graph in a way that is inferred from 
the data. 
Chapter 4 contains a published book chapter about metabolic modeling and methods for integration 
of genome-scale experimental data. The chapter is a review of existing literature and serves as an 
introduction to the field of metabolic modeling. 
Chapter 5 contains a manuscript for a research article presenting OptCouple, a new modeling 
algorithm for identifying strain designs where production is coupled to growth, such that ALE can 
be used to optimize production. The main novelty of the algorithm is the possibility of 
simultaneously finding knockouts, gene insertions and additions to the growth medium, which in 
combination cause production to be growth-coupled. The algorithm is validated by showing that it 
can predict existing growth-coupled strain designs, that are shown to work in vivo, as well as new 
strain designs that are predicted to be growth-coupled in silico. 
Both Part I and Part II begin with a short overview that introduces key concepts and frames the 
chapters in a larger context. While Chapters 2 and 3 are not manuscripts in preparation, they are 
both structured as research articles and will be adapted and submitted for publication in scientific 
journals in the future.
 1 
Part I: Metabolic engineering and evolutionary methods 
The use of microbes in the production of various commodities is an old practice that has been 
around for many centuries across most known cultures. The two major examples of this – bread and 
beverages – are both based on the growth of yeast in a sugary substrate taking advantage of 
microbe’s natural production of carbon dioxide and ethanol. In more recent times the use of 
microorganisms to produce chemicals has become increasingly deliberate and directed. Early 
examples of microbial chemical production include using filamentous fungi to produce organic 
acids, e.g. citric acid (Max et al., 2010), and using the bacterium Clostridium acetobutylicum to 
produce acetone and butanol (Weizmann and Rosenfeld, 1937). Culturing microbes solely for the 
purpose of production, in contrast to as part of food production, allows employing various process 
optimizations to maximize production outcomes specifically. Through such process optimization 
techniques, the efficiency of industrial applications of microbial production has steadily increased. 
While manufacturers up until the late 20th century have had to rely on optimizations regarding the 
physicochemical parameters of the processes, the possibility of modifying the production strain 
allowed further improvements to be made. This was first done through a process of random 
mutagenesis and subsequent screening (Rowlands, 1984), while the later availability of genetic 
engineering techniques opened new venues to the targeted creation of mutant strains with 
modified characteristics, including production capabilities (Nielsen, 2001). An example of targeted 
engineering of a production strain is the insertion of genes from other organisms, introducing a new 
metabolic pathway in the production strain. This can be beneficial as many natural producers of a 
target compound may be hard to culture in a production process. Transferring the pathway to 
another organism can thus improve production. An example of this was the production of 
cephalosporin antibiotics, which are naturally produced by fungal Acremonium species, in the 
common laboratory organism Penicillium chrysogenum (Cantwell et al., 1992). Another type of 
modifications frequently made during strain engineering is the deletion of native genes to improve 
production, e.g. by reducing formation of byproducts. An example of this was a reduction in oxalic 
acid formation during expression of heterologous proteins in the fungus Aspergillus niger, by 
deleting a gene encoding an oxaloacetate hydrolase (Pedersen et al., 2000). 
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The practice of genetically modifying microbial organisms to obtain good production strains is 
known as metabolic engineering and has become increasingly widespread since the 1990’s (Bailey, 
1991; Nielsen, 2017). Even though examples of successful metabolic engineering abound, it is by no 
means an easy process, owing to the overwhelming complexity of microbial biology. Most efforts to 
engineer useful production strains follow an iterative process, commonly called the Design-Build-
Test-Learn cycle (Nielsen and Keasling, 2016), shown in Figure 1. In the design step, the metabolic 
engineer plans a set of genetic modifications, which are expected to improve production 
characteristics. These modifications are introduced into the organism in the build step, whereby a 
new strain is made. The resulting strain is subjected to testing to evaluate how production 
characteristics have been affected by the modifications. In the learn step, the results from the tests 
are evaluated in order to gain insight into the functioning of the production process, which leads to 
new hypotheses about the production organisms that can be used to generate new designs. This 
process is known as rational engineering, as each strain is designed based on the best current 
understanding of the process. 
 
Figure 1: The Design-Build-Test-Learn cycle. 
Each of the steps in the cycle requires a significant amount of work, but in the last decade a disparity 
between the steps has emerged. New advances in genetic engineering technology has allowed 
Learn Test
BuildDesign
Design. In the design step, a 
set of modifications to the 
production strain is planned. 
This can be based on previous
results, computer simulations 
or a combination.
Build. The planned
mutant strains are created
in the laboratory, through
the use of the relevant 
genetic engineering tools.
Test. The constructed strains
are subjected to a number of 
tests in order to evaluate the 
effect of the introduced
mutations.
Learn. The results from the 
test step are analyzed to 
extract new insights about
the functioning of the 
production organism.
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genetic modifications to be performed faster than ever (Schmidt and Platt, 2017), and even the 
synthesis of completely novel DNA sequences can now be done routinely (Chao et al., 2015). 
Additionally, many assays in the testing step can be done with a very high throughput, due to the 
increasing availability of laboratory automation systems (Nielsen and Keasling, 2016). This leaves a 
significant bottleneck in the design and learn steps. In other words, the main challenges in metabolic 
engineering are currently more concerned with deciding what do to than with actually doing it. 
Several approaches to evening out this disparity have been developed. One approach is to simply 
take advantage of the increased testing throughput to collect more extensive systems data on the 
production strains. This allows more comprehensive characterization of the developed strains, such 
that subsequent strain design can focus on addressing the specific problems that are identified (Lee 
and Kim, 2015). An example is to use transcriptomics analyses to identify problematic regulatory 
effects of overproducing the target compound, e.g. causing inhibition in the production pathway or 
precursor supply (Shimizu, 2011). Overproducing a target compound can also lead to broad 
physiological problems in the cell such as cofactor imbalances or energy deficits, which can also be 
identified through detailed strain analysis and subsequently addressed by targeted modifications 
(Liu et al., 2018). 
Another approach for overcoming the bottleneck in the learn and design steps is to also take 
advantage of the high throughput in the build step, to create and screen a large number of strains 
thereby increasing the chance that one of them has improved production properties. The 
effectiveness of this depends on the throughput of the screening assay being used. This approach 
represents a deviation from the Design-Build-Test-Learn cycle towards what could be called non-
rational engineering, where decisions are not made based on a theoretical understanding, but on 
the achieved screening results alone (Shepelin et al., 2018). Non-rational engineering is an 
alternative to the Design-Build-Test-Learn cycle and the process is illustrated in Figure 2A, where 
the design and build steps are replaced by generation of variation while the test and learn steps are 
replaced by selection. The higher the screening throughput, the more of a compromise can be 
accepted with regard to the rational design and learn steps, as even random generation of 
modifications can lead to better strains if enough candidates are screened. Very high throughputs 
can be achieved if the desired phenotype can be selected for under certain growth conditions. This 
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allows rapid identification of the best performing mutants among millions of variants. The non-
rational engineering process can either utilize artificially created genetic variation in specific regions, 
e.g. through error-prone PCR, resulting in a method known as directed evolution (Vick and Schmidt-
Dannert, 2011), or, if the desired phenotype can be selected for, it can rely on the naturally occurring 
mutations in a continuously grown culture, giving rise to an iterative selection process known as 
adaptive laboratory evolution (ALE) (Portnoy et al., 2011). Directed evolution is useful if the 
metabolic engineer has a good idea of which genes or DNA regions should be mutated to improve 
the desired strain characteristic, as a large and diverse library of variants can be generated quickly. 
It has for example been used to modify heterologous pathway enzymes taken from thermophilic 
organisms to function better in Escherichia coli (Atsumi and Liao, 2008; Wang et al., 2000). ALE takes 
advantage of natural selection by continuously passaging a culture to fresh media, whereby mutants 
with increased growth rates will outcompete the other cells and become enriched in the culture 
(Winkler et al., 2013). The ALE process can be used to optimize microbial strains on a systems level, 
without any prior hypotheses about which genes should be targeted to increase growth and is very 
similar to natural evolution. After application of ALE, the final culture, or isolates from it, is subjected 
to sequencing to learn which mutations have arisen and might be responsible for the improved 
growth rate (Figure 2B). 
 
Figure 2: A) Illustration of how ALE can replace manual iterations through the Design-Build-Test-Learn cycle. B) The 
process of ALE through serial passaging of cultures. After a desired increase in fitness has been observed, isolates from 
the ALE experiment may be sequenced to investigate which mutations are responsible for the improvements. 
A B
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Some traits of production strain performance are inherently related to growth and can thus be easily 
optimized with ALE. An example of this is substrate utilization. Growing cells on a sub-optimal 
substrate allows them to gradually adapt to the new condition, as there is a constant selection 
pressure for the cells that grow fastest on the new substrate (Apel et al., 2016). Evolution for 
substrate utilization can be a very useful part of strain engineering, as economic considerations can 
constrain the use of usual laboratory substrates in the production process (Hansen et al., 2017). 
Another growth-related trait that is easy to evolve is tolerance to toxic environments (Mohamed et 
al., 2017). This can also be easily achieved by growing cells in the toxic environment, whereby the 
most tolerant mutant strains will continuously be selected. In strain engineering this can be useful 
for overcoming product toxicity, which is the phenomenon where the production strain is inhibited 
by the compound it is producing. Product toxicity limits the attainable titers in the production 
process and thus the economic feasibility (Hansen et al., 2017). Additionally, during production 
processes the production strains are often grown under stressful conditions, e.g. due to suboptimal 
aeration and mixing and the use of complex feedstocks that may contain inhibitors or toxic residue 
from pretreatment. Chapter 1 describes these issues in more detail as well as an application of ALE 
to study the evolution of tolerance and the effect this has on the production characteristics of the 
strains. 
Arguably the most important characteristic of a production strain, at least for high-value products, 
is the production rate of the compound of interest. The production rate is not inherently related to 
growth, rather there is in general a tradeoff between biomass production and product formation. 
This tradeoff is a consequence of mass balance as both are sinks for limited cellular resources, the 
most important of which being carbon. Some compounds, however, are obligate by-products of 
growth, which means that the cell cannot grow without producing them. Such compounds are said 
to be growth-coupled and include for example ethanol and lactate under anaerobic growth of 
Saccharomyces cerevisiae and E. coli respectively (Clark, 1989; Deken, 1966). In addition to 
compounds that are naturally growth-coupled it is possible, through clever strain engineering, to 
construct mutant strains where the compound of interest is coupled to growth (von Kamp and 
Klamt, 2017). If a compound is growth-coupled it is possible to use ALE to indirectly optimize the 
production rate through selection of faster growing strains. Making production of a target 
compound growth-coupled often requires introduction of genetic modifications that are not 
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intuitively obvious. It can therefore be beneficial to use model-based computational methods in the 
strain design process in order to engineer specific desired phenotypes, such as growth-coupling 
(Feist et al., 2010). Computational strain design and methods for constructing growth-coupled 
strains will be addressed in Part II of this thesis. 
After performing ALE and obtaining one or more mutant strains with improved characteristics, it is 
most often of interest to sequence the genome of the strains. The mutants might have accumulated 
random mutations that can have a detrimental effect on overall strain performance and must be 
reverted before the strain is used for production. Alternatively, a core set of mutations responsible 
for improved growth, can be identified and reintroduced into the background strain (Shepelin et al., 
2018). Additionally, sequencing the mutants can allow investigation of the mechanisms through 
which growth was improved (Sandberg et al., 2014). This can be useful for gaining an understanding 
of the strain’s characteristics and might allow for more direct rational strain engineering in the 
future. Unfortunately, it is rarely obvious why the mutations that arise in the evolved strains confer 
improvements in the phenotype. This challenge raises the need for a variety of experimental and 
computational methods for interpreting the sequencing results of strains evolved using ALE 
(Shepelin et al., 2018). Furthermore, the evolved strains can be probed in other ways to explore 
how their physiology has been altered through the ALE process. This can include growth 
characterization in various conditions or systems analyses such as transcriptomics or metabolomics. 
In combination with the genomic information gained from sequencing this can give a deeper 
understanding of the process through which the evolved strain improved. An example of how 
metabolomics can be used to elucidate details about evolved strains and the evolution process is 
described in Chapter 2, using the strains constructed in the study described in Chapter 1. Chapter 3 
describes a novel machine learning method for relating genetic mutations to changes in metabolism 
in a systematic way. Such a method can potentially help understand the effects of mutations 
observed in ALE experiments, as well as integrate other systems-level data obtained from evolved 
strains. 
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Abstract 
Tolerance toward high concentrations of product is a major barrier to achieving economically viable 
processes for biobased chemical production. Product tolerance cannot currently be rationally 
engineered due to lack of knowledge of the cellular mechanisms of chemical toxicity and tolerance. 
We used an automated platform to evolve parallel populations of Escherichia coli to tolerate 
previously toxic concentrations of 11 chemicals that have applications as polymer precursors, 
chemical intermediates, or biofuels. Re-sequencing of isolates from 88 independently evolved 
populations, reconstruction of mutations, transcriptomic and proteomic analyses, and cross-
compound tolerance profiling was employed to uncover general and specific tolerance mechanisms. 
We found that the broad tolerance of strains to chemicals varied significantly depending on the 
condition under which the strain was evolved in and that strains that acquired high levels of 
osmotolerance were also tolerant to most chemicals. Specific genetic tolerance mechanisms 
included alterations in regulatory, cell wall, and broad transcriptional and translational functions, as 
well as more chemical-specific mechanisms related to transport and metabolism. Finally, we show 
that pre-tolerizing the host strain can significantly enhance endogenous production of chemicals 
and is especially valuable when a large number of independently evolved isolates are screened. 
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1.1 Introduction 
Despite significant advances in synthetic and systems biology tools to engineer and study 
metabolism, developing microbial strains for commercial-level production of chemicals still remains 
a challenge (Van Dien, 2013). One of the major problems relates to the stressful conditions that 
production strains encounter in large-scale industrial production processes where numerous 
stresses that are not encountered in laboratory conditions are present (Deparis et al., 2017). Some 
of these stresses relate to the presence of high concentrations of a carbon source or toxic 
compounds related to feedstock processing such as ionic liquids (Mohamed et al., 2017). 
Irrespective of the production system or substrate, cells will encounter high intracellular and 
extracellular levels of the primary product that they have been engineered to produce. Frequently, 
high levels of such products can have inhibitory effects on the host organism, which effectively limits 
the titers that can be achieved and thereby the economic feasibility of the process. This issue can 
be overcome by engineering a production strain that is tolerant to higher titers of the product, 
however rational engineering of tolerance to either native or non-native chemical products is rarely 
possible due to a lack of knowledge about the molecular mechanisms of tolerance. This often 
necessitates choosing an otherwise difficult to engineer production host that already has desirable 
tolerance characteristics. Alternatively, one can use non-rational approaches to obtain strains with 
high chemical tolerance by mutagenesis, screening of transporter and other libraries, or adaptive 
laboratory evolution (ALE) (Hansen et al., 2017). ALE in particular has been successfully used to 
obtain strains that tolerate product chemicals (Winkler and Kao, 2014). In some cases the 
mechanisms of chemical tolerance have been at least partially deciphered through resequencing 
and other omics approaches applied to evolved strains (Haft et al., 2014; Kildegaard et al., 2014; 
Reyes et al., 2013), but in most cases the full toxicity and tolerance mechanisms remain to be 
determined. While ALE applied to product tolerance has resulted in strains that increase actual 
production of the target chemical (Mundhada et al., 2017), in many cases these strains have not 
shown improved production (Atsumi et al., 2010; Kildegaard et al., 2014). 
Here we take a broad approach to elucidating mechanisms of chemical tolerance across a wide 
spectrum of chemicals enabled by automated ALE as well as systematic genomic and phenotypic 
analyses of the resulting large collection of evolved strains. This approach allows us to determine 
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general features of chemical tolerance and build a large dataset as a reference for future tolerance 
studies. For two products we also investigate whether pre-evolving for tolerance can significantly 
improve production. A similar approach has been previously take to study adaptation to diverse 
stresses including some non-native chemical stresses in E. coli (Horinouchi et al., 2017), but in the 
present study we use significantly higher concentrations of chemicals to mimic industrially relevant 
conditions and evolve and characterize a significantly larger number of strains per condition. 
1.2 Materials and Methods 
1.2.1 Strains and media 
E. coli K-12 MG1655 (ATCC 47076) strain was used as a starting point strain for the adaptive 
laboratory evolution experiments and as reference strain for all subsequent characterization. 
Chemicals were purchased from either Sigma-Aldrich (Merck KGaA, Darmstadt, Germany) or Fisher 
Scientific (Part of Thermo-Fisher Scientific). Plasmids for isobutyric acid and 2,3-butanediol 
production were obtained from the authors (Xu et al., 2014; Zhang et al., 2011). 
M9 glucose medium supplemented with 10 g/L glucose was formulated with 1x M9 salts, 2 mM 
MgSO4, 100 µM CaCl2 and 1x trace elements. A stock solution of 10x M9 salts consisted of 68 g/L 
Na2HPO4 anhydrous, 30 g/L KH2PO4, 5 g/L NaCl, and 10 g/L NH4Cl dissolved in Milli-Q filtered water 
and autoclaved. M9 trace elements stock concentration was a 2000x solution containing of 3.0 g/L 
FeSO4·7H2O, 4.5 g/L ZnSO4·7H2O, 0.3 g/L CoCl2·6H2O, 0.4 g/L Na2MoO4·2H2O, 4.5 g/L CaCl2·H2O, 0.2 
g/L CuSO4·2H2O, 1.0 g/L H3BO3, 15 g/L disodium ethylene-diamine-tetra-acetate, 0.1 g/L KI, 0.7 g/L 
MnCl2·4H2O in Milli-Q filtered water and sterile filtered. 
1.2.2 Selection of initial chemical concentrations 
The toxicity of each of the chemicals was tested by screening growth of MG1655 in different 
concentrations. Biological triplicates of E. coli MG1655 were cultivated at 37 °C with 300 RPM 
shaking. After 14 to 18 h, the cultures were inoculated into M9 + 0.2 % glucose and one of the 
chosen chemicals at different concentrations. The cultures were then incubated in a BioLector 
microbioreactor system (m2p-labs GmbH, Baesweiler, Germany) at 37 °C with 1,000-rpm shaking. 
The growth rates at different concentrations were calculated for each chemical (Supplementary 
 13 
Figure 1). Initial concentrations for adaptive laboratory evolution were chosen so that MG1655 
could obtain a growth rate of approximately 0.4 /h. 
The initial and final evolution concentrations, as well as the screening concentrations for all the 
chosen chemicals are shown in Table 1. 
Table 1: Concentrations of each chemical used during ALE and for growth screening. All concentrations are g/L. 
 
 
Initial ALE 
concentration 
 
Final ALE 
concentration 
Isolate 
screening 
concentration 
Cross-tolerance 
screening 
concentration 
1,2-propanediol 52 83 83 62 
2,3-butanediol 49 79 69 59 
Hexamethylenediamine 20 38 38 32 
Putrescine 20 38 38 32 
Glutarate 20 47.5 47.5 40 
Adipate 25 50 50 45 
Hexanoate 2 7.5 5 3 
Octanoate 3.5 10 8 8 
Isobutyrate 3 12.5 12.5 7.5 
Coumarate 4 20 10 7.5 
Butanol 5.7 16.2 11.34 11.34 
 
1.2.3 Adaptive laboratory evolution 
The starting strain K-12 MG1655 was adaptively evolved for higher concentrations of each chemical 
through independent parallel replicates. Bacterial cells were cultivated in M9 + glucose 
supplemented with the initial chemical concentration listed in Table 1, with gradual increase in each 
chemical concentration over the time span of the adaptation. Cells were serially passaged during 
exponential growth for approximately 40 days using an automated liquid-handler platform as 
described by LaCroix et al. (2017). Cells were cultured at 37 °C with full aeration at 1200 RPM stirring 
speed. Once OD600 reached approximately 1.0, 150 µL was passed into a new tube with 15 mL fresh 
media containing the respective chemical concentration. Over the course of the experiment, cells 
were kept in exponential growth phase in order to keep a constant selection pressure for growth 
rate. The OD600 was measured by a Sunrise Plate Reader (Tecan Inc., Switzerland). Growth rates 
were determined by computing the slope of log(OD) using linear regression with the Polyfit function 
in MATLAB (The Mathworks Inc., Natick, Massachusetts). When an increase in the apparent growth 
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rate was achieved (average growth rate for all of the parallel replicates) at a particular 
concentration, the chemical concentration was increased by 10-15%. This process was repeated in 
cycles until a significant increase in tolerated concentration was achieved. In incidents where the 
increase in the chemical concentration caused cells to crash, i.e. cell death, chemical concentration 
was reduced to a level that allowed cell growth. Periodically, samples were frozen in 25% v/v 
glycerol and stored at -80 °C for further use. 
1.2.4 Growth screening of ALE isolates 
1.2.4.1 Primary tolerance screening 
Populations from evolution endpoints were plated on LB agar plates and 10 individual colonies from 
each population were screen for growth at the maximum concentration for which robust growth 
rates were achieved during the evolution. Cultures of wild-type strain, E. coli K-12 MG1655, were 
used as controls. The isolates were inoculated in 500 µL M9 + glucose in deep-well plates and 
incubated in plate shaker at 37 °C and 300 RPM. The next day, cells were diluted 10X in M9 + glucose 
and 30 µL was transferred to clear-bottom 96 half-deep plates containing M9 + glucose 
supplemented with the corresponding toxic chemical at concentrations as in Table 1 (isolate 
screening concentration). The plates were incubated at 37 °C with 225 RPM shaking in a Growth 
Profiler screening platform (EnzyScreen BV, Heemstede, Netherlands). The resulting growth curves 
for all isolates were inspected qualitatively for isolates exhibiting robust growth as assessed by lag 
time, final OD and growth rate. Each of the 10 isolates from the primary screening was grouped 
according to close similarities based on the above criteria. For each population, isolates 
representative of each group were picked (2-3 isolates per population). 
1.2.4.1 Cross-tolerance screening 
The E. coli strains were inoculated into 300 µl of M9 + glucose medium in 96 deep well plates (in 
biological triplicates) and the cultures were incubated at 37°C and 300 RPM for overnight. Next day, 
30 µl of a 10-fold was added to 270 µl of M9 + glucose supplemented with chemicals in 96 well plate 
and the plates incubated in growth profiler (EnzyScreen BV, Heemstede, The Netherlands) at 37 °C 
and 225 RPM. The chemical concentrations are shown in Table 1 (Cross-tolerance screening 
concentration). 
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1.2.5 Genome editing of E.coli 
Strains containing the relevant single gene deletions were obtained from the Keio Collection and 
were transduced into the MG1655 background strain using the protocol described in (Lennen et al., 
2011). Multiple gene deletions were constructed using the protocol described in (Lennen et al., 
2011). Site directed changes in the E. coli genome of evolved strains were done using the protocol 
described in (Lennen et al., 2015). 
1.2.6 Quantification of 2,3-butanediol production 
The hsdR gene was deleted from each of the strains evolved on 2,3-butanediol. The strains were 
then transformed with pET-RABC plasmid (Xu et al., 2014) and precultured in 300 µl of M9 + glucose 
supplemented with 5 g/L yeast extract and kanamycin (50 µg/mL) in 96 deep well plate and 
incubated at 37 °C with 300 RPM overnight (incubated for 20 h) in quadruplicates. E. coli MG1655 
ΔhsdR/pET-RABC was used as a control. The following day, 20 µL of pre-inoculum was transferred 
into 2 mL of ALE-M9-YE-Km media in 24 deep well plates and incubated at 30 °C and 300 RPM. At 
24 h and 48 h, optical densities of the culture broths were determined at 600 nm (OD600nm). Then, 
400 µL of the cultures were harvested, centrifuged at 4000 RPM for 10 min and 30 µL of the collected 
supernatants were injected into high performance liquid chromatography (HPLC). Subsequently, the 
samples were subjected to electrospray ionization mass analysis. 
The amounts of 2,3-butanediol in the supernatants were quantified by HPLC (Ultimate 3000, 
Thermo Scientific, USA) equipped with an organic acid analysis column, Aminex® HPX-87H ion 
exclusion column (300 mm x 7.8 mm, Bio-Rad Laboratories, Denmark) connected to a refractive 
Index (RI) detector and a UV detector (205 nm, 210 nm, 254 nm and 280 nm).  An isocratic elution 
with flow rate of 0.5 mL/min of 5 mM sulphuric acid was used for 30 min. Under these conditions, 
stereoisomers of 2,3-butanediol were detected under the RI detector channel at the retention times 
of 17.4 min and 18.3 min. Using the peak areas of the stereoisomers, total amount of 2,3-butanediol 
was calculated. For absolute quantification a calibration curve was drawn using 1, 5, 10, 12.5, 15 
and 25 g/L concentrations (y = 6.5119x + 0.5464, R² = 0.9999). 
The exact mass of the compounds was analyzed by using Oribtrap Fusion (Thermo Scientific, USA) 
with a Dionex 3000 RX HPLC system (Thermo Scientific, USA) in the positive and negative ion mode. 
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1.2.7 Quantification of isobutyrate production 
The yqhD gene was deleted from each of the strains evolved on isobutyrate. The strains were then 
transformed with pIBA1 and pIBA7 plasmids (Zhang et al., 2011) and precultured into 300 µl of LB 
media supplemented with kanamycin (50 µg/mL) and ampicillin (100 µg/mL) in 96 deep well plate 
and incubated at 37 ºC with 300 RPM overnight (incubated for 18 h) (in quadruplicates). E. coli 
MG1655 ΔyqhD/pIBA1/pIBA7 was used as a control. The following day, 24 µL of pre-inoculum was 
transferred into 2.4 mL of half-FIT media (1:1 FIT media: MOPS of 200 mM) media supplemented 
with antibiotics. Then the culture plates were incubated at 30 °C and 300 RPM.  After 6 hours of 
incubation, OD600 was measured and the cultures were induced with 100 µM of IPTG and continued 
the incubation at 30 °C and 300 RPM. At 24 h, 48 and 72 h, OD600 was measured again.  Then, 300 
µl of the cultures were harvested, centrifuged at 4000 RPM for 10 min and 30 µL of the collected 
supernatants were injected into HPLC. Subsequently, the samples were subjected to electrospray 
ionization mass analysis. 
The amounts of isobutyrate in the supernatants were quantified by HPLC (Ultimate 3000, Thermo 
Scientific, USA) equipped with an organic acid analysis column, Aminex® HPX-87H ion exclusion 
column (300 mm x 7.8 mm, Bio-Rad Laboratories, Denmark) connected to a refractive Index (RI) 
detector and a UV detector (205 nm, 210 nm, 254 nm and 280 nm).  An isocratic elution with flow 
rate of 0.5 mL min-1 of 5 mM sulphuric acid was used for 30 min. Under these conditions, isobutyrate 
was detected under the 210 nm UV channel at a retention time of 20.3 min. Using the peak area, 
total amount of isobutyrate was calculated. For absolute quantification a calibration curve was 
drawn using 0.5, 1, 2.5, 4, 5, 7.5 10, and 12.5 g/L concentrations (y = 35.487x - 2.3142, R² = 0.9993). 
1.2.8 Resequencing 
Genomic libraries were generated using the TruSeq® Nano DNA LT Library Prep Kit   (Illumina Inc., 
San Diego CA). Briefly, 100 ng of genomic DNA diluted in 52.5 µL TE buffer was fragmented in Covaris 
Crimp Cap microtubes on a Covaris E220 ultrasonicator (Woburn, MA) with 5% duty factor, 175 W 
peak incident power, 200 cycles/burst, and 50-s duration under frequency sweeping mode at 5.5 to 
6°C (Illumina recommendations for a 350-bp average fragment size). The ends of fragmented DNA 
were repaired by T4 DNA polymerase, Klenow DNA polymerase, and T4 polynucleotide kinase. The 
Klenow exo minus enzyme was then used to add an 'A' base to the 3' end of the DNA fragments. 
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The adapters were ligated to the ends of the DNA fragments, and the DNA fragments ranging from 
300 - 400 bp were recovered by beads purification. Finally, the adapter-modified DNA fragments 
were enriched by 3 cycle PCR. Final concentration of each library was measured by Qubit® 2.0 
Fluorimeter and Qubit DNA Broad range assay (Life Technologies). Average dsDNA library size was 
determined using the Agilent DNA 7500 kit on an Agilent 2100 Bioanalyzer. Libraries were 
normalized and pooled in 10 mM Tris-Cl, pH 8.0, plus 0.05% Tween 20 to the final concentration of 
10 nM. Denaturated in 0.2N NaOH, 10 pm pool of 20 libraries in 600 µL ice-cold HT1 buffer was 
loaded onto the flow cell provided in the MiSeq Reagent kit v2 (300 cycles) (Illumina Inc., San Diego 
CA) 300 cycles and sequenced on a MiSeq (Illumina Inc., San Diego CA) platform with a paired-end 
protocol and read lengths of 151 nt. 
1.2.9 Resequencing data analysis 
The Illumina sequencing reads were analyzed with the Breseq pipeline (Deatherage and Barrick, 
2014) through the ALEdb platform (Phaneuf et al., 2018) to generate lists of mutations for each 
evolved strain. The reference strain for this analysis was E. coli K-12 MG1655 with the Genbank 
accession number NC_000913.3. 
1.2.9.1 Mapping mutations to genes 
Each mutation was mapped to one or more genes. Intragenic mutations were mapped to any 
gene(s) whose coding sequence overlapped with the mutation. Intergenic mutations were mapped 
to the closest gene downstream from the mutation. 
1.2.10 Growth data analysis 
The growth curves generated by the instruments were processed using the croissance python 
package (http://github.com/biosustain/croissance), which performs automated growth phase 
identification and growth parameter fitting. Biomass concentration was quantified by OD600 values. 
For each extracted growth rate, a normalized growth rate was calculated by subtracting the mean 
growth rate of the wild-type strain, MG1655, on the same plate and in the same medium. This was 
done to remove the effects of any between-plate and between-experiment growth variations. 
The croissance algorithm consists of two separate steps: 
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Step 1: The growth curve is smoothed and analyzed to find regions of exponential growth. This is 
done by identifying time intervals where the first- and second-order time derivatives of the 
smoothed biomass function are strictly positive. 
Step 2: Each growth phase identified in step 1 is fitted with an exponential function of the form 
!(#) = & ∙ ()∙* + , (1) 
where μ (growth rate) is of particular interest in this study. The offset parameter b is included to 
enable analysis of growth curves that are not background-subtracted. 
Post-processing was done to filter the returned growth rates. This served both to exclude growth 
rates from growth phases that were not thought to be real, and to select between several growth 
phases in the same growth curve. Growth rates higher than 1.5 h-1 were excluded, as were growth 
phases where the absolute value of the fitted offset parameter b was larger than a certain threshold, 
c (0.5 for growth profiler curves, 4 for Biolector curves). Growth phases where the initial biomass 
concentration deviated more than c from the fitted offset b were also excluded, as these were likely 
to be secondary growth phases. Furthermore, growth curves starting after a certain time point were 
also excluded. This was done to prevent growth from contaminations from being used. The chosen 
time cutoff was dependent on the growth conditions (30-40 hours). Very short growth phases were 
also excluded as they were most likely artifacts. For standard M9 glucose cultures growth phases 
shorter than 2 hours were excluded, while the cutoff was 5 hours for cultures in the stress 
conditions. 
1.3 Results 
We selected 11 chemical compounds representing a diversity of chemical categories with variable 
initial levels of toxicity to E. coli (Figure 1a). We chose the chemicals to 1) include compounds that 
have potential as a bio-based product, 2) have examples of multiple chemical compound classes 
(diols, diamines, diacids, fatty acids, aromatic compounds), 3) include in four cases two examples of 
the same compound class, and 4) to have compounds that had the right solubility and volatility 
profile to allow ALE and downstream characterization. We included two compounds (octanoate and 
n-butanol) that have previously been used in ALE studies in E. coli (Reyes et al., 2013; Royce et al., 
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2015). For the majority of the compounds there have been efforts to engineer improved production 
in E. coli. All but one of the compounds (putrescine) are compounds that do not occur naturally in 
E. coli metabolism. The initial concentrations of the compounds were chosen so that the wild type 
strain would grow at a growth rate of approximately 0.4 h-1. 
We used an automated serial passaging platform to independently evolve a total of 88 populations 
of E. coli MG1655 in M9 glucose base media to tolerate previously toxic levels of the 11 target 
chemicals. For each chemical, 8 independent populations were evolved. The growth medium was 
kept at neutral pH to ensure an evolutionary pressure for tolerating the specific chemical 
compounds rather than tolerance towards low or high pH. During the laboratory evolution process, 
we increased the chemical concentrations from the initial concentration in a stepwise manner over 
approximately 800 generations. The starting and end concentrations that allowed population 
growth are listed in Table 1 and shown in Figure 1b. From each endpoint population, we isolated 10 
strains that were subjected to growth screening, to test their ability to tolerate the chemical they 
had been evolved in the presence of. Among these isolates, 2-3 isolates per population were 
selected for further characterization, representing as diverse growth characteristics as possible. This 
resulted in a total of 224 strains that showed robust tolerance to the chemical that they were 
evolved in the presence of. All 224 strains were subjected to whole genome resequencing and cross-
compound tolerance screening. A subset of the mutations were reconstructed in clean background 
strains to confirm their causative role in tolerance. Finally, in the cases of isobutyrate and 2,3-
butanediol we engineered production pathways into all genetically distinct isolates in order to 
determine if evolved product-tolerant strains actually show increased production when the product 
is made endogenously. The overall workflow of the study is shown in Figure 1c. 
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Figure 1: a) Chemicals selected for the study grouped by chemical category. b) Initial and final concentrations of the 
chemicals used during ALE. c) Overall workflow of the study. 
Resequencing of the evolved isolates showed that the median number of sequence variants per 
strain was 6, although a subset of the strains had more than 10 times this number. This drastic 
difference was determined to be caused by a hypermutator phenotype, as all the strains in question 
had mut* mutations (e.g. mutS). Since these hypermutator strains were assumed to have 
accumulated mostly random neutral variants, they were not included in further analysis of sequence 
variants in the evolved strains. The 1,2-propanediol condition was also dropped from the sequence 
variant analyses as only three isolates from a single population were not hypermutators. The 
median number of variants per strain among the remaining 189 strains was 5 and the numbers of 
variants for strains evolved in different conditions were quite similar (Figure 2a). A subset of strains 
contained large duplications - these were especially common in strains evolved on isobutyrate and 
coumarate (Figure 2a). A full list of the mutations in each strain can be found in Supplementary 
Table 1. 
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To investigate which cellular functions were affected by the mutations, the functional domains of 
all the mutated genes were analyzed (Figure 2b). More than half of the variants affect genes with 
regulatory or transport functions, indicating that these gene classes play a significant role in the 
evolution of tolerance. 
Even in the non-mutator strains, it is likely that a subset of the observed mutations have arisen by 
random chance and are thus not associated with tolerance. However, the availability of isolates 
from independent parallel ALE populations allows some degree of distinction between random and 
adaptive mutations. Specifically, if a mutation is observed in isolates from several independent 
populations, it is quite unlikely that it is a product of chance. In four conditions we identified genes 
that were mutated in all isolates from that condition: all glutarate and adipate strains had kgtP 
mutations while all isobutyrate strains had pykF mutations and all 2,3-butanediol strains had relA 
mutations. Aside from these, mutations in a number of other genes were observed in at least one 
strain from each population or in almost all populations as shown in Table 2. We observed limited 
overlap between the different evolution conditions in terms of the of the genes that were mutated 
- this set of genes included primarily global regulators (e.g. rpoB, rpoC and rpoA) and a handful of 
other genes that are commonly found to be mutated in E. coli ALE studies (Wang et al. 2018). In 
cases where the same gene was mutated in different evolution conditions, e.g. the RNA polymerase 
genes, the specific mutations were usually distinct indicating that the effects of the mutations may 
also be different (Supplementary Figure 2). 
Table 2: The five most commonly mutated genes for each condition. The numbers in parentheses denote the number of 
ALE populations in which mutations in the given gene were observed in at least one strain. 
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Figure 2: a) Boxplots showing the distributions of mutations per strain and duplication size per strain for each condition. 
The numbers above the boxes show the values of outliers not shown in the plots. b) Genetic variant landscape. The chart 
shows an overview of the genes mutated in the different conditions and the functional classifications of these genes. The 
width of the lines is proportional to the number of strains in which a given gene was mutated. 
In order to determine whether the strains had tolerance to a broad range of chemicals, we 
measured growth rates of all 224 isolates in the presence of moderately toxic levels of each of the 
11 chemicals. In addition, we measured growth rates of all the strains on M9 glucose to determine 
general growth improvements and on M9 glucose + 0.6 M NaCl to determine osmotic stress 
resistance of the strains. We found that strains evolved on diamines, diols and diacids were in 
general resistant to the other chemical of the same functional class (Figure 3a). In contrast, strains 
evolved on either of the medium chain-length fatty acids were not tolerant to the other medium 
chain-length fatty acid. We also tested whether strains that were tolerant to four specific 
compounds (HMDA, 2,3-butanediol, adipate and isobutyrate) were also tolerant to other similar 
compounds (diamines, diols, diacids or carboxylic acids, respectively; Figure 3b). We found that in 
most cases strains tolerant to one compound also have significantly higher growth rates on similar 
compounds compared to the ancestral strain. 
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Figure 3: Chemical cross-tolerance between similar and dissimilar compounds. a) Cross-tolerance between the 
compounds used for ALE. Circle color and size represent the mean growth rate of the group of strains relative to the 
unevolved reference strain. The grey boxes indicate pairs of compounds that are structurally similar. The growth rates 
on 0.6 M NaCl and M9 are also shown. b) Tolerance to compounds structurally related to four of the compounds used 
for ALE. Blue points represent growth rates of evolved strains, while the orange points show the growth rates of the 
reference strain. c) Distribution of global tolerance values for strains evolved on each of the 11 compounds d) Global 
tolerance as a function of osmotolerance (growth rate on NaCl) and improvement in baseline growth (growth on M9 
glucose). 
We sought to understand some of the general mechanisms that make an E. coli strain tolerant to a 
broad range of chemicals. We used the average growth rate of an ALE strain relative to the wild type 
strain across all 11 chemicals as a metric of global chemical tolerance of a strain. The global chemical 
tolerance of strains depended significantly on what chemical the specific strain had been evolved 
to tolerate (F-test, F = 10.06, p < 10-13; Figure 3c). Strains evolved on HMDA had typically high 
chemical tolerance whereas strains evolved on coumarate and hexanoate were significantly less 
tolerant to most other chemicals than the wild-type strain. We found that osmotic stress tolerance 
(as measured by the growth rate of the strain in 0.6 M NaCl) was predictive of global chemical 
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tolerance (Pearson’s r = 0.52, p < 10-20) (Figure 3d) whereas growth rate of the ALE strain in M9 
glucose minimal media was not (Pearson’s r = 0.06, p = 0.31) (Figure 3d). Interestingly, the 
osmolarity of the medium at the end of the ALE experiments did not seem to be associated with 
either osmotolerance or global tolerance of the strain (Supplementary Figure 3). 
The mechanisms by which strains acquired tolerance to each chemical were usually quite complex 
and hard to decipher from the resequencing data alone. However, in the cases where transporter 
mutations were found in many strains it was possible to formulate a clear mechanistic hypothesis 
and test it experimentally. All strains evolved to tolerate adipate and glutarate contained mutations 
in the kgtP gene, which encodes an active alpha-ketoglutarate importer (Seol and Shatkin, 1991). 
Approximately half of these mutations were clearly deleterious for the transport function, i.e. 
deletions or insertions causing frameshifts or SNPs causing premature stop codons. We tested the 
ability of a kgtP deletion strain to grow in the presence of high levels of glutarate or adipate and 
found that especially on glutarate a kgtP deletion strain grew significantly faster than the wild type 
strain (Figure 4a and b).  Some of the diacid-evolved strains also contained apparent loss-of-function 
mutations in two other transporters, proV (ATP-binding subunit of the glycine-betaine transporter 
ProVWX) and ybjL (putative uncharacterized transporter). Deleting these transporters in addition to 
kgtP deletion increased the growth rate further on glutarate and adipate (Figure 4a and 4b) with 
the triple deletion strain reaching approximately the same growth rate on glutarate as the best 
evolved strains. Furthermore, the strains where kgtP was either deleted or otherwise inactive were 
not able to grow with glutarate as a carbon source whereas the wild type and proV and yjbL single 
deletion strains were able to grow in this condition (data not shown). 
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Figure 4: Transport modulation as a tolerance mechanism for diacids. a) Growth curves of reference strain MG1655, four 
genetically distinct glutarate-evolved strains as well as single, double and triple transporter deletion strains on 47.5 g/L 
glutarate (in M9 Glucose media). b) Growth curves of reference strain MG1655, four genetically distinct adipate-evolved 
strains as well as single, double and triple transporter deletion strains on 50 g/L adipate (in M9 Glucose media). 
We wanted to determine whether pre-evolving strains to tolerate a non-native chemical product 
would result in enhanced production when the relevant pathways are engineered into a tolerant 
host strain. We chose the two relatively simple pyruvate-derived compounds isobutyrate and 2,3-
butanediol as examples for this study because production of these compounds had previously been 
demonstrated in E. coli (Xu et al., 2014; Zhang et al., 2011) and engineering the production 
background into a large number of background strains was feasible. In the case of isobutyrate we 
also have some understanding of tolerance mechanisms from resequencing and mutation 
reconstructions. As previously mentioned, all isobutyrate-evolved strains had deletions of the pykF 
isozyme of pyruvate kinase, and this deletion alone was demonstrated to significantly improve 
isobutyrate tolerance (Figure 5a). In addition to pykF deletions some of the strains also had point-
mutations in acetolactate synthase regulatory subunits ilvH/N that are involved in feedback 
inhibition by valine. These mutations alone or in combination with pykF deletions did not confer 
improved isobutyrate tolerance (Figure 5b), but significantly improved strain growth in the presence 
of exogenous valine (Figure 5c), suggesting that they disable or reduce valine feedback inhibition. 
We hypothesize that the mechanism of isobutyrate toxicity is inhibition of 2-isopropylmalate 
synthase (encoded by the gene leuA) due to the similarity between isobutyrate and the native 
substrate alpha-ketoisovalerate (KIV) (Figure 5d). This inhibition would lead to overproduction of 
valine and feedback inhibition of the biosynthesis of all branched-chain amino acids. 
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Figure 5: Isobutyrate tolerance modulated by variants in metabolic genes. a) pykF deletion strain growth compared to 
growth of evolved and wild type strains in the presence of toxic concentrations of isobutyrate (12.5 g/L). b) Growth 
comparison of the reference strain, the IBUA8-3 isolate, and the same isolate where the ilvH point-mutation was reverted 
to wild type in the presence of toxic concentrations of isobutyrate. c) Comparison of growth curves of the same strains 
shown in panel b in the presence of 1 g/L valine. d) Schematic description of the proposed mechanism of toxicity and role 
of the major genetic changes identified in IBUA8-3 strain. 
We engineered the native production of isobutyrate into wild type MG1655 and 12 genetically 
distinct isobutyrate-tolerant strains by expressing three heterologous genes from plasmids and 
deleting a competing pathway in each strain (Figure 6a). The engineered ALE strains had highly 
variable levels of production of isobutyrate compared to the engineered reference strain (Figure 
6b). In particular some strains produced almost no isobutyrate and also grew very poorly. On the 
other hand, there were ALE strains that produced more than three times more isobutyrate than the 
engineered wild-type with a particularly large difference in production during the first 24 hours. The 
strains that produced and grew best (IBUA8-3 and IBUA8-10) both had ilvH/N mutations whereas 
the other strains lacked these mutations, indicating that the removal of acetolactate synthase 
feedback inhibition was beneficial to production. 
We also engineered production of 2,3-butanediol into MG1655 and 20 tolerant ALE strains by 
expressing three heterologous genes in the strains (Figure 6c). Deletion of the native gene hsdR 
encoding a restriction enzyme was necessary to perform the transformation. Again, there was 
significant variation in 2,3-butanediol among the engineered ALE strains, but in this case the 
majority of strains had production levels similar to the engineered wild type strain with only two 
specific ALE strains showing improved production of 2,3-butanediol compared to engineered wild 
type strain (Figure 6d). We could not identify a mechanistic basis for the improved production even 
if we could quite clearly pinpoint which mutations were responsible for the improved production 
due to differences between isolates obtained from the same ALE populations (Supplementary Table 
1). 
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Figure 6: Production of isobutyric acid and 2,3-butanediol using pre-tolerized strains. a) Production pathway schematic 
for isobutyrate, with heterologous expression of an acetolactate synthase AlsS, ketoisovalerate decarboxylase KIVD, and 
PadA to generate isobutyric acid from ketoisovalerate (KIV), with deletion of native yqhD to prevent reduction of 
isobutyraldehyde (IBAL) to isobutanol (IBOH). b) Production of isobutyrate in wild-type and evolved isolates harboring 
production plasmids for isobutyrate and deletion of yqhD after 24 and 48 hours growth in FIT (feed-in-time) medium. c) 
Production pathway schematic for 2,3-butanediol from pyruvate, with heterologous expression of BudA, BudB, and 
BudC. d) Production of 2,3-butanediol in wild-type and evolved isolates harboring a production plasmid for 2,3-
butanediol and deletion of hsdR after 48 hours in M9 + 5% glucose + 0.5% yeast extract. 
1.4 Discussion 
Consistent with previous findings described in the literature, our results show that ALE can be used 
to significantly increase the tolerance of microbial cells to an exogenously supplied chemical of 
interest. The relative increases in tolerance were largest for the chemicals that initially were most 
toxic to E. coli (primarily acids) whereas tolerance to compounds that were initially tolerated at high 
levels, such as diols, was increased more modestly. Since we neutralize the acids, the reasons for 
limited ability of E. coli to tolerate acids is not related to low pH. It is likely that further increases in 
tolerance would be achievable for most compounds by continuing the evolution experiments at 
ever increasing chemical concentrations, however, physico-chemical properties such as volatility 
and solubility become issues for many of the compounds at higher concentrations, thus limiting the 
ability to further evolve tolerant strains. In comparison to previous ALE studies, the systematic 
approach used here allows direct comparisons of the evolvability of E. coli to different conditions. 
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Resequencing of 224 tolerant strains obtained from 88 independently evolved populations revealed 
that most strains had a relatively modest number of mutations and that large genome 
rearrangements were also rare. In principle, this makes it possible to develop a good understanding 
of which genes are important for tolerance to a given compound. However, the overall genomic 
variant landscape across all strains is quite complex with most genes targeted by mutations only in 
specific evolution conditions. These results indicate that there is high diversity in mechanisms of 
toxicity and tolerance between the different chemicals. The interpretation of the resequencing data 
alone is also made difficult by the high frequency of mutations in regulatory genes that are known 
to have pleiotropic effects (RNA polymerase subunits, genes involved in stringent response, 
termination factors, etc.). The overall conclusions from the resequencing results is that there are no 
universal chemical tolerance mechanisms at the genetic level and that tolerance usually involves 
both specific (e.g. transporters) and general (e.g. adjustments in global regulation) adaptations. 
The cross-tolerance screening showed that in the case of diacids, diols and diamines, strains evolved 
to tolerate one specific chemical usually had tolerance to the other chosen chemical of the same 
class (Figure 3a). However, for the medium chain fatty acids hexanoate and octanoate, this pattern 
of cross-tolerance was not observed. It is not clear why this is the case, in particular since the genetic 
adaptations were not necessarily more similar between e.g. diamines than medium chain fatty 
acids. Furthermore, strains evolved to tolerate a specific chemical (Figure 3b) tend to be tolerant to 
a wide range of highly similar chemicals, which is of great practical relevance. Because of this, it is 
only necessary to perform ALE once for a category of chemicals (e.g. diols) in order to obtain a series 
of potential platform strains that have high levels of tolerance within the category. 
Cross tolerance profiling could also be used to define a measure of global chemical tolerance of each 
evolved strain. Global tolerance was found to be highly variable within the set of genetically distinct 
strains evolved under each condition and even more so between strains evolved under different 
conditions. Global tolerance was found to be unrelated to the growth rate of the strain on the base 
M9 glucose medium (Figure 3d) indicating that the fast growth and stress tolerance phenotypes are 
not related to each other biologically. On the other hand, the ability of a strain to grow in osmotic 
stress conditions (NaCl) was found to be significantly predictive of the global chemical tolerance of 
the strain (Figure 3d). This result is expected due to the high osmolarity of the final growth medium 
for many chemicals although the osmolarity of the evolution condition was not predictive of global 
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tolerance of a strain. Some of the strains that were highly osmotolerant (and hence globally 
chemical tolerant) contained mutations in genes such as nagC and proV that have previously been 
implicated in osmotolerance in ALE experiments (Winkler et al., 2014). Unfortunately, the exact 
mechanisms by which many of the observed mutations or their combinations confer osmotolerance 
remain somewhat elusive. The result that osmotolerance is predictive of general chemical tolerance 
indicates that choosing a well-characterized osmotolerant strain as a starting platform strain for 
metabolic engineering efforts may in general be a good strategy for any target chemical. 
Determining the exact mechanisms of chemical tolerance was challenging, but in specific cases 
where convergent mutation targets in either transporters or metabolic genes were discovered in 
independently evolved strains, mechanistic hypotheses could be generated and validated 
experimentally. Since all strains evolved on adipate and glutarate contained apparent loss-of-
function mutations in a gene encoding a known alpha-ketoglutarate transporter (kgtP), this 
transporter was likely the primary transporter importing the two diacids. Indeed, deletion of the 
transporter conferred a large increase in tolerance and prevented growth with glutarate as the sole 
carbon source. As alpha-ketoglutarate is structurally similar to glutarate and adipate, the 
transporter most likely has significant promiscuous activity towards the two diacids. Two further 
transporters were mutated in specific diacid-tolerant strains and a triple deletion of these 
transporters was sufficient to achieve levels of tolerance to glutarate and adipate almost on par 
with the evolved strains. One of these genes encoding transporters (proV, encoding the ATP-binding 
subunit of the ProVWX glycine betaine transporter complex) is a known to import the 
osmoprotectant glycine betaine whereas the other one (yjbL) is previously completely 
uncharacterized. As proV mutations were also observed in many other strains, it is likely that the 
ProVWX transporter can promiscuously import many of the chemicals and deleting proV is therefore 
beneficial for chemical tolerance in general. 
Exogenous chemical tolerance alone is  not a very useful phenotype for metabolic engineering 
applications where the strains are engineered to produce a chemical endogenously. In order to 
demonstrate that pre-evolving for exogenous tolerance could help in obtaining better endogenous 
production strains we engineered production pathways for isobutyrate and 2,3-butanediol into 
genetically distinct strains that had been evolved to tolerate the respective compounds. In both 
cases we found that engineered ALE strains did not generally show increased production compared 
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to the similarly engineered wild-type strain. However, for both isobutyrate and 2,3-butanediol we 
could identify specific strains that did have significantly higher production. This indicates that pre-
evolving for exogenous tolerance would be a viable strategy for obtaining improved production 
strains as long as a sufficient number of independently evolved and genetically distinct strains are 
created and screened. With rapid improvements in genetic manipulation and automation 
technologies, engineering the same pathway into multiple strain backgrounds can be readily done, 
making this approach feasible. 
All isobutyrate-evolved strains contained pykF mutations the majority of which were clear loss-of-
function mutations. pykF mutations are commonly seen in many E. coli ALE experiments (Wang et 
al. 2018; Phaneuf et al. 2018) and pykF deletions have also been proven to allow increased 
production of many metabolites (Harder et al., 2016; Sengupta et al., 2015). It is not clear exactly 
how pykF deletion would specifically increase isobutyrate tolerance, but this deletion has been 
shown to have broad effects in redirecting fluxes in central carbon metabolism and in changing the 
regulation of pyruvate supply (Al Zaid Siddiquee et al., 2004). Deleting pykF conferred significantly 
improved tolerance to isobutyrate, but in terms of production the different ALE strains showed very 
different levels ranging from no production to three times higher production than the wild type 
strain, indicating that pykF mutations alone did not explain production differences. The highest 
producing strains from population IBUA8 had mutations in ilvH/N encoding regulatory subunits of 
acetolactate synthases. These mutations were shown to alleviate feedback inhibition by valine, 
which may explain their ability to produce higher levels of isobutyrate as the engineered strains 
contain a heterologously expressed acetolactate synthase AlsS, which increases not only isobutyrate 
production but also production of branched-chain amino acids including valine. In the case of 2,3-
butanediol production, only one of the engineered evolved strains had considerably higher 
production than the wild-type strain. The genotype of the strain did not provide clear clues to the 
reasons for improved production although the high producing strain was the only one containing a 
mutation in the acrB gene encoding a subunit of the AcrB/AcrB/AcrZ/TolC multidrug efflux pump. 
However, the mutation present in the strain was a frameshift mutation close to the 5’ end of the 
gene indicating that the efflux pump was likely inactivated. 
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1.5 Conclusion 
In this study we used ALE to evolve strains of E. coli to tolerate high concentrations of 11 different 
industrially relevant chemicals. The tolerated concentrations increased by factors of 60 % to 400 %. 
Genome sequencing of the evolved strains showed that the median number of mutations per strain 
was 6, and that only a small degree of mutation overlap was seen between conditions and even 
between independently evolved strains in the same condition. This made it difficult to infer 
mechanisms of tolerance in all but a couple of cases. Cross-compound tolerance screening revealed 
a general trend of cross-tolerance between compounds of the same class. This suggests that a single 
broadly tolerant platform strain could be used for production of several compounds of the same 
class. Furthermore, we observed that tolerance to high osmolarity was predictive of the overall 
tolerance to all 11 compounds, suggesting that high osmolarity is a significant factor of toxicity at 
the utilized concentrations. For two compounds, the evolved strains were transformed with 
plasmids carrying production pathways and screened for improved production compared to the 
wild-type. In both cases we could identify strains that produced considerably better than the wild-
type, although the majority of evolved strains had similar or reduced production compared to the 
wild-type. This suggests that pre-evolving a strain to tolerate the target compound before 
engineering production can be a viable strategy as long as a large number of independently evolved 
strains can be isolated and screened. 
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1.7 Supplementary Materials 
Supplementary Table 1: Summary of the mutations and mutated genes in all the non-mutator strains. The mutation 
names denote the type, location and change of the mutations. 
 
GENES MUTATIONS 
12PD4-6 relA, metJ, yeaR, sspA, rpsA SNP-3377240-G, SNP-4128078-G, SNP-2912634-G, SNP-962923-T, MOB-1879829-Δ1-: 
12PD6-3 lrhA, rpoA, fabR, dusA, yfgF SNP-4161155-A, SNP-4261586-C, SNP-3440194-A, MOB-2628616-IS2-5, MOB-2406831-IS2-5 
12PD6-9 rpoA, fabR, yfgF, ypjA SNP-3440194-A, MOB-2628616-IS2-5, SNP-2780609-C, SNP-4161155-A 
23BD1-6 gabP, nanK, rnb, metJ, elfA, rpoB, 
purT, relA 
MOB-998193-IS5-4, SNP-4182583-T, SNP-2794550-G, SNP-1931977-G, SNP-3369969-A, DEL-
2911491-7528, SNP-4128380-A, MOB-1347480-IS5-4 
23BD1-9 gabP, nanK, rnb, metJ, elfA, rpoB, 
purT, relA 
MOB-998193-IS5-4, SNP-4182583-T, SNP-2794550-G, SNP-1931977-G, SNP-3369969-A, DEL-
2911491-7528, SNP-4128380-A, MOB-1347480-IS5-4 
23BD2-4 nanK, uspC, metJ, rpoC, rpsA, 
gtrS, relA 
SNP-1979639-C, MOB-4128293-IS5-4, SNP-4186152-G, SNP-3369969-A, SNP-962056-T, MOB-
580116-IS5-4, SNP-2470411-G, DEL-2911491-7528 
23BD2-7 metJ, rpoC, nanK, relA, rpsA MOB-4128293-IS5-4, MOB-1096841-IS2-5, SNP-4186152-G, SNP-3369969-A, SNP-962056-T, 
MOB-580116-IS5-4, DEL-2911491-7528 
23BD2-9 metJ, rpoC, nanK, relA, rpsA MOB-4128293-IS5-4, SNP-4186152-G, SNP-3369969-A, SNP-962056-T, MOB-580116-IS5-4, 
DEL-2911491-7528 
23BD4-3 yeaR, mprA, rnb, fadB, umuD, 
metJ, rpoC, purT, relA 
SNP-1347775-A, SNP-4128361-C, SNP-2810756-T, SNP-2913536-T, DEL-4187816-15, SNP-
1931977-G, MOB-1879829-Δ1-:, SNP-4031019-A, SNP-1230727-A 
23BD4-4 yeaR, umuD, rpoC, metJ, purT, 
relA 
SNP-4128361-C, SNP-1931977-G, MOB-1879829-Δ1-:, SNP-2913536-T, DEL-4187816-15, SNP-
1230727-A 
23BD4-7 rpoC, nanK, metJ, relA SNP-4186274-T, SNP-3369969-A, SNP-4128169-G, DEL-2911491-7528 
23BD5-1 yeaR, spoT, umuD, metJ, rpoC, 
purT, relA 
SNP-4128361-C, MOB-1879829-Δ1-:, SNP-3823036-C, SNP-2913536-T, DEL-4187816-15, SNP-
1931977-G, SNP-1230727-A 
23BD5-7 ybeT, nanK, ybhP, ydhK, rpoC, 
metJ, zntR, relA 
SNP-4186274-T, SNP-1722386-T, SNP-4128379-T, SNP-824028-G, SNP-3369969-A, SNP-
3438773-G, DEL-2911491-7528, SNP-679090-G 
23BD5-10 rpoC, nanK, metJ, relA SNP-4186274-T, SNP-3369969-A, SNP-4128169-G, DEL-2911491-7528 
23BD6-1 essD, rpoC, metJ, nusG, purT, relA DEL-575786-3027, DEL-2912618-10, SNP-4185573-G, SNP-1930993-G, SNP-4128250-C, SNP-
4178172-G 
23BD7-4 treR, nanK, elfD, tolC, metJ, rpoC, 
yhjA, flu, purT, relA 
SNP-4128386-C, MOB-3668878-IS2-5, SNP-4186152-G, MOB-4466841-IS5-4, SNP-1931668-G, 
SNP-3369969-A, DEL-2911491-7528, SNP-3178128-G, SNP-2073463-A, MOB-998719-IS2-5 
23BD7-5 acrB, nanK, elfD, metJ, rpoC, flu, 
purT, relA 
SNP-4128386-C, SNP-4186152-G, SNP-3369969-A, MOB-998719-IS2-5, DEL-2911491-7528, 
INS-484102-AT, SNP-2073463-A, MOB-1931499-IS5-4 
23BD7-7 treR, nanK, elfD, tolC, metJ, rpoC, 
yhjA, flu, purT, relA 
SNP-4128386-C, MOB-3668878-IS2-5, SNP-4186152-G, MOB-4466841-IS5-4, SNP-1931668-G, 
SNP-3369969-A, DEL-2911491-7528, SNP-3178128-G, SNP-2073463-A, MOB-998719-IS2-5 
23BD8-2 ygaH, iscR, relA, rpoB, pyrE, lon SNP-2661816-G, SNP-2913641-T, SNP-4184579-G, DEL-3815810-1, SNP-2810459-C, SNP-
461034-G 
23BD8-7 ygaH, iscR, metJ, lacZ, rpoB, pyrE, 
relA 
DEL-3815810-1, DEL-365742-1, SNP-2661816-G, SNP-4128212-G, SNP-2810459-C, SNP-
2913641-T, SNP-4184579-G 
ADIP1-1 sspA, kgtP, gltP, ybjL, proV, yicC, 
uvrB, pyrE 
SNP-814029-G, DEL-3377068-21, MOB-2725207-IS1-9, SNP-3815823-A, DEL-2804648-38, 
SNP-4294366-T, DEL-889569-1, SNP-3816848-T 
ADIP1-9 allD, sspA, kgtP, ligA, gltP, ybjL, 
proV, yicC, pyrE 
DEL-3377068-21, SNP-2530235-T, MOB-2725207-IS1-9, SNP-3815823-A, SNP-546309-T, DEL-
2804648-38, SNP-4294366-T, DEL-889569-1, SNP-3816848-T 
ADIP2-5 lacY, rph, nagC, kgtP SNP-362830-A, MOB-700529-IS1-9, DEL-3815884-2, SNP-2725613-A 
ADIP2-6 lacY, rph, nagC, kgtP MOB-700529-IS1-9, SNP-362830-A, SNP-2725613-A, DEL-3815884-2 
ADIP2-10 ydcD, pyrE, nagC, kgtP SNP-1530007-A, MOB-700628-IS5-4, DEL-3815810-1, SNP-2725613-A 
ADIP3-2 yfgO, sspA, kgtP, ybjL, proV, yicC, 
pyrE 
DEL-3377068-21, MOB-2725207-IS1-9, SNP-3815823-A, DEL-2804648-38, SNP-2614996-G, 
SNP-3816848-T, MOB-889534-IS5-4 
ADIP3-4 yeaR, kgtP, sspA, ybjL, yhiL, proV, 
yicC, mltD, pyrE 
DEL-3377068-21, INS-233963-GT, MOB-2725207-IS1-9, SNP-3815823-A, MOB-3633911-IS5-4, 
DEL-2804648-38, MOB-1879829-Δ1-:, SNP-3816848-T, MOB-889534-IS5-4 
ADIP3-8 sspA, kgtP, ybjL, proV, yicC, pyrE DEL-3377068-21, MOB-2725207-IS1-9, SNP-3815823-A, DEL-2804648-38, SNP-3816848-T, 
MOB-889534-IS5-4 
ADIP4-8 purL, kgtP, malQ, ybjL, yphC, 
pdxJ, srmB, nagA, rnt, metL 
DEL-4130167-462, SNP-1728708-G, SNP-2713302-T, MOB-889488-IS1-9, SNP-2675452-C, 
SNP-2724590-T, SNP-3548179-T, SNP-2701175-C, SNP-2693818-G, INS-702444-
GCATAACGCGCACGCCCTGTTTCATCAGCTCATCGC 
ADIP6-3 spoT, kgtP, ubiE, proQ, nagC, ybjL, 
proV 
SNP-3823700-T, SNP-700928-A, DEL-2804864-13, SNP-1915297-A, SNP-2725155-T, MOB-
889534-IS5-4, SNP-4019173-G 
ADIP6-9 spoT, kgtP, proQ, nagC, ybjL, 
proV, icd, ycjG 
SNP-3823700-T, SNP-1196319-A, SNP-700928-A, SNP-1915297-A, SNP-2725155-T, MOB-
889534-IS5-4, SNP-1389396-C, DEL-2804835-7 
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ADIP6-10 spoT, kgtP, proQ, nagC, ybjL, proV SNP-2805493-T, SNP-3823700-T, SNP-700928-A, SNP-1915297-A, SNP-2725155-T, MOB-
889534-IS5-4 
ADIP7-2 kgtP, yagL, rpoS, yneO, hns, pstS SNP-2725329-A, SNP-293574-G, MOB-1293038-IS1-9, MOB-1598223-IS5-4, DEL-2867359-9, 
INS-3911001-TTTC 
ADIP7-5 ybjL, idnR, proV, sspA, kgtP MOB-889540-IS5-4, SNP-3377240-G, DEL-2725643-1, MOB-4490689-IS1-9, DEL-2804864-13 
ADIP8-3 pstS, yehD, hns, kgtP MOB-1293015-IS1-8, SNP-2724588-T, DEL-2192452-1, MOB-3911563-IS1-9 
ADIP8-7 pstS, yehD, hns, kgtP MOB-1293015-IS1-8, SNP-2724588-T, MOB-3911563-IS1-9, DEL-2192452-1 
ADIP8-10 pstS, insI1, yehD, hns, kgtP MOB-1293015-IS1-8, MOB-280003-IS5-4, SNP-2724588-T, DEL-2192452-1, MOB-3911563-
IS1-9 
BUT1-2 tqsA, adeP, manY, rob, cspC, pyrE DEL-3815810-1, SNP-3895843-C, DEL-1907330-2, SNP-1903497-C, SNP-4635114-C, MOB-
1673883-IS5-4 
BUT1-3 manY, pyrE, tqsA, cspC, rob SNP-4635114-C, SNP-1903497-C, MOB-1673883-IS5-4, DEL-1907330-2, DEL-3815810-1 
BUT1-5 tqsA, manY, yobF, ycaN, rob, pyrE MOB-1907448-IS5-4, DEL-3815810-1, SNP-1674448-A, INS-4635196-G, SNP-1903497-C, SNP-
949006-G 
BUT2-9 hfq, marC, rob SNP-1618698-A, SNP-4400407-G, DEL-3815859-82, INS-4634895-A 
BUT3-3 manY, yobF, leuA, marC, pyrE DEL-1618281-1, SNP-1903497-C, MOB-1907448-IS5-4, DEL-3815810-1, SNP-82594-G 
BUT3-6 tqsA, manY, yobF, pheU, marC, 
pyrE 
INS-4362600-C, MOB-1907448-IS5-4, DEL-3815810-1, SNP-1903497-C, MOB-1673883-IS5-4, 
DEL-1618281-1 
BUT3-7 tqsA, manY, yobF, pheU, marC, 
pyrE 
INS-4362600-C, MOB-1907448-IS5-4, DEL-3815810-1, SNP-1903497-C, MOB-1673883-IS5-4, 
DEL-1618281-1 
BUT4-4 manY, marC, rob, glmU, cspC, 
pyrE 
MOB-1907343-IS1-8, MOB-1618666-IS2-5, DEL-3815810-1, SNP-4635159-T, SNP-1903497-C, 
SNP-3915089-T 
BUT4-7 manY, marC, rob, glmU, cspC, 
pyrE, sapA 
MOB-1907343-IS1-8, MOB-1618666-IS2-5, DEL-3815810-1, SNP-4635159-T, SNP-1356672-G, 
SNP-1903497-C, SNP-3915089-T 
BUT4-9 manY, marC, rob, glmU, cspC, 
pyrE 
MOB-1907343-IS1-8, MOB-1618666-IS2-5, DEL-3815810-1, SNP-4635159-T, SNP-1903497-C, 
SNP-3915089-T 
BUT5-2 manY, marC, mppA, rob, glmU, 
cspC, pyrE 
MOB-1907343-IS1-8, DEL-3815810-1, SNP-4635159-T, DEL-1394081-2, SNP-1903497-C, MOB-
1618850-IS5-4, SNP-3915089-T 
BUT5-3 manY, marC, rob, glmU, cspC, 
pyrE 
MOB-1907343-IS1-8, MOB-1618666-IS2-5, DEL-3815810-1, SNP-4635159-T, SNP-1903497-C, 
SNP-3915089-T 
BUT6-1 manY, yobF, marC, pyrE, rob SNP-4635243-T, SNP-1903497-C, MOB-1907448-IS5-4, DEL-3815810-1, DEL-1606886-11558 
BUT6-3 manY, yobF, marC, pyrE, rob DEL-1606886-11558, SNP-1903497-C, MOB-1907448-IS5-4, SNP-4635243-T, DEL-3815810-1 
BUT6-8 manY, yobF, marC, pyrE, rob SNP-4635243-T, SNP-1903497-C, MOB-1907448-IS5-4, DEL-3815810-1, DEL-1606886-11558 
BUT7-6 manY, yobF, pyrE, rob, mppA MOB-1907611-IS5-4, SNP-4635203-T, SNP-1903497-C, DEL-3815810-1, DEL-1392752-3292 
BUT7-7 manY, yobF, pyrE, rob, mppA MOB-1907611-IS5-4, SNP-4635203-T, SNP-1903497-C, DEL-3815810-1, DEL-1392752-3292 
BUT7-9 manY, yobF, pyrE, rob, mppA MOB-1907611-IS5-4, SNP-4635203-T, SNP-1903497-C, DEL-3815810-1, DEL-1392752-3292 
BUT9-7 pyrE, manY, rob, marC, rraA DEL-4119238-18, INS-1618379-C, SNP-4635048-C, DEL-3815810-1, SNP-1903497-C 
BUT9-10 rraA, manY, marC, rob, pyrE, otsB INS-1618379-C, SNP-4635048-C, DEL-3815810-1, SNP-1903497-C, SNP-1981720-A, DEL-
4119238-18 
COUM1-2 rho, fimD, ycfQ, sapC, rpoC, polB, 
nadR 
SNP-3966727-T, SNP-4627958-T, DEL-4546637-1, SNP-1168483-T, SNP-4185540-T, SNP-
1354284-A, SNP-64352-C 
COUM2-3 rho, atpI, murC, sapF, rpoC, nadR SNP-1352163-A, DEL-102228-1, MOB-3922629-IS5-4, DEL-4627451-124, SNP-3966751-T, 
SNP-4185540-T 
COUM2-4 rho, atpI, murC, ccmA, sapF, rhaT, 
rpoC, nadR, yecT 
SNP-3966751-T, DEL-102228-1, MOB-2297586-IS5-4, DEL-4627451-124, SNP-4185540-T, SNP-
4099695-A, SNP-1352163-A, MOB-1961829-IS5-4, MOB-3922629-IS5-4 
COUM2-7 rho, atpI, murC, sapF, rpoC, nadR SNP-3966751-T, DEL-102228-1, DEL-4627451-124, SNP-4185540-T, SNP-1352163-A, MOB-
3922629-IS5-4 
COUM3-1 rho, atpI, mprA, dacA, manY, 
rpoB, hns, pyrE 
SNP-663746-T, DEL-3815810-1, DEL-2810080-1165, MOB-1293196-IS5-4, SNP-3966727-T, 
DEL-260217-13738, SNP-3922483-A, SNP-4183802-G, SNP-1903497-C 
COUM3-9 rho, atpI, mprA, dacA, manY, 
rpoB, hns, pyrE 
SNP-663746-T, DEL-3815810-1, DEL-2810080-1165, MOB-1293196-IS5-4, SNP-3966727-T, 
SNP-4183802-G, SNP-3922483-A, SNP-1903497-C 
COUM3-10 rho, atpI, mprA, dacA, manY, 
rpoB, hns, pyrE 
SNP-663746-T, DEL-3815810-1, DEL-2810080-1165, MOB-1293196-IS5-4, SNP-3966727-T, 
SNP-4183802-G, SNP-3922483-A, SNP-1903497-C 
COUM4-2 epmB, rpoA, rpsG, nadR, dcd SNP-4375431-C, SNP-3473615-T, SNP-2141832-T, SNP-3440924-G, SNP-4627567-T 
COUM4-5 rpsG, dcd, yfiN, ompN, nadR, 
rpoA 
SNP-3473615-T, SNP-2141832-T, SNP-3440924-G, SNP-2743181-G, SNP-4627567-T, SNP-
1436746-C 
COUM4-10 rpoA, rpsG, nadR, dcd SNP-3473615-T, SNP-2141832-T, SNP-3440924-G, SNP-4627567-T 
COUM5-3 rho, atpI, sapF, yphF, ypjC, glnG, 
rpoC, mrdA, nadR 
SNP-3966751-T, MOB-2784452-IS5-4, MOB-2678755-IS5-4, DEL-4054531-104, SNP-667158-T, 
SNP-4185540-T, SNP-1352163-A, DEL-4628232-1, MOB-3922629-IS5-4 
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COUM5-5 rho, sapF, ypjC, rpoC, mrdA, nadR SNP-3966751-T, MOB-2784452-IS5-4, SNP-667158-T, SNP-4185540-T, DEL-4628214-1, SNP-
1352163-A 
COUM5-8 focA, rho, atpI, sapF, ypjC, tufA, 
rpoC, mrdA, ydiJ 
SNP-3966751-T, MOB-2784452-IS5-4, SNP-954638-T, SNP-1768309-T, SNP-667158-T, SNP-
4185540-T, DEL-3471319-1, SNP-1352163-A, INS-3922570-TAG 
COUM6-2 rho, yjiP, manY, rnb, yhgE, nusA, 
pyrE 
MOB-1347892-IS5-4, DEL-3815810-1, SNP-3966727-T, SNP-4569172-A, SNP-3317438-A, SNP-
1903497-C, SNP-3530902-G 
COUM6-5 rho, yjiP, manY, rnb, yhgE, nusA, 
pyrE 
MOB-1347892-IS5-4, DEL-3815810-1, SNP-3966727-T, SNP-4569172-A, SNP-3317438-A, SNP-
1903497-C, SNP-3530902-G 
COUM6-9 rho, yjiP, manY, rnb, yhgE, nusA, 
fimC, pyrE 
DEL-3815810-1, SNP-3530902-G, MOB-4544671-+G-S5, MOB-1347892-IS5-4, SNP-3966727-T, 
SNP-4569172-A, SNP-3317438-A, SNP-1903497-C 
COUM7-5 rho, mprA, ypjA, manY, prlF, 
rpoB, ydjH, pyrE 
SNP-4183814-A, DEL-3815810-1, SNP-3966727-T, DEL-2810804-1, MOB-1856052-IS5-4, SNP-
1903497-C, INS-3277273-TTCAACA, MOB-2782626-IS5-4 
COUM7-6 rho, mprA, ypjA, manY, mgrB, 
rpoB, pyrE 
MOB-1908812-IS5-4, SNP-4183814-A, DEL-3815810-1, SNP-3966727-T, DEL-2810804-1, SNP-
1903497-C, MOB-2782626-IS5-4 
COUM8-1 manY, thrA, pyrE, mprA, yhjK DEL-3815810-1, DEL-3683736-1, SNP-1903497-C, SNP-2374-T, DEL-2801966-11843 
COUM8-6 manY, rho, pyrE, mprA, yhjK INS-3966718-GAT, SNP-1903497-C, DEL-3685181-273, DEL-3815810-1, DEL-2801966-11843 
GLUT1-3 spoT, kgtP, rnb, nagC, rpoC, ydfI SNP-4186605-C, SNP-1630841-A, SNP-3823664-C, MOB-700614-IS1-9, DEL-2725672-1, SNP-
1347104-T 
GLUT1-9 rpoC, rnb, spoT, nagC, kgtP SNP-3823664-C, MOB-700614-IS1-9, DEL-2725672-1, SNP-4186605-C, SNP-1347104-T 
GLUT1-10 yiaT, hofM, spoT, insG, sspA, kgtP, 
proV, greA 
SNP-3522182-A, INS-3377241-AGCTCACGATCCACCAGGGTC, INS-2805532-T, MOB-3328463-
IS4-11, SNP-3823664-C, MOB-3751884-IS5-4, DEL-2725672-1 
GLUT2-1 spoT, kgtP, tomB, ygjP, proV, 
nagA 
SNP-3823751-A, MOB-701614-IS1-9, DEL-2725643-1, SNP-3236414-C, DEL-2804864-13, SNP-
481075-G 
GLUT2-9 nagA, spoT, rnb, kgtP SNP-3823751-A, MOB-701614-IS1-9, DEL-2725643-1, DEL-1347882-1 
GLUT2-10 rspA, spoT, kgtP, rpoC, proV, 
nagA 
SNP-1654069-C, SNP-4186605-C, SNP-3823751-A, MOB-701614-IS1-9, DEL-2725643-1, DEL-
2804864-13 
GLUT3-5 rpoC, spoT, kgtP SNP-3823770-T, SNP-2724971-C, SNP-4186605-C 
GLUT3-7 rpoC, spoT, kgtP SNP-3823770-T, SNP-2724971-C, SNP-4186605-C 
GLUT3-9 spoT, kgtP, wzzE, ssuA, rclB, rnt SNP-318484-T, SNP-996768-A, SNP-1728882-C, INS-2725518-C, INS-3969051-G, SNP-
3823759-C 
GLUT4-1 nagC, proX, spoT, kgtP SNP-3824137-T, SNP-2724611-A, DEL-2807199-8, MOB-701188-IS1-9 
GLUT4-4 proX, spoT, nagC, kgtP SNP-2390019-A, MOB-3195220-IS186-4, DEL-2807199-8, MOB-701188-IS1-9, SNP-3824137-T, 
SNP-2724611-A 
GLUT4-10 csiD, rpoC, spoT, kgtP MOB-2788702-IS5-4, SNP-2724971-C, SNP-4186605-C, SNP-3823751-T 
GLUT5-4 ytfR, spoT, sspA, kgtP, yagU, rpoB DEL-3377359-18, DEL-2725375-1, SNP-3823106-T, DEL-303121-1, SNP-4451123-A, SNP-
4181852-C 
GLUT5-5 ytfR, spoT, rpoB, sspA, kgtP MOB-3377491-IS2-5, SNP-4451123-A, DEL-2725375-1, SNP-3823106-T, SNP-4181852-C 
GLUT5-9 ytfR, spoT, rpoB, sspA, kgtP MOB-3377491-IS2-5, SNP-4451123-A, DEL-2725375-1, SNP-3823106-T, SNP-4181852-C 
GLUT6-4 kgtP, spoT, yfjL, nagC, cspE SNP-3823105-A, DEL-657215-25, MOB-700680-IS1-9, DEL-2765456-8, SNP-2725370-C 
GLUT6-5 nagC, spoT, yfjL, kgtP, cspE SNP-2725370-C, SNP-3823105-A, DEL-657215-25, DEL-2765456-8, MOB-700680-IS1-9 
GLUT6-10 hcaD, nagA, spoT, rnt, kgtP INS-2724732-AAAAGC, MOB-701889-IS1-9, SNP-3823139-A, SNP-1728425-A, DEL-2672981-6 
GLUT7-2 spoT, rnt, nagC, kgtP SNP-701396-A, SNP-1728926-C, SNP-2724848-A, DEL-3824201-6 
GLUT7-6 nohQ, spoT, rnt, kgtP SNP-2724848-A, SNP-1636300-G, SNP-1728926-C, DEL-3824201-6 
GLUT7-7 kgtP, rlmI, yhfA, ravA, spoT, dkgA, 
rplM, nagC, rrlA, rrlC, uvrD, ybeF, 
rsmC, fruB, yhiL, tdcD, yfdC, lldR, 
yliE, rnt, aceK, roxA, yhfX 
SNP-443040-T, DEL-3943892-1, DEL-1029739-1, SNP-3823724-T, SNP-2262665-A, DEL-
2465722-1, SNP-3263200-A, DEL-701381-1, SNP-660573-C, SNP-4219696-T, SNP-3779384-G, 
SNP-4037513-C, INS-3931183-G, DEL-2725672-1, SNP-3510180-C, SNP-874067-A, SNP-
1728884-A, SNP-3378539-G, SNP-3485967-G, SNP-3634152-C, SNP-3156603-C, SNP-
4607712-T, SNP-1187352-A, DEL-3999387-1 
GLUT8-5 rpoC, polB, proV, mprA, kgtP SNP-2725818-G, DEL-2804864-13, MOB-2810987-IS1-9, SNP-4185540-T, SNP-64352-C 
GLUT8-6 kgtP, sapC, rpoC, polB, proV, 
nagA 
DEL-2804864-13, SNP-2725232-A, SNP-1354284-A, SNP-4185540-T, INS-702338-T, SNP-
64352-C 
GLUT8-9 kgtP, yobF, sapC, sdaC, rpoC, 
proV, polB, lit 
MOB-1907448-IS5-4, DEL-2804926-1, INS-1198505-AATGATGA, DEL-2725209-9, SNP-
4185540-T, SNP-2927703-A, SNP-1354284-A, SNP-64352-C 
HEXA1-1 ptrA, rpoA, rpoC, bioB, sapB SNP-809340-G, SNP-3440378-T, SNP-3440212-A, SNP-4185540-T, MOB-2957831-IS5-4, SNP-
1354687-A 
HEXA1-4 opgH, rpoA, rpoC, bioB, sapB SNP-809340-G, SNP-3440378-T, DEL-1112435-5, SNP-3440212-A, SNP-4185540-T, SNP-
1354687-A 
HEXA1-5 sapB, rpoA, rpoC, bioB SNP-809340-G, SNP-3440378-T, SNP-1354687-A, SNP-4185540-T, SNP-3440212-A 
HEXA2-3 pykF, ompR, mdtK, prpE SNP-353944-A, SNP-1743611-A, DEL-3536285-1, SNP-1756622-A 
  38 
HEXA2-9 ompR, mdtK, prpE SNP-1743611-A, SNP-353944-A, DEL-3536285-1 
HEXA2-10 rpoA, mdtK SNP-3440212-A, SNP-3440929-A, DEL-1744016-757 
HEXA3-1 rpoC, rpoA, yfjL, mdtK, sapA SNP-1356317-T, SNP-3440378-T, MOB-1743880-IS1-9, SNP-3440212-A, SNP-2764096-T, SNP-
4185540-T 
HEXA3-7 mdtK, rpoA, rpoC, yfjL SNP-3440212-A, SNP-3440378-T, SNP-2764096-T, MOB-1743880-IS1-9, SNP-4185540-T 
HEXA3-9 mdtK, rpoA, rpoC, yfjL SNP-3440212-A, SNP-3440378-T, SNP-2764096-T, MOB-1743880-IS1-9, SNP-4185540-T 
HEXA4-4 rpoA, ompR, proQ, glxK, hns MOB-1293196-IS5-4, MOB-542938-IS5-4, DEL-1915293-5, INS-3536332-T, SNP-3440923-T 
HEXA4-7 dosP, rpoA, ompR, proQ, hns MOB-1293196-IS5-4, INS-3536332-T, DEL-1915293-5, SNP-1564102-G, SNP-3440923-T 
HEXA4-10 rpoA, ompR, proQ, hns MOB-1293196-IS5-4, INS-3536332-T, SNP-1915353-C, SNP-3440923-T 
HEXA6-5 sapB, rpoA, mdtK SNP-3440212-C, DEL-1744675-1, SNP-1354687-A, INS-3440937-CGCTCT 
HEXA6-6 rpoA, mdtK SNP-3440212-C, DEL-1744675-1, INS-3440937-CGCTCT 
HEXA6-7 rhmD, rpoA, mdtK, sapB SNP-3440212-C, SNP-2360829-A, DEL-1744675-1, SNP-1354687-A, INS-3440937-CGCTCT 
HEXA6-9 mdtK, rpoA, rsd, sapB SNP-3440212-C, DEL-1744675-1, INS-3440937-CGCTCT, SNP-1354687-A 
HEXA7-2 ompC, emrY, rsfS, sfmF, rpoB, 
hns, rpoA 
MOB-563324-IS1-9, SNP-2481325-A, SNP-4182358-T, MOB-2312877-IS5-4, MOB-1293124-
IS5-4, SNP-3440923-T, DEL-668970-1 
HEXA8-1 ompC, yedP, sapB, cydA, barA, 
murG, rpoA 
SNP-99891-T, SNP-1354761-T, INS-2025248-TC, MOB-771258-IS5-4, MOB-2312877-IS5-4, 
DEL-2916392-12, SNP-3440923-T 
HEXA8-2 ompC, yedP, sapB, cydA, murG, 
rpoA 
SNP-99891-T, MOB-771306-IS5-4, SNP-1354761-T, INS-2025248-TC, MOB-2312877-IS5-4, 
SNP-3440923-T 
HEXA8-5 ompC, yedP, sapB, murG, rpoC, 
rpoA 
SNP-99891-T, SNP-1354761-T, INS-2025248-TC, MOB-2312877-IS5-4, SNP-3440923-T, SNP-
4187619-T 
HMDA1-10 purL, rph, spoT, lexA, proV, rpoB, 
rpsA 
SNP-2694102-A, SNP-962939-A, SNP-3816611-A, DEL-2804864-13, SNP-4257602-T, SNP-
4181786-T, SNP-3823025-A 
HMDA2-1 ptsP, proV, pyrE, rpsA MOB-2804836-IS1-9, DEL-2968163-1, DEL-3815808-1, SUB-963273- 
HMDA2-8 ptsP, proV, pyrE, rpsA MOB-2804836-IS1-9, SUB-963273-, DEL-2968163-1, DEL-3815808-1 
HMDA3-4 rpoC, nagA, pyrE, kup SNP-3933122-A, INS-702597-G, DEL-3815810-1, SNP-4188767-T 
HMDA3-5 nagC, ygeG, kup, ygbT, pyrE, ybeX SNP-3933122-A, SNP-2879763-A, DEL-3815810-1, DEL-691774-12, SNP-701405-A, SNP-
2991218-G 
HMDA3-6 gatY, rpoC, nagA, pyrE, kup SNP-3933122-A, DEL-3815810-1, MOB-2177307-IS1-9, INS-702597-G, SNP-4188767-T 
HMDA5-4 ptsP, ampC, pnp, pyrE, nagC SNP-2966573-G, DEL-3815810-1, SNP-3310266-A, SNP-4378331-G, MOB-700602-IS1-9 
HMDA5-5 ptsP, pyrE, nagC, ybeX SNP-2966573-G, DEL-3815810-1, MOB-700602-IS1-9, SNP-691321-T 
HMDA5-10 ptsP, pstB, pyrE, pepA, stpA SNP-2966573-G, DEL-3815810-1, MOB-2798597-IS1-9, SNP-4485639-C, SNP-3908248-T 
HMDA7-1 rpsG, wbbK, sspA, nusA SNP-3377173-C, DEL-2104077-1, SNP-3473612-C, SNP-3317072-C 
HMDA7-7 rpsG, sspA, nusA SNP-3377173-C, SNP-3473612-C, SNP-3317072-C 
HMDA7-10 rpsG, wbbK, sspA, nusA SNP-3377173-C, DEL-2104077-1, SNP-3473612-C, SNP-3317072-C 
HMDA8-5 mdtK, xapR, nagC, proV, cynR, 
pyrE, lhr, rnt 
SNP-1728512-C, DEL-3815808-1, SNP-1732811-T, DEL-2804864-13, SNP-2522653-A, SNP-
358399-G, SNP-700980-C, SNP-1744313-A 
HMDA8-9 mdtK, nagC, proV, pyrE, lhr, rnt SNP-1728512-C, DEL-3815808-1, SNP-1732811-T, DEL-2804864-13, SNP-700980-C, SNP-
1744313-A 
HMDA8-10 mpl, mdtK, nagC, proV, pyrE, lhr, 
rnt 
SNP-1728512-C, DEL-3815808-1, SNP-1732811-T, DEL-2804864-13, DEL-4457113-4, SNP-
700980-C, SNP-1744313-A 
IBUA1-7 ptsP, pykF, insA, rpoB SNP-20771-A, MOB-1755755-IS5-4, MOB-2967576-IS5-4, SNP-4183097-T 
IBUA1-9 yedV, pykF, rlmE, rpoB, cheR DEL-255591-18364, SNP-4182938-C, SNP-1969313-A, SNP-2037332-T, MOB-3327665-IS5-4, 
SNP-1756637-C 
IBUA2-1 rpsC, yobF, yijD, bglF, sapD, rpoC, 
pykF 
SNP-4187619-A, DEL-3905639-1, MOB-1907448-IS5-4, SNP-4161966-A, SNP-1352926-T, SNP-
3449388-T, MOB-1755687-IS5-4 
IBUA2-6 rpsC, yobF, yijD, bglF, sapD, rpoC, 
pykF 
SNP-4187619-A, DEL-3905639-1, MOB-1907448-IS5-4, INS-3449508-GAACATAACGCGACG, 
SNP-4161966-A, SNP-1352926-T, MOB-1755687-IS5-4 
IBUA2-9 rpsC, yobF, yijD, bglF, sapD, rpoC, 
pykF 
SNP-4187619-A, DEL-3905639-1, MOB-1907448-IS5-4, SNP-4161966-A, SNP-1352926-T, SNP-
3449388-T, MOB-1755687-IS5-4 
IBUA3-10 pykF, sapF, ydbA, rpoB SNP-4182820-T, SNP-1352163-A, MOB-1472662-IS5-4, MOB-1757082-+G-S5 
IBUA4-1 yjjQ, pykF, sapB, rpoB SNP-4182820-T, SNP-4603494-A, SNP-1354686-C, INS-1756894-TG 
IBUA4-8 rpsD, pykF, rpoB SNP-3441417-A, SNP-4182820-T, INS-1756894-TG 
IBUA4-9 yaiP, speA, infA, pykF, rpoB, bglG SNP-383289-T, SNP-4182820-T, DEL-3084357-1, SNP-926293-T, SNP-3906597-A, INS-
1756894-TG 
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IBUA5-2 rpoS, pykF, prfA, rpoB SNP-2866767-T, SNP-4182820-T, SNP-1265009-A, SNP-1756217-T 
IBUA5-6 rpoS, pykF, prfA, rpoB SNP-1265009-A, SNP-1756217-T, SNP-4182820-T, DEL-2867337-96 
IBUA6-7 glyQ, rpoS, pykF, rpoB, infB, pyrE SNP-3315513-G, DEL-3815808-1, INS-1756495-A, SNP-3725175-G, DEL-2867356-1, SNP-
4184792-T 
IBUA6-9 glyQ, rne, prfA, rpoC, pykF, ybbW MOB-538086-IS5-4, INS-1756495-A, SNP-3725175-G, SNP-1143323-T, MOB-4281707-IS5-4, 
SNP-1265009-A, SNP-4187214-C 
IBUA7-6 sapC, pykF, rpoB SNP-1756434-G, SNP-4182820-T, SNP-1354314-G 
IBUA7-7 sapC, pykF, rpsL, rpoB, lysU SNP-4182820-T, SNP-4354843-T, SNP-1756434-G, SNP-3474485-A, SNP-1354314-G 
IBUA7-9 gadE, pykF, sapC, rpoB SNP-1756434-G, SNP-4182820-T, SNP-1354314-G 
IBUA8-3 pykF, glyQ, ilvH DEL-3815859-82, SNP-87381-T, SNP-3725175-G, INS-1756495-A, DEL-1995819-40006 
IBUA8-4 pykF, glyQ, ilvH DEL-1995819-40006, SNP-87381-T, SNP-3725175-G, DEL-3815859-82, INS-1756495-A 
IBUA8-10 rrsA, glyQ, ilvN, pykF, yffQ SNP-3725175-G, INS-1756495-A, SNP-2563402-A, SNP-4037067-C, DEL-3815859-82, SNP-
3851044-G 
OCTA1-3 rpoA, mreB, arpA, sapB, lit INS-1198505-AATGATGA, MOB-4222091-IS1-9, SNP-3400673-C, SNP-3440923-T, SNP-
1354687-A 
OCTA1-5 lit, mreB, rpoA, yejO, sapA MOB-2290201-IS5-4, SNP-1356297-T, SNP-3400673-C, DEL-1198498-8, SNP-3440923-T 
OCTA1-9 lit, rpoA, mreB, sapA SNP-3440923-T, SNP-1356297-T, SNP-3400673-C, DEL-1198498-8 
OCTA2-10 dusB, cydX, rpoC, rlmH, nrdE SNP-2803042-A, INS-774243-T, SNP-668691-A, MOB-3410273-IS5-4, INS-4186115-
TTCCGCTGG 
OCTA2-14 dusB, rpoC, rlmH SNP-668691-A, INS-4186115-TTCCGCTGG, MOB-3410273-IS5-4 
OCTA2-16 dusB, rpoC, rlmH SNP-668691-A, INS-4186115-TTCCGCTGG, MOB-3410273-IS5-4 
OCTA4-9 rpoA, trkH, mrdB SNP-665850-T, SNP-4033217-A, SNP-3440923-T 
OCTA4-10 rpoA, trkH, mrdB SNP-665850-T, SNP-4033217-A, SNP-3440923-T 
OCTA4-13 sapD, rpoA, mreB SNP-3440923-T, SNP-3400300-A, SNP-1353062-A 
OCTA5-4 gtrS, rpoC, ydcI, yihQ MOB-4069461-IS5-4, SNP-1495028-C, SNP-4186605-C, MOB-2469636-IS5-4 
OCTA5-8 recE, ydcI, rpoC, hns, gtrS, yihQ MOB-4069461-IS5-4, SNP-4186605-C, MOB-1293196-IS5-4, MOB-1416518-IS5-4, SNP-
1495028-C, MOB-2469647-IS5-4 
OCTA5-9 rpoC, ydcI, yihQ MOB-4069461-IS5-4, SNP-4186605-C, SNP-1495028-C 
OCTA7-2 dusB, rpoC, mreC, pyrE, ycfQ DEL-3410240-1, DEL-3815808-1, SNP-1168895-T, SNP-4186605-C, SNP-3399666-A 
OCTA7-9 mreC, yfcZ, ycfQ, rpoC, dusB, pyrE DEL-3815808-1, SNP-4186605-C, SNP-2460805-A, DEL-3410240-1, SNP-1168895-T, SNP-
3399666-A 
OCTA7-10 dusB, rpoC, mreC, pyrE, ycfQ DEL-3410240-1, DEL-3815808-1, SNP-1168895-T, SNP-4186605-C, SNP-3399666-A 
OCTA8-5 gtrS, hfq MOB-2469886-IS1-9, SNP-4400417-T 
OCTA8-7 gtrS, yciA, hfq SNP-1311924-C, MOB-2469886-IS1-9, SNP-4400417-T 
PUTR2-4 rpoC, cspC, mreB SNP-4186706-A, INS-1907273-CGTCCTG, SNP-3400986-C 
PUTR2-6 rpoC, cspC, mreB SNP-4186706-A, INS-1907273-CGTCCTG, SNP-3400986-C 
PUTR3-1 rph, ygaC, spoT, iscR, lexA, edd, 
proV, nusG, fliK, icdC 
SNP-2661793-A, SNP-2799867-A, INS-2018716-CGGTGGCTG, SNP-3816611-A, SNP-1211308-
T, SNP-4257602-T, INS-2804946-T, SNP-3823025-A, SNP-1934806-T, SNP-4178239-T 
PUTR3-9 rph, spoT, yphF, yfjW, lexA, pstS, 
mreB 
MOB-2678755-IS5-4, SNP-3816611-A, SNP-3400453-G, SNP-4257602-T, DEL-2774809-1, SNP-
3823025-A, INS-3911366-T 
PUTR3-10 rph, ygaC, spoT, iscR, lexA, tyrB, 
proV, nusG, icdC 
SNP-2661793-A, SNP-2799867-A, SNP-3816611-A, SNP-4267824-C, SNP-1211308-T, SNP-
4257602-T, DEL-2904286-122, INS-2804946-T, SNP-3823025-A, SNP-4178239-T 
PUTR4-3 mrdB, cspC, proV, clpX, rpoB DEL-457406-7, INS-2805131-T, MOB-1907410-IS5-4, SNP-4183154-T, SNP-665554-T 
PUTR4-7 mrdB, proV, cspC, rpoB, rpsA MOB-1907410-IS5-4, INS-2805131-T, SNP-4183154-T, SNP-962473-T, SNP-665554-T 
PUTR4-8 glyX, ycgB, proV, rpoB, rpsA, cspC, 
mrdB 
DEL-4392446-1, SNP-4392456-G, SNP-4183154-T, SNP-962473-T, SNP-4392453-T, INS-
2805131-T, MOB-1907410-IS5-4, DEL-1236007-50, SNP-665554-T 
PUTR5-1 spoT, pykF, fliR, waaS, pstS, mreB, 
yjhG, ybcK 
DEL-3910569-7, SNP-3401016-C, SNP-4522146-A, MOB-2023551-IS5-3, SNP-3823799-T, SNP-
568660-T, SNP-1755770-A, DEL-3805056-1 
PUTR5-6 ytfR, rpoC, rpoD SNP-3214770-C, SNP-4186551-G, SNP-4452005-A 
PUTR5-8 rpoC, rpoD SNP-3214770-C, SNP-4186551-G 
PUTR6-2 yieK, stpA, pstA, sspA, murA DEL-3908805-2, SNP-3899249-G, SNP-3377150-A, SNP-3336073-G, MOB-2798597-IS1-9 
PUTR6-7 yeaR, nmpC, rph, yobF, intE, rpoC, 
proV, rpsA, cmtB, glnE 
MOB-1907448-IS5-4, SNP-4186186-C, DEL-2804864-13, MOB-1879829-Δ1-:, DEL-3815859-82, 
SNP-3079559-T, SNP-962933-G, SNP-576891-T, DEL-3197154-12, MOB-1199680-IS1-8 
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PUTR6-10 yeaR, nmpC, rph, tdcR, yobF, tolA, 
yjcF, proV, rpsA, cmtB, intE 
MOB-1907448-IS5-4, SNP-3267294-T, DEL-777151-48, SNP-4282760-C, DEL-2804864-13, 
MOB-1879829-Δ1-:, DEL-3815859-82, SNP-3079559-T, SNP-962933-G, SNP-576891-T, MOB-
1199680-IS1-8 
PUTR7-1 rpsA, spoT, mreB, nusA SNP-3823799-A, SNP-3316916-C, SNP-962922-T, SNP-3400811-T 
PUTR7-7 rpoD, rpoB, murA SNP-3214770-C, SNP-3335317-G, SNP-4183154-T 
PUTR7-9 rpoD, mdtJ, rpoB, murA SNP-4183154-T, SNP-3335317-G, DEL-1673532-181, SNP-3214770-C 
PUTR8-3 spoT, rpsG, proX, mreB, pyrE, 
argG 
SNP-3400195-A, SNP-3318960-A, DEL-3815808-1, INS-2807248-T, SNP-3473612-C, SNP-
3823811-A 
PUTR8-6 yedP, spoT, rpsG, nagC, proX, 
mreB, leuL, pyrE, argG 
SNP-2025435-A, SNP-3400195-A, SNP-3318960-A, DEL-3815808-1, INS-2807248-T, DEL-
83679-3, DEL-701233-1, SNP-3473612-C, SNP-3823811-A 
PUTR8-10 spoT, rpsG, nagC, proX, mreB, 
sfmH, pyrE, argG 
SNP-3400195-A, SNP-3318960-A, DEL-3815808-1, INS-2807248-T, DEL-700785-47, SNP-
3473612-C, SNP-562667-C, SNP-3823811-A 
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Supplementary Figure 1: Compound toxicity screening. Growth rates of MG1655 for varying concentrations of the 11 
selected compounds. Each individual concentration was tested in biological triplicates. 
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Supplementary Figure 2: Overview of the locations of observed mutations in RNA polymerase genes. The mutations are 
shown per population. Mutations found in at least one isolate from a given population are included in the plot. 
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Supplementary Figure 3: Relationship between final osmolarity of ALE and NaCl tolerance and global tolerance, 
respectively. Global tolerance is calculated as the mean tolerance to all the 11 chemicals. Each point represents a single 
evolved strain. The differences in osmotolerance and global tolerance between strains from different conditions does 
not seem to be caused by the differences in osmolarity between the conditions. 
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Chapter 2: The metabolism of evolved tolerance 
2.1 Introduction 
As seen in the previous chapter, ALE can be used to quickly produce strains with improved 
characteristics for a target phenotype. Specifically, it was demonstrated that strain tolerance to 
several industrially relevant products could be improved significantly through ALE. Sequencing the 
evolved strains allows identification of the exact genetic changes that give rise to the improved 
phenotypes. Although such improvements can be very valuable in a strain engineering process, it is 
often desirable to also obtain a deeper understanding of the evolved strains and the observed 
mutations, i.e. what impact a mutation has on the cell, and why the presence of the mutation 
confers a growth advantage in the evolution condition. Elucidating such mechanisms of adaptation 
requires further characterization of the evolved strains in order to investigate how each strain 
differs from the unevolved parent strain. For instance, changes in regulation or metabolism can give 
indications of key cellular mechanisms that mediate the adaptive improvement of a desirable 
phenotype such as tolerance. 
In metabolic engineering, where the ultimate objective is to reroute metabolic flux to production 
pathways, adaptive changes in metabolism are especially interesting. A key question to ask after 
successful strain optimization with ALE is thus whether the mutations have caused metabolic 
perturbations, and whether these perturbations are related to the observed growth adaptations. 
Metabolic changes are amenable to study using metabolomics methods, or other methods that 
derive from metabolomics such as fluxomics. While fluxomics would be the most informative way 
to examine metabolic flux rerouting, this approach primarily gives information on central carbon 
metabolism and  is also challenging to apply to large numbers of strains due to the experimental 
and computational efforts required (Niedenführ et al., 2015). Metabolomics on the other hand can 
be performed relatively quickly and cheaply and also provides insight into the functioning of the 
strain’s metabolism. Data obtained with different metabolomics methods differ with regard to both 
quality, e.g. the precision of the measurements and whether the data is absolute or relative; and 
quantity, e.g. how many metabolites are covered and how quickly a sample can be run (Griffiths and 
Wang, 2010). Since there is usually a trade-off between quality and quantity, the choice of method 
depends on the requirements for the specific use case. 
 45 
In this chapter a metabolomic characterisation of the ALE strains obtained from the study in Chapter 
1 will be described. For this analysis a high-throughput, high-coverage untargeted metabolomics 
method (Fuhrer et al., 2011) was chosen, sacrificing some data quality in exchange for the ability to 
characterize a larger number of strains. The chosen method is a direct-injection mass-spectrometry 
method, meaning that the samples are injected into a mass spectrometer without any prior 
chromatography. Whereas more traditional chromatography-coupled mass-spectrometry methods 
provide a list of ions annotated with mass-charge ratio and column retention time, a direct-injection 
method only provides mass-to-charge ratio (Fuhrer and Zamboni, 2015). This makes the subsequent 
metabolite annotation less accurate and prevents discrimination of isomers but increases 
throughput dramatically. The method does not use any standards, which limits measurements to 
relative ion intensities but allows a high coverage of known metabolites to be obtained. Objectives 
of the metabolomic characterization of the tolerant ALE strains were to: 
1. Determine the metabolic similarity between strains evolved to tolerate the same or different 
chemicals 
2. Investigate to which extent metabolism is involved in the evolution of chemical tolerance 
3. Use the metabolomics information to elucidate in more detail the effect of each mutation 
observed in the evolved trains.  
In addition to the metabolomic characterization of the ALE strains, metabolomics was also used to 
try to characterize the toxic effects of each chemical to a wild type strain from a metabolic 
perspective. 
2.2 Methods 
2.2.1 Strains 
The strains used in this study were isolates from a series of evolution experiments designed to 
evolve chemical tolerance to industrially relevant compounds (See Chapter 1). All these strains were 
derived from E. coli K12 MG1655, which was also used as the reference strain for all analyses. As 
almost all strains evolved on 1,2-propanediol were hypermutators, no strains from this condition 
were included in this study. Due to problems with evaporation during the butanol evolutions, the 
evolved strains did not have significant increases butanol tolerance and were also not included in 
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this study. The strains that were used were evolved on 2,3-butanediol (23BD), hexamethylene-
diamine (HMDA), putrescine (PUTR), glutarate (GLUT), adipate (ADIP), hexanoate (HEXA), octanoate 
(OCTA), isobutyrate (IBUA) and coumarate (COUM). 
2.2.2 Mass spectrometry 
All metabolomics data was obtained from an Agilent qTOF 6550 instrument, using a direct injection 
method with no prior chromatography step (Fuhrer et al., 2011). 
2.2.3 Cultivations 
All cultures were grown in triplicates in 96-deep well plates with sandwich cover lids at 37 deg.C 
with shaking at 300 rpm. The growth medium was M9 (6.8 g/L Na2HPO, 3 g/L KH2PO4, 1 g/L NH4Cl, 
0.5 g/L NaCl, 1 mM MgSO4, 0.1 mM CaCl2) with 1% glucose. Additionally, the medium contained the 
following trace elements: 22.17 µM ethylenediaminetetraacetate, 7.82 µM ZnSO, 1.77 µM MnCl2, 
0.63 µM CoCl2, 0.51 µM CuSO4, 0.83 µM Na2MoO4, 5.40 µM FeSO4, 8.09 µM H3BO3, 0.30 µM KI. 
2.2.4 Metabolic profile characterization 
2.2.4.1 Sampling 
The strains were cultivated overnight and reinoculated in fresh medium. In each cultivation plate 
the MG1655 reference strain was inoculated to 12 different starting densities over a 15-fold range 
in order to obtain a large number of reference metabolite measurements at different densities. 
When the cultures were at densities between OD600 of 0.5 and 1.5 they were sampled at three to 
four timepoints with approximately 1-hour intervals. The samples (30 µL of each culture) were 
immediately quenched in 120 µL cold extraction solution (50% methanol, 50% acetonitrile). The 
densities of the cultures were measured on a Tecan Sunrise plate reader at each sampling. 
The quenched samples were incubated at -18 deg.C for 2 hours and centrifuged at 3000x g for 10 
minutes. The supernatants were transferred to clean plates, which were sealed and kept at -80 
deg.C until the time of mass spectrometry measurements. 
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2.2.4.2 Data processing 
All detected ions were matched to deprotonation products of native E. coli metabolites by 
mass/charge ratio with a tolerance of 0.003 Dalton/charge. The list of native E. coli metabolites was 
obtained from the iJO1366 genome-scale reconstruction (Orth et al., 2011). Ion intensities were 
normalized by OD and compared to the MG1655 reference. This was done by fitting a linear relation 
between log2(OD) and log2(intensity) for the MG1655 reference samples for each ion 
log123#(342#56789 = : ∙ log1;<6789 + = (1) 
For each sample a log Fold Change (logFC) for each ion was calculated by the deviation from the 
linear relation for MG1655, as shown in Figure 1. 
>?@AB = log(23#(342#5CD*) − : ∙ log(;<CD*) − = (2) 
Evolved strain logFC’s were calculated as the mean logFC for all the corresponding samples taken at 
a culture density between 0.5 and 1.5. 
 
Figure 1: Illustration of the calculation of logFC from the correlations of log(OD) and log(intensity) for the reference 
strain and a mutant strain. The blue points show OD and ion intensities for samples from the reference strain, while the 
orange points are samples from the mutant. The parallel linear trends between log(OD) and log(intensity) for the two 
strains show that the ion is systematically less abundant in the mutant strain compared to the reference strain. 
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2.2.5 Chemical perturbation 
2.2.5.1 Sampling 
Cultures of MG1655 were grown in M9 medium with 1% glucose overnight and reinoculated in fresh 
medium inside a 37 deg.C climate chamber where all the chemical perturbation experiments were 
carried out using temperature-equilibrated equipment and materials. When the cultures reached 
OD 1, a sample of 20 µL was transferred to 80 µL cold extraction mix, as a baseline measurement. 
390 µL of culture was then transferred to a well containing 10 µL of a solution of the given chemical 
and quickly mixed by pipetting. Immediately after, 200 µL of the perturbed culture was aspirated in 
an electronic pipette. At each sampling time 20 µL was dispensed into 80 µL of cold extraction mix. 
Sampling times were 10, 20, 30, 45, 60, 80, 100, 120, 180 and 300 seconds after perturbation. This 
was replicated for three separate cultures per perturbation chemical, and nine cultures for 
perturbation with water. The used perturbation concentrations are shown in Table 1. 
2.2.5.2 Data processing 
All detected ions were matched to deprotonation products of native E. coli metabolites by 
mass/charge ratio with a tolerance of 0.003 Dalton/charge. The list of native E. coli metabolites was 
obtained from the iJO1366 genome-scale reconstruction (Orth et al., 2011). For each annotated ion, 
the response to each chemical perturbation was compared to the response to the water 
perturbation. A linear model was used to identify significant interactions between metabolites and 
chemical perturbations, i.e. metabolites that responded differently to perturbation with the 
chemical compared to water. The linear model was given as: log(5G) = : + =HIJKG*GIJL + =*GC7G + =HIJKG*GIJL:*GC7L + NG (3) 
The left-hand term is the logarithm of the intensity of the ion in question for a sample 2, while the 
right-hand side contains the intercept and the parameters associated with the condition and time 
point of sample 2, as well as the residual, NG. The significance of the interaction term was tested 
using analysis of variance. For each condition the interaction p-values for each ion were corrected 
for multiple comparisons using the Benjamini-Hochberg False Discovery Rate (Benjamini and 
Hochberg, 1995). A corrected p-value less than 0.05 was considered evidence that the time-
dependent response of the ion was different between the perturbation condition and the water 
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control. Additional control samples containing each one of the perturbation compounds and no cells 
were used to exclude ions that are associated with the perturbation compounds themselves. 
2.3 Results and discussion 
2.3.1 Metabolic characterization of evolved strains 
All 169 evolved strains from the nine selected evolution conditions (2,3-butanediol (23BD), 
hexamethylenediamine (HMDA), putrescine (PUTR), glutarate (GLUT), adipate (ADIP), hexanoate 
(HEXA), octanoate (OCTA), isobutyrate (IBUA), and coumarate (COUM)) as well as the reference 
strain were subjected to metabolic characterization. Including biological replicates and multiple 
samplings, this resulted in a total of 2103 samples being analysed. Of the detected ions, 544 could 
be matched to metabolites found in the iJO1366 genome-scale metabolic model of E. coli. For each 
evolved strain, a metabolic profile was constructed, defined as the calculated logFC of each of these 
544 ions compared to the reference strain. 
The first question to be addressed was that of metabolic similarity between strains evolved in the 
same and different selective conditions, respectively. This was done by comparing the metabolic 
profiles of all evolved strains measured in a standard reference condition (M9 with 1 % glucose). 
Metabolic similarity can be defined as a function of the Euclidean distance between two metabolic 
profiles in the N-dimensional metabolic space, with N being the number of measured metabolites. 
All metabolic similarities were visualized simultaneously using the nonlinear dimensionality 
reduction method t-distributed Stochastic Neighbour Embedding (t-SNE) (van der Maaten and 
Hinton, 2008). Since the metabolic similarities between independently evolved populations in 
particular were of interest, metabolic profiles for each independent population were calculated as 
a simple mean of all isolates from that population. A t-SNE visualization of the metabolic similarities 
between independently evolved populations is shown in Figure 2. The t-SNE plot shows a very clear 
trend of high similarity between populations evolved in the same condition compared to 
populations evolved in different conditions. This suggests that each evolutionary condition has 
conferred a characteristic metabolic fingerprint that distinguishes the strains evolved in a given 
condition from strains evolved in other conditions. The existence of such a characteristic metabolic 
phenotype in all strains from a given conditions is evidence of some degree of convergent evolution, 
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i.e. parallel populations finding genetically distinct paths towards similar phenotypes, as opposed 
to parallel populations evolving to metabolically distinct phenotypes with similar fitness. 
 
Figure 2: t-SNE plot of all evolution populations and MG1655 based on the mean metabolic profile of strains from each 
population. Each point represents a single independent population and is coloured by the condition it was evolved in. 
Given that each evolution condition seems to be associated with a characteristic metabolic profile, 
a relevant question was to which degree these metabolic profiles correlated with the tolerance 
phenotypes that the strains were evolved for. If the characteristic metabolic profiles are associated 
with tolerance phenotypes, it would be expected that evolution conditions with similar 
characteristic metabolic profiles would also result in strains with similar tolerance profiles, as 
measured by tolerance to each of the toxic chemicals (see Chapter 1, Figure 3a). To investigate this, 
each condition’s characteristic metabolic profile was calculated as the centroid of the metabolic 
profiles of all isolates from that condition. Similarly, the mean tolerance profile for each condition 
was calculated as the centroid of tolerance profiles of all isolates from that condition. For each of 
the 36 pairs of evolution conditions, the cosine similarity between their metabolic and tolerance 
profiles, respectively, were compared. A scatter plot of this comparison is shown in Figure 3, 
showing a positive correlation (Pearson’s r = 0.44, p = 0.0001) between metabolic similarity and 
tolerance similarity. This could indicate that the metabolic state plays a role in chemical tolerance, 
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even though non-metabolic factors are clearly also involved, given the modest correlation 
coefficient. 
 
Figure 3: Comparison of the metabolic similarity and phenotypic similarity between all 36 pairs of evolution conditions. 
Since independent populations evolved in the same condition seem to have reached similar 
metabolic phenotypes, a reasonable hypothesis would be that the metabolic phenotype in question 
is involved in the mechanism of tolerance. The reasoning in this argument is identical to the one 
used in Chapter 1 to hypothesize that a mutation arising independently in several parallel 
populations is likely to be directly related to tolerance. To investigate this hypothesis, the first step 
is to elucidate the details of the characteristic metabolic profile for each condition – in other words, 
which specific metabolic changes are characteristic for strains from a single condition? 
While the t-SNE algorithm is a powerful method for identifying complex structures in large datasets, 
it partly sacrifices interpretability compared to simpler methods. While structure found by Principal 
Components Analysis can be investigated by analyzing the individual component vectors, no similar 
strategy can be applied with t-SNE, as the dimensionality reduction is not based on a linear 
transformation but on a complex non-linear mapping (Gisbrecht and Hammer, 2015). Instead an 
approach based on decision trees was used (Tan et al., 2005). For each evolution condition a 
decision tree was used to predict whether a strain was evolved in this condition or not based on the 
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measured metabolites. Because the rules of a fitted decision tree can be easily inspected, this 
allowed identification of metabolites that are important for distinguishing strains from a given 
condition from the remaining strains. Important metabolites were found by inspecting the nodes 
near the root of the tree. The usefulness of each single metabolite for distinguishing strains could 
then be visualized by showing the distribution of relative concentrations of this metabolite within 
each group of strains (Figure 4). Each panel of Figure 4 displays the logFC values for a metabolite 
that was found to be important for distinguishing strains from at least one of the evolution 
conditions. The points represent strains, separated by the conditions they were evolved in. This 
analysis shows that there are indeed metabolites in all conditions, that have consistently either 
increased or decreased concentrations in most strains. This confirms the pattern seen from Figure 
2 of strains from the same condition being metabolically similar. 
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Figure 4: The distributions of relative metabolite concentration for eight different metabolites that were found to be 
important for distinguishing strains from at least one condition. The points represent strains split by the condition they 
were evolved in. The conditions where the given metabolite was found to be important for distinguishing strains are 
highlighted in blue.  
In some cases, the consistently perturbed metabolites correspond to similar mutations seen in all 
strains from a given condition. More specifically these cases are the strains evolved on isobutyrate, 
glutarate and adipate. The strains evolved on isobutyrate all had mutations in the pykF gene and 
also had increased phosphoenolpyruvate (PEP) levels (Figure 4a). A disruptive mutation in the 
pyruvate kinase encoded by pykF could well be expected to create a bottleneck at this step, causing 
the substrate PEP to accumulate (Chapter 1, Figure 5d). While the presence of high PEP levels in the 
  54 
isobutyrate strains is not surprising, it can help understand the effect of pykF mutations in these 
strains. PEP is a known regulator of upper glycolysis, specifically by inhibiting phosphofructokinase 
activity (Uyeda, 2006), and thus the isobutyrate strains presumably have decreased flux through the 
Embden-Meyerhof-Parnas pathway and increased flux through the Entner-Doudoroff or pentose 
phosphate pathways instead. The strains evolved on glutarate and adipate all had mutations in the 
kgtP gene, and also had very high levels of alpha-ketoglutarate (AKG) (Figure 4b). Since kgtP encodes 
an active AKG importer (Seol and Shatkin, 1991) this might seem unintuitive. This result can however 
be explained by AKG leaking out through the cell membrane, which has previously been 
documented (Yan et al., 2011). In the absence of a transporter to bring AKG back in, it will 
accumulate extracellularly resulting in high concentrations in the whole-culture sample being 
injected into the mass spectrometer. 
The above cases are examples of convergent evolution on the genetic level, as all the independent 
populations have mutations in the same gene, which can explain the corresponding metabolic 
feature (high PEP or AKG levels respectively). In other conditions there is evidence of convergent 
evolution on the metabolic level, as all isolated strains share certain metabolic characteristics 
despite not having specific mutations in common. Examples of such conditions are HMDA and 
hexanoate. All the strains evolved on HMDA had decreased levels of deoxy-ribose-phosphate 
(Figure 4c). This cannot be explained by a common genetic change, as no single gene was mutated 
in all these strains. Indeed, one population did not have any mutational overlap with any one of the 
remaining populations. Likewise, all strains evolved on hexanoate had increased levels of methyl-2-
oxopentanoate (Figure 4d) even if these strains do not share any universal mutations. The presence 
of characteristic phenotypic (e.g. metabolic) commonalities between strains with little or no genetic 
overlap might provide insight into the mechanisms with which individual genes contribute to 
tolerance. If gene A is mutated in some strains while gene B is mutated in other strains, it is likely 
that tolerance arises mechanistically from an effect that genes A and B have in common. In trivial 
cases genes A and B might simply be analogous, e.g. subunits of the same complex or different steps 
in a linear pathway, whereas if A and B have diverse sets of effects, such as transcriptional 
regulators, overlaying the two sets of effects with each other might indicate which effects are 
important for tolerance. While this method can be used for many different types of phenotypic 
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effects, the effects of each mutation must generally first be characterized, and thus, depending on 
the effect phenotype in question, a significant amount of work is required. 
Further analyses were performed to elucidate the relationship between mutations and metabolic 
profiles in the evolved strains. A simple statistical model with a specific metabolite as dependent 
variable and mutations as independent variables could be used, but due to the very high degree of 
collinearity between the mutations (because of common ancestry as well as shared evolution 
conditions), fitting such a model was not considered feasible. Instead, previously published data on 
the relationship between genes and metabolites was used, in the form of metabolomics data for all 
single-gene knockout E. coli strains in the Keio collection (Fuhrer et al., 2017). This data provides 
information on the associations between genes and metabolites and can help estimate the impact 
on gene function of the individual mutations observed in the evolved strains, which is generally not 
known. A statistical model was used having the full metabolite profile as dependent variable and 
the impact of each mutation on the affected gene(s) as independent variable, given the gene 
knockout metabolite data from Fuhrer et al. (2017). To keep the model complexity reasonable some 
simplifying assumptions were made. First, the impact of a mutation on the function of a gene was 
quantified as a continuous univariate variable ranging from loss-of-function through neutral to gain-
of-function. Second, the combined effect of several mutations on the metabolic profile was 
assumed to simply be the sum of each individual mutation effects on the metabolic profile. The 
resulting model is a multivariate linear model given by 
P = Q ∙ R ∙ S ∙ T + N (4) 
Y is the matrix of relative metabolite concentrations in the evolved strains and has shape Nstrains x 
Nmetabolites. X is a binary design matrix encoding the mutations found in each strain and has shape 
Nstrains x Nmutations, where Nmutations is the number of unique mutations identified in the evolved 
strains. W is the parameter to be fitted and is a diagonal Nmutations x Nmutations matrix, where the 
diagonal contains the estimated impact score of each mutation (loss-of-function, neutral or gain-of-
function). M is a second binary design matrix encoding which genes each mutation affects, and has 
shape Nmutations x Ngenes, where Ngenes is the number of unique mutated genes in the evolved strains. 
Finally, K is a Ngenes x Nmetabolites matrix containing the relative metabolite concentrations in each 
single-gene knockout strain. The parameter matrix W was fitted through gradient descent by 
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minimizing the sum of squares of the error term, N. The fitted model can be used to get estimated 
impact scores, predicting whether each mutation has a loss-of-function or gain-of-function effect. 
A positive estimated impact score was interpreted as loss-of-function, while a negative estimated 
impact score was interpreted as gain-of-function. 
Validating the estimated mutation impacts is difficult since, as mentioned earlier, it is not known 
what the real impacts of most mutations are. However, a rough classification into expected 
deleterious and non-deleterious mutations can be made based on their type and location in the 
genome alone. For deletions, insertions and mobile element insertions, a mutation was expected to 
be deleterious if it was within the coding sequence of a gene, while the majority of mutations 
located outside of coding sequences were not expected to be deleterious. For SNP’s only nonsense 
(stop codon inducing) polymorphisms would be expected to be highly deleterious. Comparing the 
impacts estimated from mutation location to the impacts estimated by the model using 
metabolomics data showed that mutations expected to be deleterious were significantly more often 
estimated to have loss-of-function impacts (83 out of 156) compared to mutations not expected to 
be deleterious based on location (111 out of 305) (Fisher’s exact test, p < 0.001). This pattern of 
association between impact estimated from mutation location and impact estimated from 
metabolomics data is apparent in all four types of mutations, as seen from Figure 5, which shows 
the fraction of mutations of different types being estimated to have loss-of-function impacts. This 
supports the validity of interpreting the impact scores estimated with the model using 
metabolomics data as an indicator of whether the mutation has a gain-of-function or loss-of-
function effect. It is worth noting however, that the location-estimated impact of a mutation cannot 
be regarded as a classification of the true impact, and thus the predictive performance of the model-
estimates cannot be accurately assessed. Particularly the assumption that all missense SNP’s are 
non-deleterious is dubious, given the knowledge that many proteins are indeed sensitive to amino-
acid substitutions in active sites. 
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Figure 5: Overview of the fraction of mutations estimated to be deleterious for each mutation types. The classification 
between Deleterious (orange) and Non-deleterious (Blue) is based on the nature and position of each mutation. The 
“fraction estimated deleterious” is calculated as the fraction of mutations having estimated impact scores larger than 0. 
Even though it is not generally possible to predict the impact of missense mutations, the ALE data 
does allow inferences to be drawn in certain cases. With available genetic data from populations 
evolved in parallel in the same condition, it is possible to assess whether a missense mutation is 
likely to be deleterious by considering other mutations in the same gene, within strains from the 
same condition. For instance, the pykF gene was, as previously mentioned, mutated in all strains 
from the isobutyrate condition. Seven distinct pykF mutations were observed in the isobutyrate 
strains, of which four were clearly deleterious (frameshift mutations and mobile element 
insertions), while the remaining three were missense SNP’s. Since all these mutations were selected 
under the same condition, it is reasonable to assume that they have the same effect on the function 
of the pykF gene, i.e. inducing loss-of-function. Looking at the estimated impact scores, all seven 
mutations do indeed have positive scores (Figure 6), indicating loss-of-function impacts. The same 
can be done for other genes that were mutated in several populations from the same condition. In 
the 2,3-butanediol condition the genes metJ and purT were mutated in seven and five populations, 
respectively, out of seven. A single metJ mutation was a mobile element insertion, while seven were 
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missense SNP’s of which five have putative loss-of-function effects based on the estimated impact 
score (Figure 6). The purT gene was mutated by a mobile element and three missense SNP’s, all of 
which had putative loss-of-function effects (Figure 6). 
 
Figure 6: Estimated impact scores for pykF mutations found in the isobutyrate strains and for purT and metJ mutations 
found in the 2,3-butanediol strains. The mutations that are expected to be deleterious based on their location are 
highlighted in bold. Almost all of the missense SNP’s are estimated to be deleterious, consistent with the expectation 
that mutations in the same gene in the same condition will have the same effect. The mutation names indicate whether 
they are mobile elements (MOB), SNP’s or insertions (INS), as well as the genome location of the mutation. 
Several mutations, predominantly missense SNP’s, are also predicted to have a strong gain-of-
function impact. One of these is a mutation in the ilvH gene, which was identified in two strains 
evolved on isobutyrate. The ilvH gene encodes an acetolactate synthase which converts two 
pyruvate molecules to acetolactate as part of the branched-chain amino acid biosynthesis. The 
mutation causes a substitution near the N-terminal of the protein, which contains an ACT domain 
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responsible for feedback inhibition by valine. The strains harboring the mutation had increased 
levels of valine (see Supplementary Figure 1), consistent with a disruption of feedback regulation of 
valine biosynthesis. Such a deregulation of an enzyme would indeed be an example of a gain-of-
function mutation, as the catalytic activity would be expected to increase. The enzymatic conversion 
of pyruvate into acetolactate is also the first step of the isobutyrate biosynthesis pathway that was 
inserted into the evolved strains (Zhang et al., 2011). Interestingly, the strains with the mutation in 
ilvH or an equivalent mutation in the ACT domain mutation of the isozyme ilvN seemed to be able 
to produce isobutyrate significantly better than the other evolved strains (Chapter 1, Figure 6b 
(IBUA8-3 and IBUA8-10)). This could indicate that conversion of pyruvate into acetolactate is a 
limiting step in the production pathway due to allosteric inhibition by valine. Since valine and 
isobutyrate are chemically similar, it is also possible that the acetolactate synthase is inhibited by 
isobutyrate, resulting in deficient production of branched-chain amino acids. 
Another example of a mutation predicted to have a gain-of-function effect is a nonsense mutation 
in the rpoS gene, found in the isobutyrate strains, which encodes the stress-associated sigma factor, VW. Although the induced stop codon truncates the protein by 54 amino acids, removing the sigma 
factor’s domain 4 in its entirety, the estimated impact score of the mutation suggests that it confers 
a gain-of-function. In vitro experiments have shown that the deletion of domain 4, does not abolish 
the activity of VW (Gowrishankar et al., 2003). If deletion of domain 4 affects the regulation of VW it 
is possible that this will have a positive effect on VW activity. 
Overall, the linear model based on metabolic profiles of the evolved strains and knockout strains 
shows predictive value in estimating the impact a given mutation has on the gene(s) it affects, 
although the accuracy is hard to assess due to the true impact of most of the observed mutations 
being unknown. Since the data for the knockout strains need only be collected once for a given 
organism, metabolic profiling of evolved strains can be an easy way to gain some insight into the 
nature of the observed mutations. A drawback of the method is that the metabolic effects of 
knockouts can only be measured for non-essential genes. Thus, the method is unable to provide 
information on mutations that affect essential genes. A potential solution to this challenge would 
be to use a library of over- or underexpression strains as references either for all genes or just for 
the essential genes. 
  60 
2.3.2 Perturbation time-course metabolomics 
The results presented above allow some insight to be gained into how the evolved strains have 
achieved tolerance, but in order to completely describe this process, the mechanisms of toxicity for 
the ALE conditions must be known. The nature of the toxic effects of the ALE compounds were 
investigated by perturbing wild-type MG1655 with each of nine chemicals and measuring the short-
term metabolic responses. This approach allows detection of direct interactions between 
metabolism and the perturbing chemical, and thus quantification of the degree to which the toxic 
effects are related to metabolism. To avoid major problems with ion suppression in the mass 
spectrometry measurements, perturbation concentrations in the 160-180 µM range were used. 
Even though this was significantly below the concentrations used in the ALE experiments as well as 
the minimal inhibitory concentrations (Chapter 1, Supplementary Figure 1), it was hypothesized that 
direct metabolic effects, e.g. from allosteric inhibition might still be observed. In addition to the nine 
ALE chemicals, a range of control perturbations were also carried out. The control compounds 
included antibiotics, amino acids, a synthetic uncoupler of the proton gradient and an oxidative 
stressor (Table 1). The purpose of the control compounds was to validate that the experimental 
method can be used to detect known metabolic responses. Furthermore, in case such responses 
could be detected, it might be possible to compare the response to a chemical with unknown 
mechanism of toxicity to the responses to the control compounds, for which the effects are largely 
known. 
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Table 1: Overview of the compounds used for perturbations and their concentrations. The antibiotics were used at the 
recommended concentrations for selective media. 
Compound Concentration   Compound Concentration 
2,3-butanediol 166 µM  Antibiotics Ampicillin 130 µM 
HMDA 172 µM   Kanamycin 100 µM 
Putrescine 170 µM   Chloramphenicol 130 µM 
Glutarate 174 µM  Uncoupler Dinitrophenol 170 µM 
Adipate 171 µM  Oxidative H2O2 180 µM 
Hexanoate 172 µM  Amino acids Serine 171 µM 
Octanoate 173 µM   Valine 160 µM 
Isobutyrate 172 µM     
Coumarate 152 µM  Control Water  
 
For each perturbation condition, a list of significantly responding metabolites was identified. 
Significantly responding metabolites were defined as metabolites whose time-dependent response 
to a perturbation was significantly different compared to the control (water) condition.  
As an example, in the chloramphenicol condition, the amino acids glutamate, lysine and 
leucine/isoleucine were among the metabolites found to significantly accumulate over time (Figure 
7a). This is consistent with the mechanism of action for chloramphenicol, which is to prevent growth 
by inhibiting protein synthesis. Perturbation with either serine or valine resulted in high numbers of 
significantly responding metabolites, which is consistent with the fact that both are known to inhibit 
growth through allosteric inhibition of enzymes (De Felice et al., 1979; Hama et al., 1990). For 
perturbation with valine, several intermediates of branched-chain amino acid metabolism showed 
a fast negative response (Figure 7b), consistent with valine’s known inhibition of acetolactate 
synthase, which catalyzes the first step of branch-chain amino acid synthesis. 
  62 
 
Figure 7: a) Time profiles for the amino acids leucine/isoleucine, lysine and glutamate following perturbation with water 
or chloramphenicol. b) Time profiles for branched-chain amino acid intermediates following perturbation with water or 
valine. The lines show the mean relative log intensities of biological replicates (three for chloramphenicol and valine, 
nine for water), while the shaded areas show the ± 1 standard deviation range. 
A summary of the number of significantly responding metabolites for each perturbation is shown in 
Figure 8. It is evident that perturbation with eight of the nine ALE compounds results in very weak 
or no metabolic effects compared to most of the control perturbations. In contrast to the rest of 
the ALE compounds, perturbation with coumarate does seem to elicit a metabolic response. One 
reason for this difference could be that coumarate is one of the more toxic compounds, in that 
relatively low concentrations were needed to inhibit growth (Chapter 1, Supplementary Figure 1). 
However, the same approximate levels of toxicity were observed for the compounds hexanoate, 
octanoate and isobutyrate , for which, in comparison to coumarate, only very little metabolic 
response to the perturbations was seen. Additionally, the perturbation concentration for coumarate 
is still several orders of magnitude lower than the concentrations used during ALE. It seems 
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therefore, that the toxic effects of coumarate are significantly more metabolic in nature than the 
other aforementioned compounds. The compounds 2,3-butanediol HMDA, putrescine, glutarate 
and adipate, on the other hand, might have toxic effects that are not related to metabolism, or 
alternatively the lack of a metabolic response could be explained by the relatively lower toxicity of 
these compounds, which were tolerated at concentrations approximately five times higher than 
coumarate. The considerable metabolic response to coumarate compared to the other ALE 
compounds might also be explained by the natural origin of coumarate. As a precursor in plants to 
the monolignol p-coumaryl alcohol, coumarate is involved in the formation of lignin and lignans, 
both of which are implicated in plant defenses against pathogens (Bagniewska-Zadworna et al., 
2014; Qin et al., 2016). It is likely that the constituents of lignin and lignans, including coumarate, 
have been selected through evolution because of their potential for specific inhibitory bioactivity. 
For compounds that are never or very rarely found in nature, such bioactivity would be entirely 
accidental, and the affinity of interactions with metabolic enzymes would likely be much lower. 
 
Figure 8: The number of significantly responding metabolites for each perturbation condition. Data for the nine 
perturbations using the ALE compounds are colored orange, while the data for the control perturbations are colored 
blue. 
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While the results from the control perturbations show that metabolic responses to a chemical 
perturbation can be detected using time-course metabolomics, only little information could be 
gained on the ALE compounds. Since a likely reason for the limited metabolic response to eight out 
of nine ALE compounds is that the perturbation concentrations were too low, the method might be 
better suited for investigating chemicals that are toxic at such low concentrations. On the contrary, 
the results for ampicillin and kanamycin, which were used at concentrations at which growth is 
inhibited, show that a metabolic response will not necessarily be seen just because the compound 
is toxic at the perturbation concentration. The lack of metabolic responses for these two antibiotics 
can be explained by their mechanisms of action: Ampicillin inhibits the synthesis of cell wall (Tomasz, 
1979), while kanamycin causes mistranslation (Davies and Wright, 1971), both of which will likely 
only have a modest effect on cell metabolism within the time-frame of the experiment. 
In cases where a metabolic response is detected, it would in principle be possible to use the 
responses of each metabolite to identify the specific mechanism of toxicity of a given chemical, e.g. 
targets for allosteric inhibition. As this would allow rapid identification of chemical-metabolism 
interactions, future work focusing on this aspect would be of value. 
2.4 Conclusions 
In this study high-throughput metabolomics was used to metabolically characterize a group of 
strains evolved to tolerate nine different chemicals, and to investigate the mechanisms of action for 
these chemicals. The metabolic profile characterizations of the evolved tolerant strains showed a 
strong association between metabolic profile and the condition each strain was evolved under. 
Additionally, a characteristic metabolic phenotype for a given evolution condition was often 
observed across strains with very little or no genetic commonality. This indicates that the metabolic 
phenotype is representative of the phenotypic changes that lead to improved tolerance, and that 
tolerance against a given chemical is achieved through very similar phenotypic mechanisms even 
though different strains have found different mutational paths to this phenotype. Taking advantage 
of previously published data on the metabolic effects of single-gene knockouts in E. coli, it was 
possible to use the metabolic profiles of the evolved strains to infer the impact of individual 
mutations on the functionality of the affected gene. Although the method showed promising 
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potential for differentiating between deleterious and non-deleterious mutations, additional 
validation is needed on mutations with known effects. 
Using time-course metabolomics in perturbation experiments to elucidate details of chemical 
toxicity proved to be difficult due to technical limitations on perturbation concentrations in 
combination with the relatively low toxicity of some chemicals. However, results for a set of control 
perturbations suggested that the metabolomics approach can be used to quantify the degree of 
metabolic response to a chemical perturbation. Specific metabolite responses consistent with the 
known effects of two different control perturbations could be identified, demonstrating that the 
method might be used to infer mechanisms of action from the observed responses. 
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2.6 Supplementary Materials 
 
Supplementary Figure 1: Log fold-change values for the strains evolved on isobutyrate. The strains that have mutations 
in ilvH/N are highlighted in red. These strains have increased levels of valine consistent with the hypothesized removal 
of valine feedback inhibition by these mutations. 
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Chapter 3: A deep neural network for propagation of signals 
through a metabolic network 
3.1 Introduction 
In recent years there has been a rapid increase in the performance of machine learning algorithms 
on a variety of problems. The main factor in this trend has been the advent of deep neural networks 
(LeCun, Bengio, & Hinton, 2015). Traditional neural networks, also known as multilayer perceptrons 
(MLP), have been in use since the 1980’s (Hopfield, 1988), but had started to lose popularity in the 
2000’s in favor of other algorithms such as support vector machines and other kernel-based 
methods (Hofmann, Schölkopf, & Smola, 2008).  
One of the features that has allowed modern deep neural networks to outperform most other 
machine learning algorithms is the introduction of specialized layer architectures in addition to the 
fully connected hidden layers found in MLP’s (LeCun et al., 2015). The most widespread specialized 
architectures are convolutional layers, which have successfully been used to process image, 
tomogram, and video data (Bernal et al., 2018; Karpathy et al., 2014; Krizhevsky, Sutskever, & 
Hinton, 2012), and recurrent layers which have allowed advances in analysis of sequence data, 
particularly in natural language processing (Bahdanau, Cho, & Bengio, 2015; Lipton, Berkowitz, & 
Elkan, 2015). Whereas traditional MLP’s and other machine learning algorithms usually require that 
each data point is described by a vector of features, a large advantage of convolutional layers and 
recurrent layers is that they can take input without or with only minimal processing, e.g. raw pixel 
or text data. They can thus function as trainable feature extractors, that can learn to derive 
characteristics from the data with predictive value for the given problem. 
Various problems within biology have benefited from the use of convolutional as well as recurrent 
neural networks. Convolutional networks have for example been used to identifying binding motifs 
for DNA- and RNA-binding proteins using a convolutional layer as trainable position weight matrices 
(Alipanahi, Delong, Weirauch, & Frey, 2015) and automated detection of subcellular protein 
localization in yeast from microscopy images (Pärnamaa & Parts, 2017). Recurrent neural networks 
in turn have been used among other things to predict protein secondary structure from amino acid 
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sequences (Sønderby & Winther, 2014) and predict RNA splice junctions from DNA sequences (Lee, 
Lee, Na, & Yoon, 2015). 
However, problems that can be formulated as image or sequence analysis problems are only a small 
subset of possible biological prediction tasks. A more general type of datasets is what could be 
described as graph-structured data, or network-related data. Biology in general and systems biology 
in particular is known for its large number of networks ranging from genetic interaction networks 
through regulatory networks and protein interaction networks to metabolic reaction networks 
(Bader, Kühner, & Gavin, 2008; Kitano, 2002). Datasets of measurements related to e.g. genes, 
proteins or metabolites can thus be structured in a graph according to available information of the 
relevant networks, and including information on how different data points are related to each other 
can potentially allow statistical models to better describe the data. However, it is rarely obvious 
how network structure affects the relationship between data points, and it most likely depends on 
the type of network as well as the nature of the prediction problem. A potential solution to this 
problem is to use a trainable machine learning model to infer the significance of the network 
structure directly from the data (Bronstein, Bruna, Lecun, Szlam, & Vandergheynst, 2017). 
The data used in traditional machine learning models such as MLP’s, support vector machines or 
decision trees is inherently unstructured, and such models are thus poorly suited for operating on 
graph-structured data. Deep neural architectures such as recurrent and convolutional networks 
derive part of their power from the ability to take advantage of structure in the data, in the form of 
sequences or grids, respectively. Neither can however be applied to the more general structures 
that can be represented by graphs. 
The challenge of combining machine learning and graphs such as biological networks has been 
addressed in numerous studies. This includes machine learning algorithms to infer network 
structure, e.g. in the form of protein interaction networks (Ballester & Mitchell, 2010) or 
transcriptional regulatory networks (Marbach et al., 2012), as well as algorithms that cluster or 
classify networks structures directly (Yanardag & Vishwanathan, 2015), e.g. to identify disease 
states from changes in biological networks (Mall, Cerulo, Bensmail, Iavarone, & Ceccarelli, 2017). In 
comparison, less work has focused on using prior knowledge about biological network structures to 
improve predictions based on data embedded in the network. 
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In this work a novel deep learning framework is developed to allow supervised prediction problems 
to take advantage of graph-structure between features in the input data. This framework is based 
on the concept of graph convolutional networks (GCN) developed by Kipf & Welling (2017) to do 
semi-supervised learning on datasets where observations are related to each other. The prediction 
problem used to test this deep learning framework involves using stoichiometric and regulatory 
networks of Escherichia coli metabolism to predict how a gene knockout will affect the levels of 
metabolites. The prediction problem including the types of input data, output data and graph 
structures are shown in Figure 1. 
 
Figure 1: Overview of the prediction problem used in this study. Changes in metabolite concentrations are predicted 
from predicted fluxes and genetic perturbation, using the graph structures of stoichiometric and regulatory networks. 
3.2 Methods 
3.2.1 Neural network architecture 
The deep neural network model used in this study consisted of a combination of graph convolutional 
layers (Kipf & Welling, 2017) and fully connected layers. A graph convolutional layer takes as input 
the normalized adjacency matrix, Â, for a graph, and a N x M data matrix, X, where N is the number 
of nodes in the graph and M is the number of data features per node. The trainable parameter of a 
graph convolutional layers is an M x K weight matrix, W, where K is the number of features per node 
in the output data. The activations of a graph convolutional layer are calculated as 
Y = V1	Â	Q	R9 (1) 
+ Network structure
Stoichiometry
Regulatory network
Model
Graph-
convolutional 
deep neural
network
Predictions
Changes in metabolite
concentrations
Features
Genetic perturbations
Predicted wild-type fluxes
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where V is the chosen non-linearity function (Kipf & Welling, 2017). The adjacency matrix is 
normalized using its degree matrix, D 
Â = <\	]	^	_	<\	]^ (2) 
which preserves symmetry in the adjacency matrix and ensures that all rows sum to one (Kipf & 
Welling, 2017). 
The graph convolutional layers used here were extended to allow the simultaneous use of several 
graph structures of a given set of nodes. The activations were instead calculated as 
Y = V(`ÂG	Q	RGaGb] ) (3) 
 with i denoting the index of each graph structure and the corresponding weight matrix. During 
training this was implemented by letting Â be an L x N x N tensor and W be an L x M x K tensor and 
summing over the dimension corresponding to L. 
Four consecutive graph convolutional layers were used with the output of one feeding into the next. 
The activations from each of the four graph convolutional layers were concatenated into a single 
layer, yielding an N X TcDC matrix, with TcDC being the sum of K in each respective layer. This 
corresponds to an individual feature vector of length TcDC for each node in the graph. Finally, these 
feature vectors were fed into an MLP with a single hidden layer ending with a softmax output layer. 
The weights of this MLP were shared between all graph nodes. 
All layers except the output layer used the leaky rectified nonlinearity (Maas, Hannun, & Ng, 2013): 
d(!) = e!																2d	! > 0	0.01 ∙ !				2d	! ≤ 0 (4) 
 
3.2.2 Training data 
The dataset used for training was obtained from the online supplementary material of Fuhrer, 
Zampieri, Sévin, Sauer, & Zamboni (2017). 
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The input data consisted of genetic perturbations and predicted wild-type steady state fluxes. 
Genetic perturbations were encoded in a binary format, such that reactions impacted by a given 
gene knockout, had 1-inputs and the rest had 0-inputs. The flux data was input as the raw flux values 
for each reaction, predicted using parsimonious flux balance analysis, which minimizes the total sum 
of fluxes, subject to optimal biomass production (Lewis et al., 2010). The iJO1366 genome-scale 
reconstruction of E. coli (Orth et al., 2011) was used to determine the reactions impacted by a 
knockout and to predict fluxes. 
The prediction targets were binary variables encoding whether a given metabolite level was either 
increased or decreased in the mutant strain (1) or the same as in the wild-type strain (0). Significant 
changes were defined at : = 0.05 (two-tailed) using z-values calculated by Fuhrer et al. (2017). The 
mass spectrometry data from Fuhrer et al. (2017) was mapped to 310 E. coli metabolites 
(Supplementary Table 1), which were used as targets for all knockout strains. 
3.2.3 Adjacency matrix 
3.2.3.1 Stoichiometric network 
A metabolic reaction network is often represented as metabolite nodes connected by reactions. 
This, however, is not a true graph as some reactions connect more than two metabolites. Such a 
structure can be represented as a hypergraph, a generalization of a graph where edges can connect 
arbitrary sets of nodes instead of only pairs. The metabolic hypergraph can be reformulated as a 
graph by conversion into a bipartite graph, where both metabolites and reactions are nodes and 
participation of a metabolite in a reaction is represented by an edge between the respective pair of 
nodes with a weight corresponding to the stoichiometric coefficient. Such a representation was 
used to create an adjacency matrix for the E. coli metabolic reaction network. To avoid division-by-
zero problems when normalizing the adjacency matrix, all nodes were given self-connections (Kipf 
& Welling, 2017). If the nodes in the bipartite metabolic graph are ordered such that all metabolites 
precede all reactions, the adjacency matrix thus becomes the block matrix 
_W*IGH = k 0 llm 0n + o (4) 
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where S is the usual stoichiometric matrix and I is the identity matrix. The stoichiometric structure 
was obtained from the iJO1366 genome-scale reconstruction of E. coli (Orth et al., 2011). 
3.2.3.2 Small molecule regulatory network 
In addition to the stoichiometric network, regulatory metabolite-reaction interactions were also 
included in the model in the form of a second graph structure. These interactions were embedded 
in a similar bipartite graph form as the stoichiometric network. The data for these interactions were 
obtained from Reznik et al. (2017). A regulatory matrix, R, was constructed with element rij 
describing the interaction between metabolite i and reaction j. A value of 1 was used for indicating 
activating interactions, -1 for inhibiting interactions and 0 for no interaction. The corresponding 
adjacency matrix was then calculated as 
_Wpqr = k 0 ssm 0n + o (5) 
3.2.4 Implementation and training 
The neural network including the graph convolutions were implemented in Python 3.5 using the 
Theano package (Al-Rfou et al., 2016). The training was carried out on nodes of an HPC cluster 
equipped with Tesla K40c graphics processing units. 
3.3 Results and discussion 
The neural network used to predict changes in metabolite levels contained four consecutive graph-
convolution layers, where the input data could be propagated through the metabolic network. This 
was followed by fully connected layers applied independently to every node. Between the graph-
convolution and fully connected layers was a concatenation layer, combining the outputs from all 
four graph-convolution layers. As each consecutive graph convolution enables more distant 
interactions in the graph, the concatenation allows the network to learn which combination of 
proximal and distal information provides the most predictive output. Since the graph-convolution 
layers conserve the graph structure of the input data, and the fully connected layers operate on 
individual nodes, the output has the same graph-structure as the input data. This allows the network 
to make predictions on every individual node, i.e. metabolite. Figure 2 shows a sketch of the neural 
network architecture. 
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Figure 2: Overview of the architecture of the neural network. Throughout the entire network the data maintains the 
network structure, allowing predictions on the level of individual nodes. 
The neural network was trained on the single-gene knockout metabolomics data for 1000 epochs, 
minimizing the cross-entropy between the predictions and targets. To simplify the prediction task, 
the chosen prediction target was whether a metabolite concentration was significantly changed or 
not in the knockout strain, regardless of the direction of change. To reduce overfitting, the dataset 
was randomly split into a training set (80 %) and a test set (20 %), which was used to evaluate the 
training progress after each epoch. The values of the cross-entropy loss function evaluated on the 
training and test sets throughout the training process are shown in Figure 3. As would be expected 
both the training and test losses decrease rapidly at first, after which the progress slows 
considerably. The training loss continues to slowly decrease, however the test loss stabilizes, 
indicating that further training does not generalize to new data. 
Input Graph convolution
Concatenation Node-wise feed-forward Output
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Figure 3: The values of the cross-entropy loss function evaluated on the training and test sets, respectively, following 
each training epoch. 
The network weights from the epoch with the best test performance were chosen for further 
evaluation. The overall balanced accuracy of the predictions on the test set was 0.58. Figure 4 shows 
summary plots of the prediction results. Figure 4a shows the positive prediction rates for the actual 
negatives (no change) and actual positives (change) respectively, while Figure 4b shows the 
distributions of output scores and Figure 4c shows the receiver operating characteristic. These 
results suggest that the neural network has derived some predictive value from the input data and 
the graph structure, although the predictive performance is only slightly better than random 
guessing. The plots in Figure 4 also indicate that the predictions show a clear bias towards positive 
predictions, despite the dataset containing only around 5 % positive examples. 
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Figure 4: Summary of the predictive results of the trained neural network. a) The positive prediction rates for actual 
negatives and actual positives. b) Distributions of the outputs for actual negatives and actual positives. c) Receiver 
operating characteristic of the predictive performance. 
Although the results of the trained neural network show that predictions are better than chance, 
this does not necessarily mean that the network has learned to propagate the input through the 
supplied graph structure. Training machine learning models on datasets with complex structure can 
sometimes lead to spuriously high prediction accuracies, as the model can learn to identify hidden 
but trivial patterns in the data (Chuang & Keiser, 2018). To test whether this was the case for the 
above results, the model was retrained on a control dataset. The control dataset was identical to 
the original dataset, except that the input data was randomly shuffled so that the target data 
(whether a metabolite concentration had changed) no longer corresponded to the input data (which 
reactions were affected by a knockout). If the neural network trained on the control dataset 
achieved predictive performance similar to the originally trained network, it would indicate that the 
predictive performance was a product of patterns that are not related to the input data. Conversely, 
if the originally trained network had actually learned to propagate the input data through the graph, 
the control dataset should yield a lower predictive performance. The neural network was trained 
on the control dataset using the same hyperparameters as the original training and reached a 
balanced accuracy of 0.52. This indicates that the originally trained neural network (with a balanced 
accuracy of 0.58) had indeed learned to propagate signals through the metabolic and regulatory 
networks, rather than just finding trivial patterns in the dataset. 
To investigate in more detail what the neural network had learned, the predictions were 
summarized for each individual metabolite. This allows insight into whether the 0.58 accuracy was 
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obtained by predicting all metabolites equally well, or whether a few metabolites were predicted at 
high accuracy while others were predicted near chance levels. Figure 5 shows the true positive rate 
and false positive rate for each metabolite. This shows that most metabolites are predicted to be 
either almost universally negative (lower left corner) or almost universally positive (upper right 
corner), while relatively few metabolites are predicted to sometimes be negative and sometimes 
positive. Of these few metabolites, most are predicted at near-chance levels, with only a handful 
predicted at high accuracies (upper left corner). This shows that the achieved predictive accuracy is 
based on distinguishing changing and non-changing concentrations of just a few metabolites, while 
the majority of metabolites are predicted at accuracies close to random chance. 
 
Figure 5: Predictive performance of individual metabolites. Each point shows the false positive rate and true positive 
rate for a given metabolite. 
While the predictions obtained using the deep neural network with graph-structured data did not 
reach performance levels where they would be practically useful, they still represent an interesting 
and potentially valuable step forward within machine learning in metabolic engineering. Prediction 
problems like the one attempted here are hard if not impossible to solve without including either 
graph-structures or other representations of preexisting domain knowledge in the model, and the 
results obtained here suggest that propagation of signals through a graph using deep neural 
networks is possible, even if currently not with impressive accuracy. It is also worth noting that the 
present prediction problem is inherently difficult, given the nature of the input and output data. 
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Most machine learning problems use a rich set of input features to predict one or a few outputs, 
while the prediction of metabolic changes from genetic perturbations uses a sparse input vector to 
predict a rich set of output features. Future work on graph-structured deep learning might focus on 
amending the input data with further informative features and experimenting with additional graph 
relationships between the nodes. 
3.4 Conclusion 
In this study a novel deep neural network was presented for propagating input signals through 
graph-structured stoichiometric and regulatory networks of metabolites and reactions. The network 
was tested by using genetic knockouts to predict changes in metabolite levels throughout the 
metabolic network. The obtained balanced accuracy of 0.58 showed that the network could learn 
some rules for relating genetic perturbations to metabolite levels, but further investigation showed 
that the performance was driven by good predictions on a few metabolites and near-chance 
predictions on most metabolites. Training the network on a control dataset showed that the 
predictive performance can indeed largely be ascribed to propagation of the input signals through 
the supplied graph-structures. 
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3.6 Supplementary Materials 
Supplementary Table 1: List of BiGG ID’s for all the metabolites that a detected ion in the Fuhrer et al. (2017) dataset 
was mapped to. 
1pyr5c 4mop but gal1p lald__D pyr 
23camp 4pasp camp galctn__D lald__L quin 
23ccmp 4ppan cbasp galctn__L lcts r1p 
23cgmp 4r5au cbi galt leu__L rbl__L 
23cump 5aop cdp galt1p lgt__S rib__D 
23dhb 5dh4dglc cechddd gcald lipoate rml1p 
23dhmb 6pgl cenchddd gdp lys__L ru5p__D 
23dhmp 8aonn chor gdptp lyx__L ru5p__L 
23doguln aact cinnm gg4abut mal__D s17bp 
26dap_LL ac cit ggbutal mal__L s7p 
26dap__M acac citr__L ggptrc malt sarcs 
2ahbut accoa cmp ghb man sbt6p 
2aobut acetol cpmp glc__D man1p sbt__D 
2ddg6p acgal csn glcn man6p ser__L 
2ddglcn acgam cys__D glu1sa mana skm 
2dh3dgal acgam6p cys__L glu5sa manglyc skm5p 
2dh3dgal6p acglu cytd glu__D melib sl2a6o 
2dhp acmana dca glu__L met__D so3 
2dr1p acmanap ddca glucys met__L succ 
2dr5p acmum dgdp glx mi1p__D sucglu 
2mcacn acmum6p dgmp gly micit sucorn 
2mcit acnam dgsn glyald mnl sucr 
2me4p acon_C dgtp glyb mnl1p sucsal 
2mecdp acser dha glyc msa tag6p__D 
2obut actp dhap glyc__R mthgxl tagdp__D 
2oph ade dhor__S gmhep1p nac tartr__L 
2p4c2me adn dhpppn gmhep7p no3 thdp 
2pg adp dhpt gmp ocdca thr__L 
35cgmp agm dimp gsn ocdcea thymd 
3amp ahcys dmlz gthox octa tre 
3c2hmp ahdt dpcoa gthrd op4en trp__L 
3c3hmp air dtbt gua orn ttdca 
3c4mop akg dtdpglu h2mb4p orot tyr__L 
3cmp ala_B dtdprmn hco3 pac uacgam 
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3dhq ala__D dtmp hdca pant__R uacmam 
3dhsk ala__L dxyl5p hdcea pap udp 
3gmp alaala e4p his__L paps udpacgal 
3hcinnm all__D enter histd phe__L udpg 
3hpp altrn f1p hom__L phpyr udpgal 
3hpppn ametam f6p hqn pi ump 
3mob amp fc1p hxan pnto__R ura 
3mop ara5p fdp ichor ppal uri 
3pg arbt fgam icit ppbng val__L 
3ump arbt6p fpram ile__L ppgpp xan 
4abut arg__L fprica indole pphn xmp 
4ahmmp argsuc fru inost ppi xu5p__D 
4ampm asn__L g1p ins pro__L xu5p__L 
4c2me asp__L g3p itp pser__L xyl__D 
4crsol aspsa g3pc kdo ptrc xylu__D 
4hbz athr__L g3pe kdo8p pyam5p xylu__L 
4hoxpacd atp g6p lac__D pydam 
 
4hthr btal gal lac__L pydx5p 
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Part II: Model-based strain design 
As previously mentioned, designing microbial strains for chemical production processes is a difficult 
and time-consuming task. The first part of this thesis explored how non-rational methods, 
particularly adaptive laboratory evolution (ALE), can be used to improve certain characteristics of 
production strains. Some traits, such as tolerance as shown in Chapter 1, can be easily improved in 
ALE experiments, but many production-related traits such as product yields or production rates that 
cannot be trivially selected for, are harder to optimize with evolutionary processes. For this reason, 
development of good production strains almost always also requires utilization of rational 
engineering methods. Because of the complexity of microbial metabolism, and physiology in 
general, genetically modifying a strain can sometimes have unintuitive effects on the functioning of 
the cell, which makes rational design difficult. To aid in the understanding of how genetic 
modifications impact cellular processes, mathematical models of the cell can therefore be a valuable 
tool, with mathematical models of metabolism being of particular relevance for metabolic 
engineering. Metabolic models can enable system-wide analysis of the cell and e.g. help predict 
genes that should be overexpressed in order to produce a target compound (Choi, Lee, Kim, & Woo, 
2010) or construct novel pathways for synthesizing a product of interest (Pharkya, Burgard, & 
Maranas, 2004). Some models only require knowledge of the organism’s metabolic capabilities, 
much of which can be inferred from the annotated genome (Faria, Rocha, Rocha, & Henry, 2018), 
while other models can integrate experimental data such as transcriptomics or proteomics in order 
to improve the predictive accuracy. Chapter 4 will provide an introduction to genome-scale models 
of metabolism and review different methods for integrating large-scale data into the models. 
While genome-scale metabolic models can be utilized in rational computational strain design, they 
can also be used in combination with non-rational methods, e.g. ALE. It is possible to engineer 
microbial strains that must produce a given metabolite in order to grow, i.e. where production is 
growth-coupled (Feist et al., 2010). Since ALE is based on continuous selection of fast-growing 
mutant strains, in cases where production is growth-coupled, ALE will thus indirectly select mutants 
that have an increased production rate for the growth-coupled chemical. Growth-coupled strains 
can in principle be constructed without the use of computational tools, but due to the complex 
structure of metabolism, algorithms based on genome-scale metabolic models allow identification 
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of non-obvious growth-coupled designs (Klamt & Mahadevan, 2015). In Chapter 5 a novel algorithm 
for predicting growth-coupled designs is presented and validated by its ability to identify known 
experimentally validated growth-coupled designs as well as unknown designs that are growth-
coupled in silico. 
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Abstract 
Genome-scale metabolic reconstructions have found widespread use in scientific research as 
structured representations of knowledge about an organism’s metabolism and as starting points for 
metabolic simulations. With few simplifying assumptions, genome-scale models of metabolism can 
be used to estimate intra-cellular reaction rates in any organism for which a well-curated metabolic 
reconstruction is available. However, with the rapid increase in the availability of genome-scale 
data, there is ample opportunity to refine the predictions made by metabolic models by integrating 
experimental data. In this chapter, we review different methods for combining genome-scale 
metabolic models with genome-scale experimental data, such as transcriptomics, proteomics and 
metabolomics. Integrating experimental data into the models generally results in more precise and 
accurate simulations of cellular metabolism. 
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4.1 Reconstruction and analysis of metabolic networks 
It is essential to study metabolism in order to describe and understand the functioning of living cells. 
The chemical conversion of nutrients into energy, biomass and secondary products is one of the 
main components of the cellular phenotype, and a defining characteristic of life. Since the metabolic 
capabilities of an organism are ultimately determined by its genotype, advances in genome 
sequencing technologies during the last two decades have had a substantial impact on our 
knowledge about metabolism. With a fully annotated whole genome sequence of an organism, it is 
feasible to compile a database of all the biochemical reactions that can be catalyzed inside the cell. 
Besides a list of reactions and their stoichiometries, such a database, called a genome-scale 
metabolic reconstruction, often includes information that links each reaction to the genes encoding 
the enzymes that catalyze it (Price et al. 2004). The earliest published genome-scale reconstructions 
were for organisms with small genomes such as Haemophilus influenzae (Schilling and Palsson 2000) 
and Escherichia coli (Edwards and Palsson 2000), but reconstructions for more complex organisms 
including Saccharomyces cerevisiae (Förster et al. 2003), Arabidopsis thaliana (de Oliveira Dal’Molin 
et al. 2010) and Homo sapiens (Duarte et al. 2007) have followed since. Revised versions of genome-
scale metabolic reconstructions are often published when new genes are discovered or annotated 
functions of known genes are updated. 
A genome-scale metabolic reconstruction allows systematic analysis of the metabolic network of an 
organism, and can even form a starting point for whole-cell simulations (Orth et al. 2010; Karr et al. 
2012). In order to perform such analyses, the genome-scale reconstruction must be formulated as 
a mathematical model, e.g. in the form of a system of differential equations, tut# = v ∙ w(u, y) (1) 
Here S denotes the stoichiometric matrix, derived from the genome-scale reconstruction with 
element sij denoting the stoichiometric coefficient of metabolite i in reaction j, and x is a vector of 
concentrations of all metabolites in the cell. Reaction rates, v, are a function of current metabolite 
concentrations and kinetic parameters, k. Given initial metabolite concentrations, the system of 
differential equations is readily solved numerically. While the formulation is conceptually simple, its 
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use on the genome-scale is impeded by limited knowledge of the many kinetic parameters 
(McCloskey et al. 2013). 
To avoid the issue of unknown kinetic parameters, constraint-based metabolic modeling methods 
are often used instead. Constraint-based modeling imposes constraints on the system and finds 
metabolic reaction rates that are consistent with these constraints. The most central constraint is 
the assumption of steady-state, where the concentrations of internal metabolites are assumed to 
be constant. This corresponds to setting the left-hand side of Equation 1 to zero and results in a 
system of linear equations, 
v ∙ w = z (2) 
that can be solved for the reaction rates or metabolic fluxes, v (Orth et al. 2010). The kinetic 
parameters are not accounted for explicitly in constraint-based models, which only require the 
stoichiometric matrix to be known. For most genome-scale reconstructions, the system of equations 
is underdetermined, meaning that an infinite number of flux solutions exist. One way to address 
this issue is to identify a solution that optimizes a specific objective. This is based on an assumption 
that the cell has evolved to maximize some biological objective, e.g. production of ATP or production 
of biomass. Production of biomass is modeled through a bulk-reaction that consumes biomass 
constituents such as nucleotides and amino acids in empirically determined ratios (Orth et al. 2010). 
This method is known as flux balance analysis (FBA) and has become the foundation of most work 
in constraint-based metabolic modeling. Performing flux balance analysis requires the solution of a 
linear optimization problem. The result is a set of reaction rates that satisfy the constraints of the 
system and is consistent with the defined biological objective. 
Despite the simple formulation and strong assumptions, FBA has proven useful in a number of 
metabolic modeling applications, to predict the rates of metabolic reactions, typically called the flux 
distribution (McCloskey et al. 2013). It can been used for instance to predict essential metabolic 
genes, i.e. genes that are required for the synthesis of one or more biomass constituents. This is 
done by simply removing corresponding reactions from the model and performing FBA. If the 
maximal biomass flux is zero in the knockout model, the gene is expected to be essential. 
Comparisons with experimental data from single-knockout studies have shown good 
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correspondence with the results of FBA-based essentiality predictions in E. coli and other bacteria 
such as Pseudomonas aeruginosa (Edwards and Palsson 2000; Oberhardt et al. 2008). In other 
organisms, e.g. S. cerevisiae, predictions of essentiality are less accurate, and for multiple knockouts 
in particular there is only a very low correlation between experimental data and FBA predictions 
(Heavner and Price 2015). 
The assumption of maximization of biomass production as a metabolic objective is often reasonable 
for microorganisms during exponential growth, but it will clearly not hold for most mammalian cells 
or other multicellular organisms whose evolutionary pressure has selected for far more complex 
traits than simply growth at the cellular level. As replacement for FBA, Markov chain Monte Carlo 
(MCMC) methods can be used to uniformly sample the feasible steady-state flux space described by 
Equation 2. MCMC methods provide an estimate of the joint probability distribution of fluxes and 
do not depend on a pre-specified biological objective. The applications of random sampling methods 
include the analysis of red blood cells under storage conditions (Bordbar et al. 2016), aspirin 
resistance in platelets (Thomas et al. 2015), transcriptional regulation in human adipocytes 
(Mardinoglu et al. 2014) and in bacterial communities in the human gut (Shoaie et al. 2013), as well 
as the metabolic re-wiring that takes place in epithelial to mesenchymal transition during the 
development of breast cancer (Halldorsson et al. 2017). 
4.2 Constraining metabolic models with transcriptomics and proteomics data 
Although mass balance is an essential principle, metabolism is constrained by other factors and 
physical principles as well. FBA assumes that the cell can use all metabolic reactions at a given time 
in the combination that gives the highest biomass production. However, this is contradicted by the 
fact that only a proportion of an organism’s genes will be transcriptionally active at the same time. 
Thus further constraints can be imposed on the model by leveraging information about the 
transcriptional state of the cell. This can be used to create context-specific models from generic 
models, such as the generic human reconstruction Recon1 (Duarte et al. 2007), as well as to improve 
the accuracy of flux predictions. The simplest realization of this idea utilizes the fact that an enzyme 
cannot catalyze any reaction flux if its encoding gene is not expressed. Reactions catalyzed by genes 
with transcript levels below a defined threshold can thus be forced to be inactive by removing them 
from the model. Flux distributions obtained with such a constrained model were found to be more 
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strongly correlated to experimentally measured fluxes in S. cerevisiae compared to an 
unconstrained model (Åkesson et al. 2004). More sophisticated algorithms minimize the difference 
between the predicted flux distribution and the gene expression data. The Gene Inactivity 
Moderated by Metabolism and Expression (GIMME) algorithm (Becker and Palsson 2008) finds flux 
values which minimize the utilization of reactions with low expression levels, in order to meet pre-
specified metabolic requirements such as growth. The iMAT method developed by Shlomi and 
coworkers (Shlomi et al. 2008) alleviates the need for a pre-specified cellular objective and is 
therefore suitable for analyzing mammalian cells and tissues. The method partitions gene 
expression values into three groups, corresponding to high, moderate and low expression and then 
maximizes the number of reactions with flux levels in agreement with the expression states. This 
enabled identification of tissue-specific metabolic activities in different human tissues, and the 
construction of tissue-specific models of human metabolism. An extension of iMAT was used to 
construct a model of cancer metabolism from Recon1 and expression data from cancer cell lines in 
the NCI-60 collection. The cancer model was then used to identify several cytostatic drug targets, 
and generate a list of potential selective anti-cancer treatments (Folger et al. 2011).  
Since Åkesson and coworkers first used gene-expression data to constrain metabolic models, a large 
number of methods that integrate expression data and flux predictions have been published. An 
evaluation of many of these methods, by their ability to predict flux distributions in E. coli and S. 
cerevisiae, showed that none of them performed significantly better than parsimonious FBA, an 
extension of FBA that finds the flux distribution with the smallest sum of fluxes that can support the 
optimal objective value (Machado and Herrgård 2014). This suggests that gene transcription levels 
do not correlate strongly with reaction fluxes, at least in microbial cells, which is not surprising 
considering that translational efficiency, post-translational modifications and allosteric regulation 
all have an effect on fluxes as well. 
A step closer to the actual reactions than mRNA abundance is protein concentration. A certain 
correlation between mRNA and protein concentration is to be expected (Gry et al. 2009), and 
several methods for integrating gene expression data into metabolic models can indeed use protein 
abundance data with the same algorithms, simply by replacing gene expression thresholds with 
protein abundance thresholds (Becker and Palsson 2008; Machado and Herrgård 2014). However, 
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there have also been attempts to more explicitly incorporate proteomics data into the modeling 
frameworks. A central component of enzyme kinetics is the concept of the catalytic capacity of an 
enzyme. Each enzyme molecule can only perform a certain number of conversions per second; an 
increased flux will therefore require a larger number of enzymes at some point. The maximum 
possible flux, represented by the Vmax parameter, can be calculated from the enzyme concentration 
and catalytic turnover number, kcat {C|} = ~H|* ∙ [Ä] (3) 
If the catalytic turnover parameters are known, this relationship can be used to constrain fluxes 
using protein concentration data. In the GECKO modeling framework (Sánchez et al. 2017), a 
constraint is added for each enzyme, representing the enzyme’s degree of utilization, where the 
upper bound is set to the measured enzyme concentration. The utilization of an enzyme is obtained 
by summing Ç/~H|*	 for all reactions catalyzed by that enzyme. Using GECKO with a proteomics 
dataset for S. cerevisiae, Sanchez and coworkers showed that the space of possible fluxes was 
reduced considerably by excluding all flux distributions that were not consistent with the observed 
enzyme levels. On the other hand, the fluxes predicted for S. cerevisiae grown in glucose limited 
minimal medium did not have a significantly smaller error compared to experimentally measured 
fluxes than those predicted with FBA. It is possible however, that the advantage of using proteomics 
data will be larger in cases where the assumption of maximal growth is not valid, e.g. under stress 
conditions or in genetically perturbed strains. GECKO can also be used in the absence of proteomics 
data by imposing a single overall constraint on the total enzyme mass. This resulted in more accurate 
predictions of maximal growth rates on a wide range of different carbon sources, for which FBA 
tends to overestimate growth rate. Another interesting growth effect that was captured by 
including an overall protein constraint is the shift from respiration to fermentation at high growth 
rates. This overflow metabolism, also known as the Crabtree effect in yeast (Crabtree 1929) and the 
Warburg effect in cancer cells (Warburg et al. 1927), cannot be captured by FBA, where simply the 
flux distribution with the highest biomass yield is found, independently of growth rate. The overflow 
effect is most likely caused by respiratory enzymes having a higher proteome cost than fermentative 
enzymes (Basan et al. 2015), which means that at high growth rates protein allocation becomes 
limiting and fermentation becomes more efficient even though it has a lower energy/carbon yield. 
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Overflow metabolism has been modeled e.g. in E. coli (Basan et al. 2015), S. cerevisiae (Sánchez et 
al. 2017) and cancer cells (Shlomi et al. 2011), by different models with the common trait of 
somehow constraining the proteome. 
The causes of the Warburg effect in cancer cells were studied using Recon1 by placing a constraint 
on total enzyme concentration to account for enzyme solvent capacity (Shlomi et al. 2011). To 
compute the contribution of each enzyme to the total concentration, an estimate of the enzyme 
turnover number was required. Estimates for 15% of the reactions could be obtained from 
biochemical databases, the rest was assigned a fixed value of 25/s. Using FBA and random sampling, 
the Warburg effect was shown to be a consequence of metabolic adaptations to increase biomass 
productivity. Further analysis revealed the preference of cancer cells to take up glutamine instead 
of other amino acids. 
Resource allocation between cellular processes in Bacillus subtilis was recently analyzed using a 
method that incorporates genome-wide protein quantification data and extracellular nutrient 
concentrations with a metabolic reconstruction (Goelzer et al. 2015). The method, Resource Balance 
Analysis (RBA), links flux to enzyme abundance, assuming a relationship similar to Equation 3, while 
incorporating information on protein activity and protein localization. The use of RBA is fairly 
involved compared to the methods described earlier and requires specification of a large number 
of parameters. The parameters were partly obtained from Uniprot and partly inferred from data. 
RBA accurately predicted the allocation of resources in B. subtilis over a wide range of conditions. 
In vivo knockouts of enzymes which were expressed but predicted to have zero flux in the model 
resulted in significantly increased growth (Goelzer et al. 2015). This suggests that the method may 
be useful for constructing minimal cell factories, e.g. for protein production. 
4.3 Models of metabolism and macromolecular expression 
The previously described methods for combining omics data and metabolic models are mostly based 
on heuristically formulated constraints and/or objectives. When the measured quantities – such as 
mRNA and protein abundances – are not explicitly accounted for in the modeling framework, they 
cannot be seamlessly integrated into it. To address this problem, an extended modeling framework 
that explicitly models the expression of macromolecules, such as RNA and protein, has been 
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developed. Construction of such models of metabolism and expression (ME-models) began with the 
reconstruction of the macromolecular expression network of E. coli, analogously to the metabolic 
network (Thiele et al. 2009). Transcription of a given gene to produce mRNA is modeled as a reaction 
consuming nucleotides in proportions consistent with the specific sequence, and similarly 
translation is modeled as a reaction consuming charged tRNAs while producing protein and 
uncharged tRNAs. In order to model how metabolic catalysis is dependent on translation of a 
specific protein and how translation of a protein is dependent on transcription of its gene to mRNA, 
these different reactions must be coupled (Thiele et al. 2009; Lerman et al. 2012). A certain quantity 
of an enzyme can only catalyze a limited reaction flux and Equation 3 can be rearranged to enable 
calculation of the minimum amount of enzyme required to catalyze a given flux 
[Ä] ≥ Ç~H|* (4) 
Equation 4 represents a constraint that can be used to couple metabolic reactions to the enzymes 
that catalyze them. Identical constraints can be formulated for ribosomes and mRNA in translation 
reactions and for RNA-polymerase in transcription reactions. A constraint-based modeling 
framework, however, does not model concentrations of metabolites (or enzymes) and is thus not 
directly compatible with such constraints. To circumvent this it is necessary to account for growth-
related dilution. In a growing cell, metabolite pools are continuously diluted, because of the 
expanding intracellular volume, by a rate equal to the product of the growth rate and metabolite 
concentration. This means that in steady-state, catalysis of a reaction requires that the catalyzing 
enzyme be produced at a rate proportional to the growth rate. Enzymatic conversion of compound 
A into compound B by enzyme E thus becomes (Lloyd et al. 2017): 
_ + Ö~H|* Ä → á (5) 
In FBA the requirement of enzyme production is modeled through the composition of the biomass 
reaction, but since this reaction is determined a priori¸ FBA cannot model how biomass composition 
changes under different growth rates and conditions. With ME-models the empirical biomass 
reaction is replaced by explicitly modeling the relationship between metabolism and 
macromolecular expression. ME-models can thus directly predict the expression levels of different 
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proteins, which can be compared with omics datasets. A ME-model of the thermophilic bacterium 
Thermotoga maritima (Lerman et al. 2012), found moderate correlations between predicted and 
experimentally measured mRNA profiles (r= 0.54), protein expression profiles (r = 0.57), as well as 
proteome amino acid composition (r = 0.79). A ME-model of E. coli showed improved prediction of 
growth rates in different nutrient conditions compared to FBA (Thiele et al. 2012), and could 
accurately predict several internal fluxes (O’Brien et al. 2013). Additionally, since ME-models 
explicitly include the cost of producing the enzymes required for various pathways, they implicitly 
limit the total proteome size and thus also capture metabolic overflow effects, such as the acetate 
overflow metabolism in E. coli (O’Brien et al. 2013). 
Whereas traditional constraint-based metabolic models include, and can thus directly predict, 
growth rate, uptake and secretion rates and internal fluxes, ME-models can additionally predict 
expression profiles and proteome composition, and thus they can also be directly constrained by 
expression and proteomics data. Because of this, ME-models represent an intuitive and theoretically 
justified method of integrating transcriptomics and proteomics data into metabolic models. They 
have not yet found broad usage in the metabolic modeling community, presumably because of the 
time it takes to run simulations (several orders of magnitude higher than with FBA), and the lack of 
related model and software infrastructure, but these issues are continuously being addressed (Yang 
et al. 2016; Lloyd et al. 2017). 
4.4 Augmenting models with metabolomics data 
In a discussion of data integration in metabolic models, it is impossible not to mention 
metabolomics. Different analytical methods, e.g. enzymatic assays, chromatography and mass 
spectrometry, can be used to take snapshots of the cellular metabolism with varying resolution, 
coverage, precision and throughput. However, they all provide useful information about the 
concentrations of metabolite pools in the cell. One of the earliest uses of metabolomics data to 
improve metabolic modeling was metabolic flux analysis (MFA), which utilizes time-course 
metabolite concentration data from cultures fed with isotopically labeled substrates to infer flux 
values in the metabolic network (Stephanopoulos 1999; Sauer 2006). This is done by monitoring 
how the isotopes, e.g. 13C or 15N, spread to downstream metabolite pools over time. The advantage 
of this method is that the resulting fluxes can be used directly to constrain metabolic models or to 
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compare the validity of different simulation methods. However, MFA is labor- and cost intensive 
and works best on a smaller subset of the entire metabolic network, typically just the central carbon 
metabolism (Antoniewicz 2015; Gopalakrishnan and Maranas 2015). 
Changes in extracellular metabolite concentrations over time can be used to estimate uptake and 
secretion rates and constrain the flux space. However, since constraint-based modeling frameworks 
model fluxes under an assumption of steady-state, internal metabolite concentration data at a 
single time point without isotopic labeling cannot be directly utilized. Despite this, metabolomics 
data can still be used to either constrain the models or to provide new insights in combination with 
the simulation results. In order to model cells that are not in steady-state, such as human blood cells 
undergoing physiological changes during storage, Bordbar and coworkers devised a method called 
unsteady-state FBA (Bordbar et al. 2017). Using time-course metabolomics they determined the 
rate of accumulation or depletion for internal metabolites, which was then modeled by adding 
source and sink reactions to the metabolic model. These reactions were then constrained to have 
fluxes corresponding to the experimentally determined rates of concentration changes. Subsequent 
MFA revealed that the fluxes predicted with this method were more accurate than those obtained 
by regular FBA. 
Aside from enforcing steady state, a commonly used constraint in constraint-based models is to 
force certain fluxes to only go in one direction. This is straightforward for some reactions whose 
thermodynamics make it practically irreversible under biological conditions. Other reactions are 
closer to equilibrium and can go in both directions depending on specific conditions. The 
spontaneous direction of a reaction can be calculated by the formula 
Δâä = Δâä° + så	>?@(ç) (6) 
If the left-hand side (the reaction Gibbs free energy) is negative, the reaction will proceed 
spontaneously in the forward direction, while it will proceed spontaneously in the reverse direction 
if the reaction Gibbs free energy is positive. Δâä° is the reaction Gibbs free energy under standard 
conditions, RT is the gas constant times the absolute temperature and Q is the reaction quotient, 
containing the concentrations of the reaction products and substrates. The standard Gibbs free 
energy must in principle be determined experimentally, but in most cases it can be calculated from 
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the structure of the participating metabolites and already known reaction Gibbs free energies for 
other reactions (Noor et al. 2013). This means that a dataset of metabolite concentrations can be 
used to constrain reactions to a specific direction depending on the specific metabolic conditions, 
reducing the space of feasible fluxes significantly (Soh and Hatzimanikatis 2014). In many simulated 
growth conditions, it can be sufficient simply to constrain reaction directionalities according to the 
most common mode of operation without regard to actual metabolite concentrations. Some 
reactions however, occur in the unconventional direction under extreme conditions, such as very 
high CO2 concentrations. In such cases using thermodynamics and metabolite data to inform 
reaction directionalities will be particularly beneficial and can lead to more accurate simulations 
(Soh et al. 2012). 
Constraint-based simulations can also be combined with metabolomics data in another way. In 
addition to calculating a flux distribution, simulating a constraint-based model also provides so-
called shadow prices. Each shadow price is linked to a metabolite and reflects how much the 
objective function, e.g. growth, could be improved if the model were allowed to get some of that 
metabolite “for free”. In other words a shadow price is a measure of how limiting a given 
metabolite’s mass balance is for the objective function. Depending on the algorithm used to solve 
the FBA problem, shadow prices are either a byproduct of the solution process or can be obtained 
with modest computational effort. 
Zampieri and coworkers investigated the evolution of antibiotic resistance in E. coli using adaptive 
laboratory evolution (Zampieri et al. 2017). By maximizing and minimizing flux through each 
reaction in the model and calculating the shadow prices, the authors could identify reactions, which, 
when maximized or minimized, resulted in shadow prices that were consistent with the observed 
patterns of metabolite concentration changes. Those reactions were hypothesized as being targets 
of evolution, whose flux should be increased in order to increase antibiotic resistance. 
Besides constraint-based modeling, the most common way to simulate cellular metabolism is with 
kinetic models. This involves the solution of the system of differential equations shown in Eq. 1 from 
given initial metabolite concentrations. As previously described, one of the challenges with this 
approach is the requirement of knowing the values of all the kinetic parameters of the system. For 
small biochemical systems, the kinetic parameters can sometimes be determined individually 
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through in vitro experiments, but for genome-scale models this is not feasible. Additionally there is 
no guarantee that the in vitro kinetic parameters are representative of how an enzyme functions in 
vivo (Teusink et al. 2000). Instead of the bottom-up approach of experimentally determining each 
parameter, a top-down approach may be used, where the model parameters might initially be 
estimated from prior information, such as in vitro data, but are predominantly selected by fitting 
simulation results to genome-scale experimental data. This has long been done for small-scale 
networks, using metabolomics and MFA data (Jamshidi and Palsson 2008; Srinivasan et al. 2015), 
however with continual increases in dataset sizes and computing power, it has also become feasible 
to do this for genome-scale networks. Recently a genome-scale kinetic model of E. coli was 
published along with estimated values for all kinetic parameters (Khodayari and Maranas 2016). The 
model parameters were fitted using experimental flux data and model predictions were validated 
against metabolomics data. In addition the model could quantitatively predict product yields of 24 
different compound in 320 mutant strains, which was considerably better than the constraint-based 
simulation methods it was tested against. In another study kinetic models of human red blood cells 
were used to investigate individual variations in susceptibility to side effects of the hepatitis B drug 
Ribavirin (Bordbar et al. 2015). By measuring intracellular metabolite levels in red blood cells of 24 
patients, they could determine individual kinetic parameter values for each of the patients, and 
show that those parameters were predictive of whether the patient was sensitive to side effects. 
Furthermore, the identified relationships between kinetic parameters and sensitivity to drug side-
effect were consistent with known mechanisms of Ribavirin side effects. These results show that 
kinetic modeling frameworks have the potential to significantly outperform constraint-based 
simulations, and that with modern omics technologies and computer power, it is feasible to 
parametrize them sufficiently to predict metabolic behavior (Saa and Nielsen 2017). 
4.5 Combining metabolic models and machine learning methods 
The term machine learning covers a broad range of methods where large datasets are used to infer 
relationships between variables or to predict various outcomes from given input data. Often this is 
done without much consideration of specific mechanisms of the studied phenomena. Such data-
driven methods can of course be applied to metabolic data, but with limited connection to biological 
mechanisms, the results are often difficult to interpret. Instead, machine learning methods can be 
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combined with domain-specific biological knowledge, such as the information encoded within a 
genome-scale reconstruction, to create hybrid methods that also take advantage of the metabolic 
network structure. 
Plaimas and coworkers predicted gene essentiality in E. coli using a hybrid method (Plaimas et al. 
2008). Instead of using FBA to predict essentiality as described previously, they defined a set of 
features for each reaction, including metrics of network topology, gene expression data and 
predicted FBA fluxes. These features were fed into a support vector machine classifier together with 
labels from experimental essentiality data (Baba et al. 2006). The predictive accuracy of gene 
essentiality was 92%, compared to 85% for FBA. Furthermore, the genes where essentiality was not 
correctly predicted were retested experimentally, and in several cases the authors identified errors 
in the original experimental dataset. By removing single features from the input data one at a time, 
the authors could also identify which features were most important for accurately predicting 
essentiality. Prediction with FBA suffers mainly from two problems, namely that the metabolic 
network might be incomplete, and that the assumption of growth optimality does not always hold 
(O’Brien et al. 2015). A hybrid method can instead learn from data, utilizing the biological context, 
e.g. in the form of a metabolic network, only when it improves prediction performance. A similar 
method was recently used to predict drug side effects (Shaked et al. 2016). A list of drugs known to 
inactivate one or more enzymatic reactions was used as training data, with features corresponding 
to the minimum and maximum possible FBA flux for each reaction after deactivating the drug’s 
target reaction(s) in the Recon1 model. Support vector machine classifiers were then trained to 
predict which (if any) side effects the drug would have. Using a feature selection method it was also 
possible to find the features that were most strongly associated with a given side effect. Many of 
the results were found to be consistent with the published literature of these drug side effects. 
A third example of a combination of machine learning with metabolic network data was used to 
predict novel drug-reaction interactions for cancer therapy (Li et al. 2010). The method requires the 
construction of a reaction flux similarity matrix. This matrix was obtained using the GIMME 
algorithm to predict reaction fluxes from gene expression data in 59 cancer cell lines. Reactions with 
the same flux profile across the cell lines were said to have a high similarity, while reactions with 
different flux profiles had a low similarity. The reaction flux similarity matrix was combined with 
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knowledge of existing drug-reaction interactions, using a K-nearest neighbors algorithm, to predict 
new interactions. 
Where purely model-based algorithms may suffer from lack of biological knowledge such as kinetic 
parameters, the use of machine learning methods in biomedical research is often hampered by 
difficulties in interpreting the results. The examples above show that the two methodologies can be 
combined to achieve results that are informed by experimental data, while maintaining biologically 
relevant relationships between variables. Such hybrid methods can be used to build accurate 
predictive models, while also providing new biological insights and will without doubt find 
widespread use in the future. 
4.6 Conclusions 
Genome-scale models of metabolism have found applications ranging from industrial biotechnology 
to human health. These models can now be readily built for any organism to predict metabolic 
phenotypes such as the effect of a gene knock-out on cell growth. Advanced formulations of 
genome-scale models allow integrating diverse omics data types including transcriptomics, 
proteomics and metabolomics data to the modeling. Advanced genome-scale models make more 
accurate condition-dependent model predictions, and expand the range of predicted intracellular 
variables from metabolic fluxes to concentrations of metabolites and proteins. Genome-scale 
mechanistic models can also be combined with purely data-driven machine learning methods to 
obtain hybrid mechanistic/statistical models with the potential for improving predictive 
performance. With increasing amounts of different omics data types becoming available for all 
organisms, the modeling approaches described in this chapter can be further improved and 
extended to obtain highly predictive models of cellular processes. 
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Abstract 
Biological production of chemicals is an attractive alternative to petrochemical-based production, 
due to advantages in environmental impact and the spectrum of feasible targets. However, 
engineering microbial strains to overproduce a compound of interest can be a long, costly and 
painstaking process. If production can be coupled to cell growth it is possible to use adaptive 
laboratory evolution to increase the production rate. Strategies for coupling production to growth, 
however, are often not trivial to find. Here we present OptCouple, a constraint-based modeling 
algorithm to simultaneously identify combinations of gene knockouts, insertions and medium 
supplements that lead to growth-coupled production of a target compound. We validated the 
algorithm by showing that it can find novel strategies that are growth-coupled in silico for a 
compound that has not been coupled to growth previously, as well as reproduce known growth-
coupled strain designs for two different target compounds. Furthermore, we used OptCouple to 
construct an alternative design with potential for higher production. We provide an efficient and 
easy-to-use implementation of the OptCouple algorithm in the cameo Python package for 
computational strain design. 
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5.1 Introduction 
The use of microorganisms as cell factories offers the possibility of producing a wide range of 
chemicals from renewable sources, as well as manufacturing natural compounds too complicated 
for chemical synthesis in large amounts (Becker and Wittmann, 2015). However, successfully 
engineering microorganisms to produce a target compound most often requires trial-and-error 
experimentation with different possible pathways, and even when production is achieved, many 
iterations of subsequent optimization are usually necessary to increase production rate and yield to 
satisfy industrial needs (Lee and Kim, 2015). 
One strategy for optimizing chemical production in microbial strains is to utilize the power of natural 
selection in adaptive laboratory evolution (ALE) experiments (Portnoy et al., 2011; Shepelin et al., 
2018). This allows the identification of mutant strains with enhanced viability under the evolution 
conditions. The inherent selection for cells that are able to grow faster than the rest of the 
population makes it easy to optimize for characteristics such as product tolerance or substrate 
utilization, while directly improving production characteristics such as production rate, titer and 
yield is more difficult (Hansen et al., 2017; Shepelin et al., 2018). Indeed, with the advent of more 
and more methods, models, and databases for automated running and analysis of ALE experiments, 
such as eVOLVER (Wong et al., 2018), ALEsim (LaCroix et al., 2017), and ALEdb (Phaneuf et al., 2018), 
the need for new selective pressures by clever strain and experimental design becomes the primary 
challenge for evolutionary strain engineering. 
Using evolution to improve biochemical production rates can be achieved by coupling production 
to growth, i.e. ensuring that production is a necessary by-product of cell growth, such that 
adaptations that increase the growth rate of the cells will also increase production. For a review of 
examples of successful growth-coupling for biochemical production, see e.g. Shepelin et al. (2018). 
A recent successful example is the growth-coupling of itaconic acid production in Escherichia coli by 
four gene deletions, a downregulation, and glutamate supplementation that ensure formation of 
itaconic acid to prevent accumulation of PEP inside the cell (Harder et al., 2016). The design was 
aided by the computation of minimal cut sets (MCS), which are sets of gene knockouts that will 
prevent all undesirable flux distributions while maintaining the ability to produce the target 
compound (Klamt and Gilles, 2004; von Kamp and Klamt, 2014). 
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Since growth-coupling strategies are not always obvious from looking at a metabolic map of the 
microorganism, it is beneficial to use genome-scale metabolic models together with computational 
methods like the MCS framework, to quickly search the design space for strain modifications that 
can potentially make production growth-coupled. One of the first computational methods for 
predicting strategies for improving bio-production was OptKnock (Burgard et al., 2003). OptKnock 
uses a mixed integer linear programming (MILP) formulation to predict gene knockouts that allow 
higher production under growth-optimal conditions. While the predictions made by OptKnock will 
allow for increased production, they will not necessarily make production growth-coupled, as 
alternative pathways can be used instead. The algorithm RobustKnock (Tepper and Shlomi, 2009) 
seeks to solve this problem by predicting knock-out combinations that maximize the minimal 
production under optimal growth. The more recent algorithm gcOpt (Alter et al., 2018) is similar to 
RobustKnock, but requires a fixed growth rate to be set, allowing the formulation to be simplified. 
In addition to finding gene knockouts, there are also algorithms, e.g. the RobOKoD algorithm 
(Stanford et al., 2015), that attempt to increase production rates by predicting native genes to 
under- and overexpress. However, growth-coupling a production pathway alleviates the need for 
such expression level perturbations, since these can be optimized subsequently by means of ALE 
(Shepelin et al., 2018). 
It has been shown that almost all metabolites in E. coli can be growth-coupled through knockouts, 
but in many cases this would require deletion of an infeasible number of genes (von Kamp and 
Klamt, 2017). Growth coupling may be easier to achieve by inserting heterologous genes that alter 
host metabolism in addition to knocking out native genes. The algorithm OptStrain (Pharkya et al., 
2004) predicts both knockouts and insertions for increasing production, but does so in a two-step 
process. First, heterologous reactions that enable or improve the production capabilities are 
identified from a database of known reactions. This can be a novel production pathway or 
stoichiometrically favourable alternate reactions. Subsequently, knockouts that increase the 
possible production yield at maximal growth are identified using the OptKnock algorithm. With a 
two-step procedure like OptStrain, it is only possible to find heterologous genes and knockouts that 
improve production independently of each other. To solve this problem the algorithm SimOptStrain 
(Kim et al., 2011) does simultaneous prediction of gene insertions and knockouts. This enables the 
identification of heterologous gene insertions that have beneficial effects, only in the presence of 
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specific knockouts. An example of a design where heterologous genes and knockouts are combined 
is the growth-coupling of product methylation in a cysteine auxotrophic E. coli strain described by 
Luo and Hansen (2018). Insertion of CYS3 and CYS4 from Saccharomyces cerevisiae enable cysteine 
synthesis from supplemented methionine through a pathway that requires flux through S-
adenosylmethionine (SAM)-dependent methyltransferase reactions. As seen in this design as well 
as the previously mentioned itaconic acid production design, growth-coupling strategies can result 
in auxotrophies, such that the growth medium must be supplemented with additional nutrients, i.e. 
methionine and glutamate, respectively. Although auxotrophies are generally undesirable in 
production processes as the addition of a supplement can incur a significant extra cost, auxotrophic 
growth-coupled strains can still be very useful in the strain development phase, particularly in 
combination with ALE (Shepelin et al., 2018). The recent algorithm SelFi (Hassanpour et al., 2017) 
attempts to couple growth to the flux catalysed by a target enzyme by constructing a carbon supply 
pathway including the target reaction and disabling alternative carbon supply pathways. This is done 
using a combination of knockouts and heterologous gene insertions as well as medium 
supplements. However, similar to OptStrain this is done in a two-step process, potentially excluding 
some designs. Furthermore, since growth coupling is achieved by constructing a new carbon supply 
pathway, the scope of target reactions is limited to reactions that can feasibly be incorporated into 
such a pathway.  
Here we introduce OptCouple, an algorithm that simultaneously finds gene knockouts, insertions 
and modifications to the growth medium that result in coupling the production of a target chemical 
to growth in microorganisms. We have validated OptCouple by showing that it can predict known 
successful growth-coupling designs for the common production host E. coli and have used it to 
predict novel growth-coupling strategies. 
5.2 Materials and methods 
All computations were carried out in Python 3.6.4. A list of installed packages and an 
implementation of the entire prediction workflow, and scripts for the described analyses can be 
found in the supplementary material. Simulations were done using the iJO1366 genome-scale 
reconstruction of E. coli (Orth et al., 2011) as well as the reduced EColiCore2 model (Hädicke and 
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Klamt, 2017). Simulations were performed with a maximum glucose uptake rate of 10 mmol/gDW/h 
and a maximum oxygen uptake of 1000 mmol/gDW/h. 
5.2.1 MILP-based optimization of growth-coupling potential 
The following section will go through the mathematical optimization problem forming the core of 
OptCouple. For the full mathematical formulation, see supplementary materials. 
Growth-coupling potential can be defined as the increase in maximal growth rate obtained when 
allowing flux through the target reaction, i.e. the reaction producing the chemical of interest. 
The symbol M is used to denote a full metabolic model with metabolites èG∀	2 ∈ í and reactions ìî	∀	ï ∈ s, the target reaction, ì*|6ñ7*, with the biomass reaction, ìóGIC|cc, as the objective function, 
while the symbol M* is used to denote the metabolic model without the target reaction. 
If we use f to denote objective function of a problem, the growth-coupling potential, U, can be 
mathematically described as: 
ò = dô(S) − dô(S∗) (1) 
where dô is used to denote the optimal objective value of a problem. 
Every linear optimization problem can be converted into a dual problem (Ignizio and Cavalier, 1994), 
which will be denoted by a D-subscript, i.e. MD. One property of duality in linear optimization is that 
the dual problem will have the same optimal objective value as the primal, however if M is a 
maximization problem, MD will be a minimization problem, and vice versa. 
Each potential perturbation, i.e. gene knock-out, knock-in, as well as addition of a growth medium 
supplement, can be represented by a binary variable, 5î ∈ P		∀		ï ∈ s, controlling the flux of the 
reaction associated with the given perturbation, i.e. native reactions, heterologous reactions and 
exchange reactions, for knockouts, knock-ins and medium supplements, respectively. Additional 
coupling constraints are added to ensure that a given reaction can only carry flux when its 
corresponding perturbation variable, 5î, has a value of 1 (see supplementary material). 
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The goal is to formulate an optimization problem that optimizes U, by finding an optimal 
combination of values for the control variables, Y and reaction fluxes, v: 
S&!2è2õ(ú,ù	dô(S) − dô(S∗) (2) 
This can be formulated as a bi-level optimization problem: 
	 (3) S&!2è24(ú	d(S) − d(S∗)   
subject to: 
        S&!2è24(ù	d(S) 
        subject to:  
                l ∙ Ç = 0 
                Çî = 0	∀	ï ∈ {ï	|	5î = 0} 
        S&!2è24(ù	d(S∗)  
        subject to: 
                l ∙ Ç = 0 
                Çî = 0	∀	ï ∈ {ï	|	5î = 0} 
                Ç*|6ñ7* = 0 
 
The bi-level formulation can be interpreted as finding the combination of control values that allows 
the highest growth-coupling potential, subject to the constraints that the fluxes (v) of M and M* 
must be optimal for growth (under the given control variable values). 
The bi-level formulation can be converted into a single optimization problem by replacing M* with 
its dual form, M*D: S&!2è2õ(ú,ù	d(S) − 	d(S°∗ ) (4) 
Since M is a maximization problem and M*D is a minimization problem, maximizing this expression 
automatically ensures that d(S) = dô(S) and d(S°∗ ) = dô(S°∗ ), and since the optimal objective 
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value of a dual problem is the same as the optimal objective value of its primal, the 
expression dô(S) − dô(S°∗ ) still corresponds to the growth-coupling potential. 
To maintain computational feasibility of the problem, maximum numbers of knock-outs, insertions 
and media modifications, respectively, can be set as constraints on the binary variables. 
OptCouple is implemented in the cameo Python package (Cardoso et al., 2018) for computational 
strain design (https://github.com/biosustain/cameo), and an implementation can also be found in 
the supplementary material. 
5.2.2 Selecting allowed gene insertions and medium supplements 
The set of allowed heterologous gene insertions was obtained from metanetx (Moretti et al., 2016), 
through the universal model interface of the Python package cameo (Cardoso et al., 2018). Only 
reactions with a cross-reference to the BiGG database were used. To avoid drastically increasing 
running times due to the large pool of heterologous reactions, the list of allowed insertions was 
reduced according to the number of allowed simultaneous insertions. If a single insertion was 
allowed, only reactions with metabolites native to the host were allowed. For higher numbers of 
allowed insertions, the heterologous reaction network was pruned such that only reactions whose 
metabolites could be reached with the allowed number of inserted reactions were included. The list 
of allowed medium modifications is specified manually. For all predictions described in this work 
the list comprised fructose, lactate, acetate, and all 20 standard proteinogenic L-amino acids 
5.2.3 Running MILP optimizations 
The MILP problems were optimized using the Gurobi solver (ver 7.5.2) through the optlang interface 
(Jensen et al., 2017). The computations were run on nodes of an HPC cluster equipped with Intel 
Xeon 2660v3 processors and 128 GB memory. The problems were solved to optimality, and 
subsequently reoptimized using Gurobi’s solution pool feature to collect additional optimal and sub-
optimal integer solutions. The second optimization was run with a time-limit approximately ten 
times the running time of the first optimization, up to a maximum of 30 hours. For problems that 
could not be solved to optimality within 30 hours, only as many suboptimal solutions as possible 
were collected from the second run. Each problem was optimized multiple times and the identified 
solutions from each run were all pooled together to increase the number of obtained solutions. 
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Since the identification of integer solutions is not deterministic, and since multiple solutions from 
the same run tend to be similar, this allowed a more diverse sampling of the solution space. 
5.2.4 Reducing solution redundancy 
With other MILP-based algorithms like OptKnock (Burgard et al., 2003), a common practice is to 
gradually increase the number of allowed knockouts, to avoid getting solutions with unnecessary 
knockouts. With three different upper limits on modifications (for knockouts, gene insertions and 
medium supplements, respectively), such a strategy is significantly more time-consuming. Instead, 
a postprocessing workflow was used to identify the predicted modifications in each solution that do 
not contribute to growth-coupling. Each solution was simulated, and each modification was 
removed one at a time. If a modification could be excluded without eliminating growth-coupling, it 
was removed from the solution. Solutions that could be reduced to the same set of modifications 
were merged into a single solution. The remaining solutions were summarized by production and 
growth rates, as well as a production envelope plot. 
5.3 Calculation 
OptCouple is based on an MILP formulation, conceptually similar to the formulations used in existing 
algorithms like OptKnock, RobustKnock and SimOptStrain. MILP formulations are an efficient way 
of optimizing an objective function over a combinatorial space, such as the space of possible genetic 
modifications. The objective function of OptCouple is the growth-coupling potential (Figure 1), 
defined as the amount with which the maximal growth rate will be decreased by preventing the 
target compound from being produced. Using the broadest definition of growth-coupling, 
sometimes called weak growth-coupling, namely that optimal growth requires a non-zero 
production flux (Feist et al., 2010; Klamt and Mahadevan, 2015), production is growth-coupled if 
and only if the growth-coupling potential is strictly positive. Optimizing for the growth-coupling 
potential ensures that the predicted strain designs and medium conditions will be easy to evolve 
with ALE to increase production, as the producing strains will have a large advantage over the non-
producing strains. The algorithm RobustKnock maximises the minimum production at optimal 
growth instead, which also ensures growth-coupling, however the difference in growth rate 
between producers and non-producers can sometimes be marginal. 
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Figure 1: Visual depiction of the growth-coupling potential on a production envelope. 
Most previous methods try to find the single most optimal solution based on the chosen objective 
function. Since the most optimal solution (regardless of the objective function) might not be 
practically feasible for a strain engineering project, OptCouple uses an alternate approach to 
generate a large pool of different growth-coupled designs. These solutions can then be evaluated 
based on multiple parameters in order to find candidate strategies to implement in vivo. The 
workflow of OptCouple is shown in Figure 2. In step 1, before running the MILP optimization, a 
metabolic model must be chosen, as well as the reaction to optimize. Furthermore, the universe of 
modifications must be defined. This includes deciding which native reactions may be knocked out, 
which heterologous reactions can be added, and which modifications to the medium are allowed. 
In step 2, the MILP problem is formulated, with binary variables to represent the allowed 
modifications. In step 3, the problem is solved using a dedicated MILP solver. Since the 
mathematically optimal solution is not necessarily the best strategy for a given metabolic 
engineering project, multiple solutions are identified in a single run, with high computational 
efficiency by using a solver with the capacity to find “solution pools”. Step 4 involves analysing the 
solutions found in step 3 and selecting one or more candidate strategies. Before manual inspection 
the number of solutions is automatically reduced by merging redundant solutions, i.e. separate 
solutions with only trivial differences, and ranking e.g. by growth-coupling potential or potential 
production rate. 
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Figure 2: Overview of the workflow used for predicting growth-coupling designs with OptCouple. 
5.4 Results and discussion 
Initial testing of OptCouple was done to validate the novel objective function based on growth-
coupling potential, and its ability to predict strain designs that are growth-coupled in silico. For this 
case, we chose propionic acid, which is an industrially relevant chemical that has not yet been 
produced biologically in economically viable amounts (Eş et al., 2017), and for which growth-
coupling in E. coli has not been demonstrated. Furthermore, propionic acid is a native metabolite of 
E. coli, avoiding the necessity of first identifying or predicting a production pathway. OptCouple was 
run with a maximum of three knockouts, three insertions and one medium supplement, using a 
demand reaction for propionic acid as target. After removing redundancies in the predictions, two 
promising designs were identified, as seen in Table 1, which both produce propionic acid using the 
propionyl-CoA succinate CoA-transferase (PPCSCT) reaction. The first design, which is illustrated in 
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Figure 3, achieves growth-coupling by establishing propionic acid as a by-product of the supply of 
succinyl-CoA, which is a precursor for the biomass components methionine, lysine and murein. This 
is done by knocking out the native routes of producing succinyl-CoA (AKGDH and SUCOAS) as well 
as the recycling reaction for propionic acid (ACCOAL). The second design couples the PPCSCT 
reaction to the biosynthesis of NAD, establishing production of propionic acid as a by-product. 
 
Figure 3: Overview of the designs predicted with OptCouple for growth-coupling of propionic acid. A) Pathway map of 
one of the predictd designs. Propionic acid production is coupled to succinyl-CoA production through the propanoyl-CoA 
succinate CoA-transferase. Alternative routes to succinyl-CoA are knocked out. B) Production envelope for the design 
shown in A. C) Production envelope of the second growth-coupled design, which couples production of propionic acid to 
the biosynthesis of NAD. 
Both of the strain designs for propionic acid lead to growth-coupling through non-obvious 
combinations of knockouts, but only require knockouts. To demonstrate the full potential of 
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OptCouple and to test its ability to predict designs that are growth-coupled in vivo, we further 
evaluated the algorithm by its ability to identify known and experimentally validated growth-
coupling strategies that require knockouts as well as medium supplements and gene insertions. We 
chose to use the itaconic acid growth-coupling of Harder et al. (2016) (requiring knockouts and 
medium supplement) as well as the product methylation growth-coupling of Luo & Hansen (2018) 
(requiring knockouts, medium supplement and gene insertions). Heterologous production of 
itaconic acid in E. coli can be achieved by the insertion of a single heterologous gene, cadA 
(Aspergillus terreus), encoding an enzyme that decarboxylates aconitic acid into itaconic acid 
(Harder et al., 2016). Growth-coupling has been realised by Harder et al. (2016) by knocking out the 
genes encoding isocitrate lyase, succinyl-CoA synthase, pyruvate kinase and phosphotransacetylase, 
as well as down-regulating isocitrate dehydrogenase. Additionally, Harder et al. (2016) inserted an 
orthologous citrate synthase to prevent allosteric regulation, but since the constraint-based 
modeling framework used here does not account for regulation, this modification was disregarded. 
When these modifications are applied to the iJO1366 genome-scale model of E. coli no growth-
coupling is seen, as maximal growth does not allow for any production of itaconic acid. In order to 
attempt to reproduce the design, we chose to use the reduced metabolic model EColiCore2 
(Hädicke and Klamt, 2017) instead. When the modifications from Harder et al. (2016) are introduced 
into this model, optimal growth does allow for production of itaconic acid, although it is not 
required. 
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Figure 4: Overview of the itaconic acid growth-coupling designs. The red crosses are reactions that were knocked out by 
Harder et al. (2016). The reactions whose names are written in blue are reactions that were commonly knocked out in 
the designs predicted by OptCouple. 
The itaconic acid-producing reaction was added to the model prior to running OptCouple, as the 
scope of this work was not to predict production pathways, but to identify growth-coupling 
strategies for an existing pathway. The algorithm was run, allowing up to six knockouts and a single 
medium supplement. A selection of the solutions is shown in Table 1. The majority of the identified 
designs contained modifications that are consistent with the design by Harder et al. (2016), as 
shown in Figure 4. This includes disrupting the TCA cycle downstream of aconitate, the glyoxylate 
shunt, as well as reactions that can act as a sink for pyruvate or acetyl-CoA. Additionally, the 
algorithm suggested the addition of glutamate or glutamine to the medium, as also required in the 
design by Harder et al. (2016). The similarities between these results and the design by Harder et al. 
(2016) provided an indication that OptCouple can be used to predict combinations of knockouts and 
medium supplements and create functional strategies for coupling chemical production to growth. 
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While the results obtained for growth-coupling of itaconic acid demonstrated the utility of the 
algorithm for predicting knockouts and medium modifications, they did not require prediction of 
gene insertions. To test the ability of OptCouple to predict such modifications, the product 
methylation growth-coupling design of Luo & Hansen (2018) was used. This time the iJO1366 
genome-scale model was chosen, as the modifications suggested by Luo & Hansen (2018) do confer 
growth-coupling in this context. To predict designs for product methylation, a dummy reaction 
converting SAM into S-adenosylhomocysteine (SAH) and an exportable methyl group metabolite 
was created and used as target reaction. The algorithm was run with a single knockout, two 
insertions and one medium supplement allowed. Among the predicted strategies we found a design 
that consisted of the exact same combination of modifications as suggested by Luo & Hansen (2018), 
while designs with several minor variations were also predicted. These variations consisted of 
different knockouts or insertions but resulted in the same general mechanism of growth-coupling, 
by requiring product methylation to convert SAM into SAH as part of the conversion of 
supplemented methionine into cysteine required for biomass production. The ability to predict the 
exact design of the validated methylation growth-coupling, as well as alternative seemingly 
equivalent designs, indicates that OptCouple can reliably be used to predict new feasible growth-
coupling strategies, requiring a combination of gene knockouts, insertions and medium 
supplements.  
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Table 1: Overview of selected predicted growth-coupling strategies for the three test cases. For each design is shown the 
required modifications, the production rate and yield at optimal growth (mmol/gDW/h and mol/mol glucose) and the 
growth-coupling potential, U, i.e. the difference in maximal growth rate between producers and non-producers. The 
knocked out and inserted reactions are denoted by their BIGG identifiers. The supplemented are denoted by standard 
three-letter amino acid abbreviations. 
Knockouts Insertions Supplements Production rate Yield U 
Propionic acid:          
ACCOAL, SUCCOAS, AKGDH     0.50 0.05 0.95 
MCITD, MTHFC, PFL     0.90 0.09 0.91 
      
Itaconic acid:          
GLUDy, ICL, SUCCOAS   L-glu 7.64 0.764 1.10 
GLNS, ICL, SUCCOAS   L-gln 0.24 0.024 1.11 
ACKr, AKGDH, ICL, PGL, POX   L-ile 5.68 0.568 0.29 
AKGDH, G6PDH2r, ICL, MDH, MGSA, PYK   L-asp 6.32 0.632 0.60 
      
Product methylation:          
SERAT CYSTL, CYSTGL L-met 0.10 0.01 1.02 
ASPTA AHSERL2, HSERTA L-met 2.69 0.269 0.97 
 
While the itaconic acid growth-coupling by Harder et al. (2016) results in a high production with 
yields of up to 0.68 mol/mol glucose, the methylation growth-coupling by Luo and Hansen (2016) 
has the disadvantage that only a relatively small flux is forced through the target pathway. Since 
methylation is required for the cell to synthesise cysteine, the growth-coupling will not drive 
methylation to exceed the cellular demand for cysteine which is quite low (Orth et al., 2011). We 
therefore used OptCouple to predict alternative growth-coupling strategies, which would be able to 
force a higher flux through the target methylation reaction. One such strategy was discovered, that 
uses product methylation to convert supplemented methionine into the amino acids aspartate, 
threonine and isoleucine, while disabling the native production of these. This will demand a higher 
flux through the methylation reaction at a given growth rate than the original design coupling 
methylation to cysteine biosynthesis. Figure 5 shows the two growth-coupling designs and their 
respective production envelopes. The production envelope for the alternative design (Figure 5C) 
shows a larger potential production rate by growth-coupling (indicated by the height of the right-
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most point) than the original design (Figure 5B), consistent with the combined higher cellular 
demand for aspartate, threonine and isoleucine compared to cysteine (Orth et al., 2011). 
 
Figure 5: Overview of a subset of the predicted growth-coupling designs for product methylation. A) Pathway map 
showing the mechanisms of two growth-coupling strategies. The design of Luo & Hansen (2018) (orange) converts L-
homocysteine into L-cysteine. The alternative design found here (blue) converts L-homocysteine in to L-threonine, L-
isoleucine and L-aspartic acid. Both designs require supplementing the medium with methionine. B) Production envelope 
of the growth-coupling design of Luo & Hansen (2018). C) Production envelope of the alternative growth-coupling design 
found in this study. 
The above results prove that OptCouple can be used to identify combinations of knockouts, gene 
insertions and medium supplements that make production of various compounds coupled to 
growth in E. coli. The algorithm could easily find designs allowing up to 7 modifications with running 
times less than 24 hours. The fact that OptCouple identifies designs that are identical or very similar 
to prominent, experimentally validated growth-coupling designs indicates that it will also be able to 
find novel valid growth-coupling designs. 
The main novelty and advantage of OptCouple is the possibility of simultaneously identifying 
complex combinations of three different types of modifications. Currently, other strain design 
algorithms exist that attempt to find growth-coupled designs through the identification of one or 
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two types of modifications simultaneously. Recent examples are SimOptStrain (Kim et al., 2011) that 
simultaneously identifies gene knockouts and insertions, whereas SelFi (Hassanpour et al., 2017) 
can suggest all three types of modifications, but only medium supplements and gene knockouts are 
identified simultaneously. Several successful designs, however, such as the product methylation 
growth-coupling (Luo and Hansen, 2018), show that considering all three types of modifications at 
once can enable the identification of new growth-coupling strategies. 
OptCouple guarantees that the resulting designs are truly growth-coupled. This is in contrast to e.g. 
SimOptStrain, which uses the same objective function as OptKnock, and thus does not specifically 
predict growth-coupling, as competing pathways are still allowed. A potential drawback of using the 
growth-coupling potential as objective function in OptCouple is that there is no explicit optimization 
of the target flux that can be achieved by growth-coupling. An example of this issue is seen in the 
identified growth-coupling strategies for propionic acid. The design identified by OptCouple ensures 
the production of propionic acid to supply the cell with either NAD or methionine, lysine and murein, 
all of which are only needed in relatively small amounts. The consequence is that the growth-
coupled production rate of propionic acid will not be sufficient for a commercially viable process, 
given the modest market price of propionic acid (Rodriguez et al., 2014). Even though this limits the 
practical utility of some growth-coupling strategies identified by OptCouple, it does not significantly 
reduce the utility of the algorithm itself. Computationally predicted strain designs should always be 
assessed manually before being implemented in the laboratory, as their feasibility can also be 
affected by a range of factors not considered in the models, e.g. thermodynamics, regulation, 
toxicity, etc. Through the use of suboptimal solution pools, OptCouple can quickly identify many 
design alternatives, which means that many candidate designs are obtained, increasing the 
likelihood that at least one will be deemed feasible and have a high growth-coupled production rate. 
As with all model-based predictions, the quality of the results strongly depends on the quality of the 
model that was used. As one of the most commonly used organisms for metabolic modeling, the E. 
coli genome-scale model is relatively comprehensive. While nothing prevents OptCouple from being 
used in other organisms, the predicted designs should be curated even more thoroughly if a less 
complete metabolic model is used. The in vivo presence of enzymes that are not accounted for in 
the model can effectively abolish the growth-coupling of a predicted design, as they can allow the 
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cell to circumvent the growth-coupling mechanism. Conversely, if a model contains reactions that 
are not active in vivo, e.g. due to transcriptional repression, some growth-coupling strategies will 
require more modifications in silico than they would in practice. This is seen in the experimentally 
validated itaconic acid growth-coupling design (Harder et al., 2016), which does not show growth-
coupling when simulated with iJO1366, whereas the reduced model EColiCore2 did allow 
production at optimal growth. However, during optimization with ALE, repressed reactions could 
become active allowing the cell to circumvent growth-coupling mechanisms predicted with reduced 
models. Therefore, it would most likely be preferable to use the most complete model available for 
the chosen organism. 
5.5 Conclusion 
OptCouple is an MILP-based optimization algorithm that can find combinations of gene knockouts, 
heterologous gene insertions, and additions to the growth medium, that allow the stoichiometric 
coupling of a product of interest to growth. In our validation tests OptCouple was able to reproduce 
successful growth-coupling designs from the published literature and find alternative designs that 
allow for a higher production flux. Furthermore, we showed that OptCouple can be used to predict 
novel candidate growth-coupling designs for target compounds where no growth-coupling has 
previously been demonstrated. 
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5.8 Supplementary Materials 
Mathematical formulation of OptCouple 
The metabolic model used in OptCouple is given by a set of metabolites èG∀	2 ∈ í, and a set of 
metabolic reactions ìî	∀		ï ∈ s. A stoichiometric matrix S encodes which metabolites participate in 
each reaction (Orth et al., 2010). R is partitioned by the three subsets, sJ|*Gù7, s¢7*76I£IñIDc and s|KKG*GIJc, representing native reactions, heterologous reactions and boundary reactions for 
potential medium additions, respectively. Furthermore, some reactions ìî	∀	ï ∈ sG667ù76cGó£7 can 
only proceed in the forward direction, while the remaining reactions can proceed in both directions. 
Each reaction is associated with a binary control variable, 5î ∈ P		∀		ï ∈ s. 
The primal problem (M) optimizes biomass production subject to stoichiometric constraints, limited 
glucose uptake and genetic modifications, Y: 
S&!2è24(w	ÇóGIC|cc  
subject to: 
        ∑ 4Gî ∙ Çîî∈q = 0		∀		2 ∈ í 
        ÇîCGJ ∙ 5î ≤ Çî ≤ ÇîC|} ∙ 5î			∀		ï ∈ 	s 
        Çñ£H_D¶*|ß7 ≤ 10 
        Çî ≥ 0		∀	ï ∈ sG667ù76cGó£7 
        5î ∈ {0, 1}, ∀	ï ∈ s	 
        ∑ (1 − 5î)î∈q®©™L´¨ ≤ TJ|*Gù7 
        ∑ 5îî∈q≠¨™¨ÆØ∞Ø±Ø≤≥ ≤ T¢7*76I£IñIDc 
        ∑ 5îî∈q©¥¥L™LØ®≥ ≤ T|KKG*GIJc 
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The problem can be modified to not allow flux in the target reaction ì*|6ñ7*, resulting in M*: S&!2è24(w	ÇóGIC|cc  
subject to: 
        ∑ 4Gî ∙ Çî = 0,|q|îb] 			∀		2 ∈ í 
        ÇîCGJ ∙ 5î ≤ Çî ≤ ÇîC|} ∙ 5î,					∀		ï ∈ 	s 
        Ç*|6ñ7* = 0 
        Çñ£H_D¶*|ß7 ≤ 10 
        Çî ≥ 0,				∀	ï ∈ sG667ù76cGó£7 
        5î ∈ {0, 1}, ∀	ï ∈ s 
        ∑ (1 − 5î)î∈q®©™L´¨ ≤ TJ|*Gù7 
        ∑ 5îî∈q≠¨™¨ÆØ∞Ø±Ø≤≥ ≤ T¢7*76I£IñIDc 
        ∑ 5îî∈q©¥¥L™LØ®≥ ≤ T|KKG*GIJc 
 
M* can then be converted to its dual form, S°∗  (as described by Burgard et al. (2003)): S232è24(µ,∂	10 ∙ Öñ£DHIc7_D¶*|ß7  
subject to: 
        ∑ ∑Gc*IGH¢ ∙ 4Gî + Öî = 0,				∀	ï ∈ s,			ï ≠ ,2?è&44|r|Gb]  
        ∑ ∑Gc*IGH¢ ∙ 4G,óGIC|cc + ÖóGIC|cc = 1|r|Gb]  
        ÖîCGJ ∙ 11 − 5î9 ≤ 	Öî ≤ 	ÖîC|} ∙ (1 − 5G),				∀	ï ∈ s, ï ≠ #&ì@(#  
        5î ∈ {0, 1}, ∀	ï ∈ s 
        ∑ (1 − 5î)î∈q®©™L´¨ ≤ TJ|*Gù7 
        ∑ 5îî∈q≠¨™¨ÆØ∞Ø±Ø≤≥ ≤ T¢7*76I£IñIDc 
        ∑ 5îî∈q©¥¥L™LØ®≥ ≤ T|KKG*GIJc 
 
Here ∑Gc*IGH¢ represent dual variables of the stoichiometric constraints in the primal, while ÖG  
represent other flux bounds. The minimum and maximum values, ÖîCGJ and ÖîC|}  as well as 
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ÇîCGJ	and ÇîC|}can be found by sequentially minimizing and maximizing the variables or by using a 
sufficiently large constant (the big-M method). 
The two problems S and SK∗  are combined and optimized simultaneously, together with the binary 
variables Y: 
 S&!2è24(w,∂,µ,π	ÇóGIC|cc − 10 ∙ 	Öñ£DHIc7_D¶*|ß7    OptCouple 
subject to: 
        ∑ 4Gî ∙ Çî = 0|q|îb] 	∀		2 ∈ í 
        ÇîCGJ ∙ 5î ≤ Çî ≤ ÇîC|} ∙ 5î			∀		ï ∈ 	s 
        Çñ£H_D¶*|ß7 ≤ 10 
        Çî ≥ 0		∀	ï ∈ sG667ù76cGó£7 
        ∑ ∑Gc*IGH¢ ∙ 4Gî + Öî = 0,				∀	ï ∈ s,			ï ≠ ,2?è&44|r|Gb]  
        ∑ ∑Gc*IGH¢ ∙ 4G,óGIC|cc + ÖóGIC|cc = 1|r|Gb]  
        ÖîCGJ ∙ 11 − 5î9 ≤ 	Öî ≤ 	ÖîC|} ∙ (1 − 5G),				∀	ï ∈ s, ï ≠ #&ì@(#  
        5î ∈ {0, 1}, ∀	ï ∈ s 
        ∑ (1 − 5î)î∈q®©™L´¨ ≤ TJ|*Gù7 
        ∑ 5îî∈q≠¨™¨ÆØ∞Ø±Ø≤≥ ≤ T¢7*76I£IñIDc 
        ∑ 5îî∈q©¥¥L™LØ®≥ ≤ T|KKG*GIJc 
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Concluding remarks 
Adaptive laboratory evolution (ALE) can be a valuable addition to rational engineering during 
development of microbial cell factories. Sequencing of evolved isolates can reveal new engineering 
targets for the evolved phenotype that could not have been predicted from preexisting knowledge. 
Additionally, studying the evolved strains can yield insight into the mechanisms with which the 
targeted phenotype improved. 
In this thesis, it was shown that ALE could be used to improve chemical tolerance of Escherichia coli 
– a phenotype that is difficult to engineer rationally due to a lack of knowledge about toxicity 
mechanisms. The concentrations of chemicals that the evolved strains could tolerate were high 
enough to be relevant in the context of bioproduction. Although only little information could be 
gained about the mechanisms of tolerance, cross-compound screenings revealed that tolerance to 
one compound tends to be generalizable to a wide range of chemically similar compounds. This 
demonstrates that it is possible to use broadly tolerant platform strains for production of several 
products, without having to evolve tolerance to each individual product. For two compounds it was 
also shown that some evolved tolerant strains were able to produce the respective compounds at 
higher rates than the background strain, further demonstrating the utility of ALE in cell factory 
development. 
Metabolomic characterization of the evolved strains showed a high degree of convergent evolution 
on the metabolic level despite only limited convergence on the genetic level. This suggests that 
metabolism plays a significant role in tolerance against the tested chemicals. The metabolic profiles 
of the evolved strains were also used to develop a method for predicting the impact of a mutation 
on the gene that it affects. This method can be beneficial in interpreting the mutations that are 
observed after an ALE experiment and is not limited to strains evolved for tolerance. Another 
method for interpreting mutations observed in ALE was presented, which was based on deep neural 
networks. While artificial intelligence and machine learning have the potential to revolutionize the 
field of metabolic engineering like it has other fields, it is still limited by the comparatively small 
datasets available in biology. 
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The greatest challenge of using ALE in cell factory engineering is finding ways to select for the 
phenotype that is to be improved. In particular it is desirable to be able to select for mutants that 
produce a target compound at high rates. This is possible by making production coupled to growth 
such that the target compound becomes a necessary by-product. Although growth-coupling 
production usually requires complicated rewiring of metabolism, it can be done through the use of 
mathematical models of metabolism. This thesis presented a new model-based algorithm for 
identifying genetic modifications that cause growth-coupling in combination with one or more 
supplements to the growth medium. The algorithm allowed prediction of promising design 
strategies for growth-coupling, however these strategies need to be validated in vivo and are not 
guaranteed to work. Future work might focus on directly integrating experimental data into 
algorithms for predicting growth-coupling in order to improve predictions and make the predicted 
designs more likely to function in vivo, which would further increase the effectiveness of ALE for cell 
factory development. 
 
 
